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Ageing affects every individual and the world’s ageing population is 
estimated to double by 2050.  Research in ageing would provide insights as to 
how the quality of life of aged individuals can be improved.  Ageing research 
can generally be approached in two ways – the study of extended life models 
or the study of accelerated aging models.   One of the most drastic accelerated 
ageing model in human is the Hutchinson Gilford Progeria Syndrome (HGPS).  
Most HGPS cases are caused by a splicing defect in exon 11 of the LMNA 
gene that results in a truncated form of Lamin A protein that remains 
farnesylated.   
In this thesis, ageing research is pursued by looking at mouse models 
of accelerated ageing and human in-vitro system.  The Lmna9 mouse model 
was previously established and similar to HGPS, it expresses a truncated 
Lamin A protein that retains the farnesyl group.  The Lmna9 mice shows a 
similar phenotype to HGPS patients and were found to be defective in ECM 
production.  Subsequently it was identified that Wnt signalling was affected 
with the reduction of LEF-1 levels. One striking feature discovered was the 
increased occurrence of apoptotic cells in the smooth muscle cell (SMC) layer 
of great vessels in the Lmna9 mice.  In turn, a SMC specific expressing 
Lmna9 mouse model was generated. SMC-specific expression of Lmna9 
resulted in an accelerated ageing phenotype.   
Lamin A associates with other nuclear envelope proteins such as the 
LINC complex which plays an important role in nuclear and cytoskeletal 
structure, and providing vital functional roles in nuclear positioning and 
chromatin organization.  LINC complex consists of two major groups of 
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proteins, the first being the Syne/Nesprin/KASH family and second, the SUN 
(Sad-1 UNC-84) domain proteins.  Knockdown of SUN1 in Lmna9 mice 
showed a surprising improvement of phenotype as compared to the original 
Lmna9 genotype. One interesting finding was that in the Lmna9 fibroblasts, 
SUN1 protein was found at the NE and at increased levels in the Golgi.  
Human HGPS fibroblasts also showed higher SUN1 expression level as 
compared to control cells.  
In the human in vitro studies, lineage specific SMCs were 
differentiated from previously established induced pluripotent stem cell (iPSC) 
lines.  Separately, progerin was expressed in transfected SMCs obtained 
commercially.  Preliminary 3T3 assays carried out on the lineage specific 
SMCs showed that in the HGPS-VSMCs, lateral mesoderm lineage has the 
slowest proliferation rate as compared to the paraxial mesoderm (PM) and 
neuroectoderm (NE) lines. 
A novel progeric mouse model, E145K mouse, was generated.  
Homozygous E145K mice remained small compared to controls and they 
stopped gaining weight from 6 months onwards, progressively reducing 
weight over time and dying at 1 year.  Proliferation rates of E145K fibroblasts 
were slower compared to controls.  E145K fibroblasts showed  extensive 
lobulation in the nuclear envelope while histone and centromeres were 
clustered in the central region of the nucleus.  One striking feature observed 
was that E145K mice showed a reduction in the percentage of fat mass after 6 
months of age.  By studying the accelerated ageing mouse models and human 
in-vitro systems, we hope to gain a greater insight into the role of Lamin A 
during ageing.   
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Chapter 1: General Introduction 
1.1  Ageing Populations 
Ageing is an inevitable event that affects all individuals and is 
considered a major risk factor in the development of many chronic medical 
conditions [1].  It is estimated that by 2050, more than half of the world 
populations would consist of 25% or more individuals aged 65 and above 
(Figure 1.1). Globally, the number of older persons is expected to more than 




The increase in ageing populations will have significant consequences 
on a broad range of economic, political and social processes.  In the Second 
World Assembly on Ageing in 2002, the Madrid International Plan of Action 
Figure 1.1 Proportion of Population aged 60 or Over in 2014 and 2050.  These maps show the proportion of 
population aged 60 or over in 2014 and 2050 and demonstrate the speed at which populations are ageing.  Source: 





(MIPAA) which was adopted emphasizes that the first and foremost priority in 
preparing for an ageing population is to promote the well-being of the growing 
number and proportion of older persons in most countries of the world [2]. 




1.2 Ageing Theories 
The earliest theories on ageing were proposed in the nineteenth century 
by Alfred Wallace and Charles Darwin.  They had proposed the theory of 
evolution where natural selection is the driver of biologic changes [3].   
The mutation accumulation mechanism was proposed by Nobel 
Laureate Peter Medawar in 1952.  In his proposal, natural selection has no 
effect on mutations that do not have detrimental effects until later in life, and 
such mutated genes accumulate over time and promote aging [4].  In 1956, 
Denham Harman described the free radical theory which later developed to 
become the oxidative stress theory. These theories attributed aging to the 
damaging effects of metabolism-induced reactive compounds.   
Another theory proposed in 1957 is the antagonistic pleiotropy theory, 
which proposed that genes that promote reproduction might be selected for, 
even if they induce a disadvantage (aging) later in life [4]. August Weissman 
later proposed that somatic and germ cell lines have different fates during 
organismal life which was later known as the wear-and-tear theory of ageing.   
The disposable soma theory was proposed by Thomas Kirkwood in 1977.  
This theory proposed that higher organisms develop differential kinetic 
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proofreading and accuracy-promoting mechanisms in somatic and germ lines.  
In somatic cells, reduced accuracy allows energy saving and accelerated 
development and reproduction, with the consequence of eventual deterioration 
and death.  On the other hand, high level of accuracy is maintained in germ 
cells, and any defective cells are eliminated [4, 5].  
 Replicative senescence is a mechanism that leads to the systematic and 
irreversible growth arrest of human primary cells after a finite number of 
divisions during cultivation [6].  It was first proposed by Hayflick and it was 
later revealed that replicative senescence was only one aspect of cellular 
senescence.  Cellular senescence is now characterized by (i) permanent cell 
cycle arrest, (ii) induction of cyclin dependent kinase inhibitors such as p21 
and p16, (iii) the expression of senescence-associated beta galactosidase, 
morphological and metabolic alterations, significant chromatin and nuclear 
remodeling, changes in the transcriptional program of the cell and secretion of 
specific inflammatory factors such as Interleukin-6 (IL-6).  Cellular 
senescence increases with age and can be induced by various forms of 
molecular damage and stress, suggesting its major role in aging associated 
phenotypes [4]. 
 The DNA damage response (DDR) is a collection of mechanisms 
which are required to maintain the integrity of the genome and epigenome in 
response to genotoxic stress.  The consequences of DDR include either 
temporary/permanent cell cycle arrest or failure to repair the DNA damage 
programmed cell death.  DNA repair can be error prone, introducing both 
mutations and epimutations (ie the abnormal transcriptional repression of 
active genes and/or abnormal activation of usually repressed genes caused by 
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errors in epigenetic gene expression).  The increased occurrence of 
epimutations in aged tissues favors cellular degeneration and uncontrolled cell 
proliferation and thereby potentially inducing both a progressive decline in 
organ function [4, 7].  Many progeroid syndromes such as ataxia-
telangiectasia, Werner syndrome [8], Hutchinson Gilford Progeria Syndrome 
(HGPS) and restrictive dermopathy [9] have defective DDR and genomic 
instability resulting in a premature ageing phenotype [4]. 
 It was only when telomeric structures and telomerase were discovered 
that the disposable soma theory was validated.  At the same time, this 
provided a potential link between senescence and ageing.  Telomeres, which 
cap the ends of chromosomes, are nucleoprotein structures containing 
repetitive hexameric  TTAGGG repeats and the shelterin complex [1, 4, 10].  
Telomeres shorten with every round of cell division because of the ‘end 
replication problem’.  When telomeres reach a critical length, DNA damage 
response is induced and proliferation is inhibited via replicative senescence or 
apoptosis [4, 11, 12].  Shortened telomeres affect the regenerative capacity of 
tissues and are associated with ageing and medical conditions such as aplastic 
anemia, pulmonary fibrosis and Dyekratosis Congenita [1, 13, 14]. 
 On the other hand, immortalized cells typically contain telomerase 
which maintains telomere length.  Telomerase is a ribonucleoprotein 
consisting of a reverse transcriptase (TERT) and its RNA moiety (TERC).  
Examples of telomerase containing cells include germ cells, stem cell and 85% 





1.3  Ageing Research 
There are generally two broad approaches in ageing research.  The first 
approach focuses on factors or models that increase lifespan while the second 
approach focuses on the study of accelerated ageing models.  The methods 
used in both categories frequently use genetic approaches, including the 
derivation of mutants in model organisms, dietary regulation and/or drug 
treatments [15].  Dietary restriction, which involves the reduction of food 
intake without malnutrition, has been shown to extend the life span of a 
diverse range of organisms including yeast, flies, worms, fish, rodents, and 
rhesus monkeys (Figure 1.2) [15].  
 In humans, data collected from individuals practicing long-term calorie 
restriction, without malnutrition, indicate that these individuals have 
significantly improved ventricular diastolic function and heart rate variability 
indexes, which are two accepted parameters of cardiovascular ageing. Based 
on these indexes these individuals have been reported to have a profile of that 
of individuals 20 years younger on a typical Western diet [16-18].  In addition, 
recent data suggested that those who practice calorie restriction have a skeletal 
muscle transcriptional profile resembling those of much younger individuals 
[18, 19] .  Of significance, several inflammatory genes, transcripts in the IGF-
1(insulin growth factor)/Insulin/FOXO pathway and those regulating AKT 
phosphorylation were down regulated in these individuals undergoing calorie 
restriction [18, 19].  Mutations that decrease the activity of nutrient-sensing 
pathways, particularly in the IGF /insulin and TOR (target of rapamycin) 
pathways, extend lifespan in many organisms, as first discovered in the worm 
(C. elegans) and subsequently in the fruitfly (Drosophila melanogaster) [15].  
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Mice with mutations in growth hormone (GH) and insulin/IGF-like signaling 
also show a significantly increased lifespan [15, 20]. GH deficient mice show 
increased expression of anti-oxidant enzymes and increased stress resistance 





While mutations that extend lifespan are likely to affect the rate of 
ageing, those that reduces lifespan either alters aging or increase the risk of a 
particular disease [22].  Therefore, the approach in studying accelerated ageing 
models focuses more on phenotypic features of the model organisms which 
best represent ageing to investigate the molecular causes and effects, and to 
discover potential interventions. Examples of genetic mutations in mice that 
Figure 1.2 Dietary and Genetic Alternations Increase Healthy Lifespan of Laboratory Animal Models. 
Experiments on dietary restriction (DR) and genetic or chemical alteration of nutrient-sensing 
pathways have been performed on a range of model organisms. The results differ widely, and little is 
known about the long-term effects in humans. Adapted from Luigi Fontana et al. Science 2010.   
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decrease longevity and appear to accelerate ageing are listed in Table 1.1.  
The role of these genes highlights the importance of maintaining DNA 
stability and preventing anti-oxidative stress to regulate aging and longevity 
[22].  Reduced expression of PolgA in mice results in an increase in 
mitochondrial DNA mutations while knockouts of Msra and Prdx1 in mice 




1.4 Premature Ageing Diseases in Humans  
There are five premature ageing diseases that have been described. 
These include ataxia-telangiectasia, Werner’s syndrome [8], Hutchinson 
Gilford Progeria (HGPS) , Cockayne syndrome and restrictive dermopathy.  
Two established premature ageing diseases in humans which are best 
characterized in relation to accelerated ageing are Werner’s Syndrome and 
HGPS.  Werner’s Syndrome is a rare autosomal recessive disorder that results 
in the prototypic human segmental progeroid syndrome and is caused by 
Table 1.1 Mutations in Mouse Genes that Reduce Longevity. Adapted from Yuan R et al. ILAR J. 2011. 
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mutations in the Werner RecQ helicase, a DNA helicase/exonuclease [26].  
Werner Syndrome patients are born normal and usually show no medical 
problems in their childhood.  However, growth retardation usually occurs on 
the onset of puberty and an aged appearance is associated with short stature, 
premature graying and loss of hair, cataracts, susceptibility to tumor 
formation, scleroderma-like skin changes and regional atrophy of 
subcutaneous fat (Figure 1.3) [26, 27].   
 Werner syndrome patients develop significant age-related diseases, 
including several forms of arteriosclerosis and hypogonadism, malignant 
neoplasm, bilateral ocular cataracts, diabetes mellitus, osteoporosis [26, 27].  
On the other hand, unlike normal ageing, these patients also show 
disproportionately severe osteoporosis of the limbs and increased occurrences 
of non-epithelial neoplasms.  Additional unusual clinical features include 
ulcerations around the ankles and soft tissue calcification [28-30]. Fibroblasts 
derived from these patients show a reduced replicative life-span as compared 
to fibroblasts derived from age-matched controls. The growth properties of 
these cells have been reported to be similar to the life-span of fibroblasts taken 










While the function of Werner syndrome, RecQ helicase-like gene 
(WRN) is still not well established yet, accumulating evidence suggests that 
WRN function may be of particular importance in telomere maintenance [27, 
31].  Mice deficient for both Wrn and telomerase gene (tert), (Wrn null mice 
alone have no overt phenotype) show accelerated aging phenotypes, and 
suggest the involvement of WRN in mammalian ageing [27, 32] . 
 A more severe form of premature ageing is Hutchison Gilford Progeria 
Syndrome (HGPS).  HGPS is caused by mutations in the Lamin A (LMNA 
gene), with the most common being the G608G mutation [33]. Other 
mutations in the LMNA have given rise to at least 7 other types of disease and 
are collectively called the Laminopathies. 
Figure 1.3 Werner Syndrome patients with homozygous WRN mutations. (Top) A Caucasian female with 
homozygous deletion of nucleotides 2089 to 2825 (c.2089-2825del; p.M696fsX705) in the region of the 
cDNA encoding the helicase domains resulting in a frameshift beginning with Met696 and in a premature 
stop codon in the protein. (Bottom) A Caucasian male with a homozygous mutation with deletion of eight 
nucleotides in exon 9 (c.867-874del AGAAAATC; p.I288fsX301) resulting in a protein frameshift 
beginning with Ile288and introducing a premature stop after codon 301. Notice the bandage for the ankle 




1.5 The Nuclear Lamina 
In cells, nuclei are enclosed by the nuclear envelope (NE), which 
consists of the inner nuclear membrane (INM) and outer nuclear membrane 
(ONM). The membranes are connected where they are traversed by the 
nuclear pore complexes, and together with the endoplasmic reticulum (ER), 
form a contiguous membrane system.  Underlying the INM is a network of 
intermediate filament proteins that form the nuclear lamina (Figure 1.4A).  
This nuclear lamina may be directly attached to the INM, by the farnesyl 
residues at the c-termini of the lamins and by interactions with integral 
membrane (INM) proteins [34]. The major components of the nuclear lamina 
are the nuclear lamins.  In mammals, nuclear lamins fall into 2 categories – 
type A and type B Lamins (Figure 1.4B).  Lamin-A and Lamin-B are type V 
intermediate filament proteins that are found exclusively in the nucleus.  Two 
unlinked genes, LMNB1 and LMNB2 encode the B-type Lamins – B1 and B2 
respectively [35-37].  Lamin B3, a splice variant of Lamin B2, is expressed in 
mammalian male germ cells and is believed to contribute to the characteristic 
morphology of sperm nuclei [38].  A-type Lamins are formed through 
alternative splicing of a single transcript encoded by the LMNA gene.  The 
four transcripts are Lamin A, Lamin C, Lamin AΔ10 and Lamin C2 [39-42]. 
Both Lamin A and C usually appear to be incorporated into the nuclear lamina 
in equal amounts [43] although Lamin A levels are reduced (relative to Lamin 
C levels) in neurons of the central nervous system[44].  On the other hand, 
Lamin AΔ10 and Lamin C2 are minor products with Lamin C2 being specific 
to the male germline [45]. Individual lamins self-associate and form coiled-
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coil homodimers that assemble, in a head –to-tail fashion, into longer 
filaments.   
During synthesis, Lamins A, B1 and B2 undergo a series of sequential 
post-translational modifications.  Each of these proteins contains a C-terminal 
CaaX motif that undergoes enzymatic processing, starting with the addition of 
a farnesyl group to the cysteine by a farnesyltransferase [46, 47].  
Subsequently, the –aaX amino acids are cleaved by ER-associated 
endoproteases Rce1 and Zmpste24 (FACE1) acting on Lamin A.  The 
isoprenylated cysteines are then methylated by an ER associated 
methyltransferase, isoprenylcysteine carboxyl methyltransferase (ICMT).  
Speculatively, these modifications result in Lamin A, B1 and B2 becoming 
hydrophobic, facilitating their subsequent association with the INM [43].  
Unlike the B-type Lamins, Lamin A subsequently undergoes further 
endoproteolytic cleavage, by the enzyme ZMPSTE24 that removes an 
additional 15 amino acids, including the farnesylated and methylated cysteine, 
to produce mature Lamin A [48-50] (Figure 1.4C).  The sequential  
posttranscriptional processing of the carboxy terminal of prelamin A is 
therefore important for function [51].   Lamin C lacks the CaaX domain and is 
thought to be dependent on the presence of Lamin A for its assembly into the 
nuclear lamina [52, 53].  However, a mouse line expressing only Lamin C has 
been reported to be overtly normal [54].  Throughout development, every 
mammalian cell expresses either Lamins B1 or B2 (or both), while A-type 
lamins are expressed in differentiated somatic cells, with the exception of 
some adult stem cells and most white blood cells[55].  A-type lamins are novel 
markers of stem cell differentiation [56], and this highlights their possible role 
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in regulating chromatin reorganization and gene transcription necessary for 
cell fate determination [56]. It has been reported that mouse Lmna gene has 
83% identity in the open reading frame when compared with human [57].  
With reference to Progerin, introduction of the human HGPS mutation at the 
same mutation in the mouse as in the human Progerin strongly increased the 
accessibility of the terminal loop as found for human pre-mRNA[57].  These 
findings suggest the functional importance of the conserved terminal loop 












Figure 1.4 Lamins are the Major Components of the Nuclear Lamina.  (A) Native nuclear lamina of 
Xenopus oocytes. Freeze-dried/metal shadowed nuclear envelope extracted with Triton X-100 revealing 
the nulear lamina meshwork partially covered with arrays of nuclear pore complexes.  Adapted from Aebi 
et al. Nature 1986. (B) Structures of the mammalian lamins consisting of a central rod domain flanked at 
either end by globular domains. Only lamin A undergoes a second proteolytic cleavage step (P2) that 
removes the farnesylated cysteine. P, protease cleavage site; NLS, nuclear localization sequence.  (C) The 
sequential posttranslational processing of the carboxy terminal of prelamin A. The C-terminal amino acid 
sequence is shown, as is the order of each step with farnesylation of the cysteine in the CaaX domain being 
the first step. The second step involves cleavage of the terminal—SIM peptide by either Rec1 or 
Zmpste24. Thirdly, the terminal cysteine is methylated by ICMT. The fourth and last step involves 
cleavage of the terminal, farnesylated and methylated 15 amino acid peptide byZmpste24 to produce the 
mature lamin A protein. (B) and (C) Adapted from Burke, Stewart. Curr Top Dev Bio. 2014 
13 
 
1.5.1 The LINC Complex 
The lamins are associated with many INM proteins including Emerin, 
lamina-associated polypeptides (LAPs) and MAN1 (Figure 1.5). However 
these are only a subset of the potential proteins as more than 70 INM proteins 
have been described [58].  Emerin, Man1 and Lap2, which are all LEM (Lap2, 
Emerin, Man1) domain proteins, interact with chromatin/DNA by binding the 
small protein BAF (barrier-to-autointegration factor).  BAF crosslinks and 
compacts DNA, in a sequence independent manner, suggesting a role in 
regulating and localization of heterochromatin [43, 59].  On the other hand, 
Lamin B receptor (LBR) binds to heterochromatin via the chromodomain 
protein HP1, which in turn binds to methylated histones associated with 
heterochromatin, thereby mediating DNA/chromatin attachment to the NE [43, 
60].  In a recent paper [61], it was reported that LBR and A-type lamins 
function in directly/indirectly by tethering of heterochromatin to the nuclear 
periphery.  It was suggested that Lamin A tethers heterochromatin by acting as 
a scaffold for the LEM domain proteins [61].   
 Another major complex of NE proteins is the LINC (LInkers of 
Nucleoskeleton and Cytoskeleton) complex.  The LINC complex consists of 
two major groups of proteins, the first being the Syne/Nesprin/KASH 
(Klarsicht ANC-1 Syne Homology) family and second, the SUN (Sad-1 UNC-
84) domain proteins [51, 62, 63].  LINC complex plays an important role in 
tethering the interphase nucleus to the cytoplasmic cytoskeleton, thus 
providing vital functional roles in nuclear positioning and chromatin 








1.5.2 KASH-SUN Domain Interaction  
In mammals, six different KASH-domain proteins have been identified 
to date [63, 64].  KASH-domain proteins (or Synes, Nesprins) reside in the 
ONM and where they protrude into the cytoplasm. The KASH-domain 
proteins differ significantly in their cytoplasmic domains and in their tissue 
distribution.  Despite these differences, the transmembrane and KASH 
domains are highly conserved between many species [63, 65].  KASH domain 
proteins are single-pass transmembrane proteins with their highly conserved 
C-terminus KASH domain residing in the perinuclear space (PNS) between 
the INM and ONM of the NE.  The KASH-domain proteins interact with C-
termini of the SUN-domain proteins in the PNS to form the LINC complex.  
The N-terminus of the SUN-domain proteins resides in the nucleoplasm and 
may interact with INM proteins, chromatin and the nuclear lamina.  SUN-
domain proteins have been identified as single-pass type II transmembrane 
proteins and to date, there are five different SUN proteins [63, 64]. Figure 1.6 
Figure 1.5 Diagram of NE/lamina with the localization of some of the proteins associated with the NE. 
Underlying the inner nuclear membrane is the 20–50-nm thick lamina, comprised of the lamins. 
Associated with the ONM, INM, and lamina are various proteins, with many connecting the INM to 




shows a summary of the six different KASH-domain proteins and the 
corresponding SUN1/SUN2 binding partners.   
Recent structural analysis showed that SUN proteins form trimers, 
which are essential in creating a KASH-domain binding pocket.  KASH-
domain binds to a deep groove formed from two adjacent SUN domain 
proteins [63, 64, 66]. Any mutation in the KASH-domain which affects the 
critical contact points between the KASH and Sun domain proteins would 
prevent the binding [63, 64].  The presence of hydrophobic residues in the 
KASH domain protein that binds to specific parts of the SUN-domain 
proteins, and a conserved cysteine residue in the KASH domain, enhance the 
binding between the two proteins [63, 64].  In addition, the presence of 
dimerization motifs in the KASH domain proteins allows homo-dimerization.  
This characteristic of the KASH domain proteins serves as a mechanism for 
formation of higher order SUN-KASH complexes [63-66].  However, the 
regulation of this SUN-KASH interaction and its disassembly are still not well 
understood.   
1.5.3 KASH-Domain Proteins 
In mammals, there are 6 KASH-Domain proteins - Nesprin-1/Nesprin-
2, Nesprin-3, Nesprin-4, Jaw1/LRMP and KASH-5.  Full length Nesprin-1 and 
Nesprin-2 isoforms are about 1MDa and 800kDa respectively.  However, there 
are smaller splice variants and they maybe functionally different from the full-
length isoforms, in that they localize to specific cellular compartments and are 
expressed in a tissue specific manner [63, 67, 68].  Nesprins-1 and Nesprin-2 
are expressed in cardiac, skeletal, smooth muscle and in the muscle nuclei at 
neuromuscular junctions (NMJs) [63, 69, 70]. Nesprin-1 and Nesprin-2 
16 
 
interact with the molecular motor proteins Kinesin-1 and Dynein, and also to 
F-actin through amino-terminal calponin homology domain [63, 68, 71].  
Nesprin 3 is a type II transmembrane protein and interacts with the 
intermediate filament network via the adapter protein, plectin [72].  There are 
2 isoforms of Nesprin-3 – Nesprin-3α and Nesprin 3-β [72, 73] with 3α being 
the principal isoform that bind plectin [72, 74].  Nesprin-4 is expressed in hair 
cells of the cochlea and secretory epithelia including mammary tissue, 
exocrine pancreas and salivary glands [75, 76].  Nesprin-4 interacts with the 
kinesin heavy and light chains, a plus end microtubule molecular motor 
protein.  Jaw1 or LRMP (Lymphoid Restricted Membrane Protein) was first 
identified in the ER membrane of B and T cells [77].  LRMP is also localized  
to taste receptor cells and together with the type III inositol 1,4,5-triphosphate 
receptor regulate the calcium cascade in taste signaling [63, 78]. KASH5 or 
Ccdc155, interacts with the  minus end microtubule motor proteins dynein and 
dynactin. Ectopic expression in mammalian cells leads to the centromere 
moving closer to the nucleus [63, 76, 79].  KASH5 is predominantly expressed 
in developing spermatocytes.  KASH 5 forms a functional LINC complex with 
SUN1 in spermatocytes that couples the telomere ends of chromosomes to the 
cytoplasmic Dynein motor protein to facilitate chromosome pairing and 
bouquet formation where all the telomeres cluster under the cytoplasmic 










1.5.4 SUN-Domain Proteins 
Currently, there are 5 SUN-domain proteins – SUN1, SUN2, SUN3, 
SUN4/SPAG4, SUN5/SPAG4L have been identified. SUNs1 and 2 are found 
in the INM, whereas the other SUN proteins are thought to be primarily 
located in the ER. SUN1 is expressed in many tissues and it interacts with at 
least five of the KASH-domain proteins [63, 64].  SUN1 was first identified in 
Caenorhabditis elegans as UNC-84 and was later confirmed to be a 
component of the INM LINC complex, and is required for proper NE 
localization of KASH/Nesprin 2 [63, 81-83]. Recently, more than 7 spliced 
isoforms of SUN1 has been identified with many showing tissue specific 
patterns of expression in the testis, muscle, and brain [63, 84].  SUN2 also 
Figure 1.6  Mammalian LINC complex proteins. The six known KASH-domain proteins are shown 
with their respective SUN1/2 binding partners. Also shown are the cytoskeletal components with which 
the KASH-domain proteins have been shown to interact. Nesprin-1 and -2 interact with filamentous 
actin, and also with microtubules via the molecular motor proteins dynein and kinesin. Nesprin-4 
interacts with the microtubule network via kinesin, and KASH5 interacts with  icrotubules via dynein. 
Nesprin-3 interacts with the intermediate filament network via the adapter protein  plectin. No 
cytoskeletal interactions have been reported for LRMP. Adapted from Horn H. Curr Top Bio Dev. 2014 
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interacts with Nesprins-1-3, and is expressed in a variety of tissues [63, 64]. 
Both SUN2 and Nesprin-2G are responsible for the anchoring transnuclear 
actin cables (TAN) lines to the nuclear surface [63, 85-87].  SUN2 anchors 
Nesprin-2G to the nucleus.  Nesprin-2G is the only actin-binding nesprin in 
migrating fibroblasts [63, 85].  SUN2 also interacts with Rab5 in a SUN-
domain dependent manner.  A knockdown of SUN2 disrupts transferin 
mediated endocytosis, suggesting a role in cellular functions outside the INM 
and may be important for vesicle formation and endocytosis [88] . Rab5 is a 
small GTPase that has many important roles in endocytosis and membrane 
dynamics [63, 88-90].  While synaptic nuclear anchorage in mice is partially 
perturbed in SUN1, but not in SUN2, deleting both SUN1 and SUN2 results in 
perinatal lethality and disruption in both synaptic and non-synaptic nuclear 
anchorage.  This highlights the critical function of SUN1 and Sun2 in skeletal 
muscle cell for Nesprin 1 localization at the NE [91]. SUN3 is mainly 
expressed at the posterior side of the developing sperm head in the testes.  
SUN3 may form a functional LINC complex with Nesprin-1 [63, 84].  
However, the functional significance of SUN3 is yet to be determined. 
SUN4/SPAG4 has been shown to be predominantly expressed in rat 
spermatids and interacts with Odf1.  Odf1 is a protein in the outer dense fibers 
(ODF) of the spermatozoan flagellum [63, 92].  Similar to SUN3, the roles of 
SUN4 is still not understood yet.  SUN5/SPAG4L/SRG4 has been suggested 
to play an important role in the correct positioning of the acrosome and is 
expressed only in spermatocytes, and round spermatids. However, when the 
spermatids elongate, the expression of SUN5 decreases [63, 93, 94].  A 
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summary (Table 1.2) of all the different types of Nesprins and SUN protein 
interactions across many species [64].   
 The LINC complex acts as a NE bridge tethering the nucleus to the 
interphase cytoplasmic cytoskeleton, so forming a direct physical link between 
the nucleoplasm and cytoskeletal network.  The LINC complex plays vital 
functions in nuclear positioning, migration and chromosome organization.  
Some of the roles of the LINC complexes are that they determine nuclear 
morphology, membrane  and cytoskeletal organization, transmission of forces 
at the NE, and positioning of the nucleus – including movement in syncytia, 
nuclear migration in development, cell polarization, and pronuclear migration 
and fusion following fertilization in the zygote [64].  In contrast the 
KASH5/SUN1 LINC complex organizes chromosomes by tethering 
chromosomes to the NE during bouquet formation in meiosis I [64].  LINC 
components may also regulate pathways such as Wnt signaling[95], ERK 
signaling [96], cell division and apoptosis [64].  A summary of the roles and 









Figure 1.7 Cellular functions of LINC complexes. A. Nuclear morphology. LINC complexes are 
required to maintain nuclear size and shape in mammals and in A. thaliana, as well as structure and 
integrity of the mammalian NE. B Cytoskeletal organization. LINC complexes influence structure and 
distribution of perinuclear actin and intermediate filaments (IFs) in vertebrate cells, and tether 
centrosomes to the NE in various metazoans. C Force transmission. LINC complexes transmit forces 
across the NE and affect mechanical properties of cultured mammalian cells. D Nuclear anchorage. 
LINC complexes mediate anchorage and positioning of nuclei in syncytial systems of various 
metazoans. In mammalian skeletal muscle (shown here), LINC complexes are required for the even 
spacing of extrasynaptic nuclei throughout myotubes, as well as for the clustering of synaptic nuclei 
beneath the neuromuscular junction. E Nuclear migration. LINC complexes function in nuclear 
migration during various metazoan developmental events. In neural progenitors of the mammalian 
neocortex and retina (shown here), LINC complex-mediated nuclear migration processes are essential 
for proliferation and differentiation. F Cell polarization. LINC complexes are required for nuclear 
positioning and orientation of the nuclear–centrosomal axis during fibroblast polarization. LINC 
complexes form transmembrane actin-associated nuclear (TAN) lines to couple the nucleus to 
retrograde actin flow. G Pronuclear congression. LINC complexes function in congression of male and 
female pronuclei in the fertilized zygote of C. elegans and vertebrates. Dedicated KASH domain 
proteins connect pronuclei to microtubule asters and the centrosome to allow their migration towards 
each other. H Chromosome tethering. LINC complex-mediated tethering of  chromosomes to the NE 
plays a role in various biological processes. In S. cerevisiae, tethering of telomeres and DNA double 
strand breaks has been implicated in silencing, stabilization, and repair. In S. pombe, tethering of 
centromeres is important for mitotic chromosome segregation. Meiotic chromosomes are anchored to 
the NE via LINC complexes in both yeast and metazoans with impact on homolog pairing and 















1.6 Laminopathies  
There are nearly 30 inherited diseases associated with mutations in the 
LMNA gene, and other NE proteins.  Diseases that result from defects in the 
NE proteins include osteopoikilosis, Buschke-Ollendorff syndrome, and 
melorheostosis that result from mutations in LEMD3/MAN1 [97], X-linked 
Emery-Dreifuss muscular dystrophy due to mutation in the LEM domain 
protein [98], and Dilated Cardiomyopathy (DCM) that results from mutations 
in another LEM domain protein LAP2α [99].  Diseases associated with defects 
in LMNA are classified into the primary and secondary laminopathies.  The 
primary laminopathies are caused by mutations in the Lamin A gene.  These 
are classified into 4 groups namely – 1) those affecting skeletal and cardiac 
muscle, 2) those resulting in defective white adipose tissue deposition and/ or 
the skeleton, 3) a peripheral neuropathy associated with demyelination of 
motor neurons, and 4) the premature aging diseases - Hutchison Gilford 
Progeria syndrome and some cases of atypical Werner’s syndrome [43].  The 
secondary laminopathies are caused by mutations in the gene encoding the 
endoprotease FACE-1 (ZMPSTE-24) that is required for the post-translational 
processing of the A-type lamins.  For the purpose of this thesis, I will be 
focusing on 3 groups – Laminopathies affecting striated muscle, laminopathies 
resulting in defective white adipose tissue deposition, and the premature aging 
disease – Hutchison Gilford Progeria syndrome.   
1.6.1  Laminopathies Affecting Striated Muscle 
Autosomal Dominant Emery-Dreifuss muscular dystrophy (AD-
EDMD) is caused by mutations in LMNA [100] in contrast to X-linked EDMD 
caused by emerin (EMD) mutations.  AD-EDMD results in dystrophy to 
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specific muscle groups, as well as cardiac conduction defects.  LMNA 
mutations resulting in AD-EDMD display wide variability in severity and 
penetrance.  Mutations in LMNA are also responsible for DCM with 
conduction system defects with no apparent dystrophy in the skeletal 
musculature [101, 102].  Dilation of the heart chambers, particularly the left 
ventricle, hypertrophy, arrhythmic conduction defects and cardiac arrest are all 
associated with cardiomyopathy with these often being fatal.  Another muscle 
related disease resulting from mutation in LMNA is the limb-girdle muscular 
dystrophy 1B (LGMD1B).  Patients suffering from LGMD1B exhibits tendon 
contractures and muscle wasting in the proximal limbs, but few or no cardiac 
complications [51, 103-105].   
Presently, there are seven established mouse models that resemble the 
striated muscle laminopathies to varying extent – early postnatal lethality, 
muscular dystrophy/immaturity and/or cardiomyopathy [51].  One of these 
mouse models was established by a mutation in the Lamin A gene that results 
in the deletion of Exons 8 to 10 [106].  These mice were initially considered to 
be Lmna null, but later was found to express a truncated form of Lamin A 
[107] at very low levels.  Mutant mice showed growth retardation starting at 
two weeks.  These mice die about 6 to 7 weeks after birth due to muscular 
dystrophy, cardiomyopathy, retarded muscle development that is associated 
with smaller muscle fibre diameter [106].  These mice are believed to 
resemble a more extreme case of AD-EMDM. In addition, conditional floxed 
lines Lmna
flx/flx
 have been generated more recently and when constitutively 
deleted, they have been shown to be true nulls [61, 108].  Homozygotes are 
born normal but within the first two weeks of postnatal development, they 
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exhibit growth retardation and die within three weeks [61, 108].  To date, there 
has not been any report of a live-born human patient completely lacking the 
Lamin A, although a human fetus that died in the third trimester was 
homozygous for a premature stop codon in LMNA [100, 109, 110].   
1.6.2 Fat based Laminopathies 
Besides muscle tissues, another group of laminopathies affects adipose 
tissue distribution and to some extent skeletal muscle development.  In 
humans, the two main diseases that have been documented are the Dunningan-
type familial partial lipodystrophy (FPLD) and mandibuloacral dysplasia 
(MAD) [51, 111-114].  
FPLD is a rare autosomal-dominated hereditary disease in which 80% 
of the patients carry a mutation at Arg482 of the LMNA gene.  These patients 
lose subcutaneous white adipose tissue from the limbs, gluteal and trunk 
regions, but accumulate white adipose tissue at the neck region.  These 
symptoms may commence at puberty, particularly in women, suggesting 
hormonal influence on the disease development.  These patients develop type 
2 diabetes with insulin resistance, are hyperlipidemic and show increased risk 
of atherosclerotic heart disease [51, 114]. It has been suggested that the 
abnormal adipose tissue distribution may have been caused by a defect in the 
mesenchyme adipocyte precursors [115].   
MAD is another rare disease that results from a specific mutation in the 
LMNA gene.  In this disease, the mutation occurs at the carboxy-terminal 
globular domain of A-type lamins and is autosomal recessive in nature [112, 
116].  It has been reported that 94% of cases have a mutation at residue 
Arg527 of LMNA (R527H).  Patients with this disease show similar metabolic 
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and fat depot redistribution seen in lipodystrophy. However, they also show 
skeletal abnormalities including osteolytic lesions. Bone re-absorption has also 
been observed in the craniofacial regions, termini of digits and clavicles [51].  
1.6.3 Premature Aging  
Hutchison Gilford Progeria syndrome (HGPS) is a rare dominantly 
inherited disease in which patients show symptoms of premature aging, 
including severe growth retardation, loss of subcutaneous fat, alopecia, 
reduced bone density and poor muscle development [50]. Patients with HGPS 
usually die at 12 to 15 years, due to severe atherosclerosis resulting in 
myocardial infarction and/or stroke caused by vascular occlusion [50].  
Atherosclerosis in HGPS patients is sometimes associated with smooth muscle 
depletion in sclerotic vessels and disruption to the microvasculature in various 
tissues as (Figure 1.8) [51, 117-119].  
The inheritance pattern of HGPS is autosomal dominant and is 
reproductive lethal [120]. Approximately ninety percent of classical HGPS is 
caused by a de novo mutation in a single nucleotide in exon 11 of the LMNA 
gene, 1824C>T(G608G) [121-123].  The mutation partially activates a cryptic 
splice site in Exon 11 and produces a mRNA with an internal deletion of 150-
base pairs[120]. This, in turn, results in a 50 amino acid in frame truncation of 
the Lamin A protein that does not affect the Lamin C protein [33, 124].  The 
mutant truncated A-type lamin has been assigned the name Progerin.  The 
deletion also causes the loss of the second endoproteolytic site in the Lamin A 
protein, resulting in Progerin retaining the farnesyl group, which is believed to 











Figure 1.8: Stenosis and VSMC loss in HGPS aorta. Comparison of a 16-year-old non-HGPS (left) and 
HGPS (right) aorta. A, Normal individual (16-year-old) and B, HGPS proximal aorta (H&E stain). HGPS 
proximal aorta has an enlarged intima (i) compared to the control. C, Control aorta, D, Dense and thickened 
adventitia of the distal aorta in HGPS (Movat stain). E, F, Higher magnification of the pictures of the media in 
C and D. White arrow indicates VSMC death. G, Control aorta stained with Lamin A/C (red) and SMA (green). 
H, Anti-Progerin (red) and SMA antibodies (green) show VSMC loss in HGPS. I, Control aorta was stained 
with Lamin A/C (red) and SMA (green). J, Fibroblasts and small arterioles are Progerin-positive in HGPS 
adventitia. K, Adventitia of a 16-years-old control aorta with less condensed collagen (yellow green) compared 
to L, highly condensed collagen fibers (red) present in HGPS adventitia (Picrosirius red stain). (Scale bars: A-D 
500 μm, E-F 50 μm, GJ 10 μm, K-L 25 μm).  Adapted from Olive et al. Arterioscler Thromb Vasc Biol, 2010 
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Besides the common HGPS defect in exon 11, another mutation 
(E145K) where a heterozygous base substitution (Glu-to-Lys substitution) in 
Exon 2 of the LMNA [33] was diagnosed a Progeria.  The patient with the 
E145K mutation exhibited short stature, failure to thrive, partial alopecia of 
the scalp, dry irregularly hyper-pigmented skin, pointed nose, protruding eyes, 
micrognathia, and high forehead [125].  The patient had atypical clinical 
features, including persistence of coarse hair over the head, ample 
subcutaneous tissue over the arms and legs, and severe strokes beginning at 
age 4, subtly distinguishing this phenotype from classic HGPS.  
 
 
1.7 Nuclear Lamina and Ageing 
HGPS has been regarded as a segmental progeroid syndrome because 
it only partially reproduces some aspects of normal ageing processes, affecting 
only a subset of tissues.  Unlike normal ageing, HGPS patients do not show 
any increase in tumor susceptibility, cataract formation or cognitive 
degeneration – which are hallmark features of normal ageing [126, 127].  In 
addition, HGPS may also show additional phenotypes that are not typical of 
normal ageing such as clavicular agenesis [128].  However, studying the 
molecular pathology of premature ageing disease such as HGPS may 
undeniably provide insights into normal ageing.  Such insights have been 
enabled by recent advancements in HGPS research, possibly providing links to 
normal ageing.   
Fibroblasts obtained from HGPS patients exhibit enhanced DNA 
damage and defective DNA repair, possibly due to the enhanced accumulation 
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of reactive oxygen species, compared to fibroblasts obtained from unaffected 
age-matched individuals. This is an interesting feature as it is also observed in 
fibroblasts from normally aged individuals.  This increased accumulation may 
lead to increased levels of DNA damage. In addition, there are reports that 
HGPS cells show an accelerated reduction in telomere length [129, 130] that 
may also be associated with increased DNA damage. HGPS cells also express 
markers indicative of increased DNA damage, suggesting genomic instability.  
These markers include protein kinases including the nuclear ataxia 
telangiectasia mutated (ATM) and ATM- and RAD3-related (ATR) that 
localized to the DNA damage/repair foci. In addition, HGPS fibroblasts also 
show increased expression of basal phosphorylated histone variant H2AX 
(H2AX) and phosphorylated checkpoint kinase 1 (CHK1) and CHK2 
compared to normal fibroblasts [128, 131].  Together these forms of  DNA 
damage may underlie the defects in proliferation and early senescence that 
characterize HGPS cell proliferation [128, 132-134]. 
Similar to fibroblasts from normally aged patients, HGPS fibroblasts 
exhibits altered cell proliferation and senescence.  HGPS fibroblasts in culture 
undergo accelerated entry into senescence [128, 133, 135]. There are also 
similarities between HGPS fibroblasts and aged fibroblasts in terms of 
chromatin changes.  Both types of fibroblasts show reduced nuclear levels of 
the lamina associated polypeptide 2 (LAP2), HP1α, H3 lysine 9 trimethylation 
(H3K9me3) and nucleoplasmic Lamin A/C, compared to fibroblasts from 
young normal individuals [128, 136].  More interestingly, Progerin may be 
detected, albeit at very low levels, in normal human fibroblasts and tissues 
from old individuals [136, 137], suggesting that the cryptic donor splice site 
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that is active in HGPS cells drives a low level of aberrant splicing in healthy 
normal cells.  Another similarity between HGPS fibroblasts and aged 
fibroblasts is the enhanced telomere attrition.  It has been suggested that this is 
an autonomous effect as cells from HGPS patients that do no express A-type 
lamins (such as granulocytes and T cells) have telomeres of normal length 
[128, 129, 135, 138] .  It is worth mentioning here that telomere shortening in 
this case may be not be specific for Progerin, as fibroblasts from Lmna null 
mice and knockdown of Lmna in cells have both been shown to exhibit 
accelerated telomere shortening and cause chromosomal instability [128, 129, 
139].   
Mesenchymal stem cells are multipotent progenitors that differentiate 
into adipogenic and osteogenic lineages, tissues that are primarily affected in 
Progeria [128, 140]. It has been reported that Progerin reduces the potential to 
differentiate along the adipogenic lineage, and this may underlie the loss of 
subcutaneous fat in HGPS individuals [128].     
Another tissue of the mesenchyme lineage is the vascular smooth 
muscle.  In a recent study which looked at vascular smooth muscle cells 
(VSMCs) derived from HGPS iPSC (induced pluripotent stem cells), it was 
suggested that vascular smooth muscle cells are more sensitive to the anti-
proliferative effects of Progerin [141].  Skin biopsies obtained from HGPS 
patients showed the highest level of Progerin in vascular smooth muscle 
cells[142].  In another study , it was reported that vascular smooth muscles 
isolated from arteries of 70 to 80 year old individuals, expressed elevated 
levels of pre-laminA [143].  In contrast, no pre-Lamin A was detected in 
vascular smooth muscle isolated from teenagers (Figure 1.9) [143]. Since, 
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pre-Lamin A is a farnesylated form of Lamin A, persistent expression can 
have many of the same deleterious effects on cells as Progerin. In the old 
VSM the increased expression of pre-lamin A was associated with decreased 
levels of ZMPSTE24 possibly due to ZMPSTE24 expression being sensitive 









1.8  Project Outline 
In this project, role of the nuclear lamina in ageing is investigated by 
studying accelerated ageing models.  The first model that we examined was 
the Lmna9 mouse model.  Lmna9 mice exhibits accelerated ageing 
phenotype similar to HGPS, in that they express a truncated and farnesylated 
form of Lamin A.  The homozygotes develop growth retardation and dying 
within 3 to 4 weeks.  In our recent publication, we showed that the fibroblasts 
derived from these mice had defective extracellular (ECM) production which 
was subsequently found to be attributed to a defective Wnt signaling as a 
Figure 1.9 Aged VSMCs accumulate prelamin A. A, Western blotting using antibodies to lamin A/C (top, 
SC-6215, N-18) and prelamin A (middle, SC-6214, C-20) showing prelamin A accumulation in aged and 
senescent VSMCs. Normal and senescent VSMCs are paired (ie, from the same isolate). Abbreviations are 
as defined in Figure 1 legend. B, Western blotting demonstrating absence of Progerin in aged VSMCs (77-
year-old woman, 78-year-old woman) with the use of lamin A/C, N-18, which detects Progerin in HGPS 
fibroblasts. C, Western blotting showing the specificity of the lamin antibodies. Lamin A/C N-18 detects 
lamins A and C and Progerin as well as prelamin A when overexpressed at high levels (asterisk). The 
prelamin A antibody (C-20) detects only prelamin A. Cell lysates are as follows: Ad/UC, VSMCs 
expressing uncleavable form of prelamin A; Ad/Pr, fibroblasts expressing Progerin; P6/P17, early- and 
late-passage VSMCs.  Adapted from Ragnauth et al Circulation 2010. 
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result of reduced Lef1 expression [144].  In addition, the increased occurrence 
of apoptotic cells in the smooth muscle layer of the great vessels in the mice 
suggested a defect that may be specific to a particular tissue type – smooth 
muscle cells.  This is intriguing because HGPS patients have been reported to 
show cardiovascular defects associated with either loss of vascular smooth 
muscle cells in the great vessels and/or arteriosclerosis. Moreover, vascular 
smooth muscles isolated from arteries of 70 to 80 year old individuals, 
expressed elevated levels of pre-laminA, which is an unprocessed form of 
Lamin A.  To verify this, mice expressing Lmna9 specifically in the smooth 
muscle cells were created using the Cre-LoxP system.   
Another study to examine the role of nuclear lamina and the LINC 
complex was undertaken by simultaneously knocking down the expression of 
mature Lamin A and one component of the LINC complex – the SUN1 
protein. The role of LINC complex in vital functions such as nuclear 
positioning, migration and chromosome organization makes it an interesting 
target to investigate. While the most common form of mutation found in 
HGPS patients is the G609G mutation, another mutation that has been 
reported is the E145K mutation which occurs in the Exon 2 of the LMNA 
gene.  A novel mouse model for this Progeria mutation was established and 
the mouse phenotype was characterized.   
In humans, it has been suggested that vascular smooth muscles cells 
(VSMCs) arise from multiple, independent origins [145, 146]. To investigate 
the possible role of Progerin in different lineage origins of VMSCs, we used 
previously established induced pluripotent stem cells (iPSC) to differentiate 
into the specific lineages.  This was performed using a recently published 
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differential protocol published by Cheung and colleagues [147].  Another 
study initiated was to investigate if there are any unique Lamin A protein 
interactors specific to VSMCs.  To study this, the proximity dependent biotin 
identification (BioID) system was utilized.  
Investigations focusing on SMCs may not only provide insights to 
specific tissue defects in the HGPS conditions, but also provide information on 
the general development of SMCs and its role in vascular diseases and ageing 
in general.  In addition, studies on the novel E145K progeric mouse model 
would provide an interesting alternative analysis to the common G609G 




Chapter 2: Materials and Methods 
2.1 In Vivo Murine Studies 
All mice used in this project were maintained in a temperature 
controlled environment (25 1°C) on a 12 hour light/dark cycle (0700 – 1900) 
and allowed ad libitum access to rodent chow (15% kcal from fat; Harland 
Tekland)  and water.  All experiments involving animals were reviewed and 
approved by the Institutional Animal Care and use Committee (IACUC) of 
A*Star, Singapore.  
2.1.1 Generation of Smooth Muscle Specific Lmna9 Mouse 
Model 
An established mouse model expressing smooth muscle specific cre 
(SM22α-CreKI) [148] was acquired from The Jackson Laboratories, USA.  
This mouse model was generated by knocking-in Cre-recombinase into the 
endogenous SM22α gene locus by homologous recombination of embryonic 
stem cells [148].  To define the spatial and temporal extent of Cre-mediated 
recombination of the SM22α-CreKI mice, we obtained a global double-
fluorescent cre reporter mice, mT/mG [149]. The reporter mice was obtained 
from The Jackson Laboratories, USA.  mT/mG is a double-fluorescent Cre-
reporter mouse that expresses the cytoplasmic tandem dimer Tomato (mT) 
prior to Cre-mediated excision and membrane targeted green fluorescent 
protein (mG) after excision [149].  Homozygous or Heterozygous SM22α-
CreKI mice were crossed to the reporter mT/mG mice.  Cre expression in 
heterozygous SM22α-CreKI mouse is sufficient to induce homologous 
recombination at loxP sites resulting in the expression of the green fluorescent 
protein (mG) instead of the endogenous red Tomato fluorescent protein (mT).   
35 
 
A tissue targeted expression of Lmna9 to be specifically expressed 
in SMC was created using the Cre-Lox technology by crossing the above 
SM22α-CreKI expressing mice with mice heterozygous Lmna9/flx mice. 
Lmna
9 /9 and Lmna
flx/flx 
mice were obtained from Dr Colin Stewart and was 
previously established in the National Cancer Institute, USA.  Lmna
9/flx 
mice 






mice.  The presence of 
Cre recombinase in the smooth muscle cells will remove the wildtype Lamin 
A allele in Lmna
9/flx 
mice, resulting in only Lmna
9 
expression in these 
tissues. Mouse genotypes were verified by PCR (refer to Table 2.1). 








9/9  mice are reproductively defective [150-153], SUN1
+/-
 
mice were crossed with Lmna
9/+ 
mice to generate Lmna
9/9 :SUN1
-/-  
mice.   
SUN1
 
mutant lines were a gift from Dr Kuan-Teh Jeang of the National 
Institute of Allergy and Infectious Diseases, USA.  Lmna
9/9  were obtained 
from Dr Colin Stewart.  Mouse genotypes were verified by PCR. 
2.1.3 Generation of E145K Mouse Model 
Recombinant E145K mouse embryonic stem cell (ES) clones were 
established in Dr Colin Stewart’s previous lab in National Cancer Institute, 
USA.  In brief, a genomic Lmna fragment containing part of intron 1 and 
exons 2 through 4 was altered using the QuickChange XL Mutagenesis Kit 
(Stratagene, La Jolla, CA, USA). Three nucleotides were changed: one 
introduced the E145K variation in the Lmna gene and the other two nucleotide 
changes created a restriction site by altering the nucleotides, which did not 
further change the amino acid sequence.  A PGK–neomycin resistance 
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selectable marker flanked by loxP sites was introduced into intron 1 at a 
unique restriction site. The linearized targeting construct was electroporated 
into W9.5 ES cells (129S1 genetic background), selected with neomycin.   
In our lab, established recombinant , ES clones were injected into C57Bl/6 day 
4 blastocysts, as previously described [154]. Chimeric mice established 
independent recombinant mouse lines harboring the Lmna E145K variation 
and neomycin cassette. F1 pups derived from chimeras were genotyped by 
PCR analysis, which identified mutants carrying a neomycin resistance 
cassette. The neomycin marker was removed using Cre–loxP recombination 
by crossing Neo
+
 mice to a constitutive, general Cre-deletor line, -actin Cre 
(obtained from Dr. Nancy Jenkins and Dr Neal Copeland (IMCB)) or Zp3-Cre 
line (obtained from Dr Barbara Knowles), leaving only the point mutations. 
All phenotypic characterization was performed on Neo-deleted lines.  
2.1.4 Genotyping of Mice 
2.1.4.1 Tail Digest 
During weaning, mice tails were clipped and stored in 1.5ml tubes.  
DNA was extracted from the tails either by the alkaline lysis technique or by 
using a DNA extraction kit. In the alkaline lysis technique, 75l of lysis buffer 
(25mM NaOH, 0.2mM EDTA (pH 8.0)) was dispensed into the tube and 
allowed to heat at 95°C for 30 minutes.  After heating, the buffer was 
neutralized with an equal volume of 40mM Tris-HCL.  The DNA extraction 
kit used was DNEasy Blood and Tissue Kit from Qiagen and DNA extraction 





2.4.1.2 PCR Genotyping 
Routinely 4l of the resultant lysed solution or purified DNA (from the 
kit extraction) were amplified in a 20l reaction using 2X MangoMix 
(Bioline) master mixes. The different primers used to genotype the different 
mouse strains are listed in Table 2.1.   
Table 2.1:  Mouse Genotyping Primers List 
Mouse 
Strain 
Forward Primer Reverse Primer 
Lmna9 CTAAAGGCTGGGCAGGTGGT CCTTGTCCAGCAAGCTACCG 
SM22α-
CreKI 
GGCCCAGGGGTTGTCAAAATAGTC WT: CTCCTCCAGCTCCTCGTCATACTTC 
Mut: CGCCGCATAACCAGTGAAACAG 
mT/mG CTCTGCTGCCTCCTGGCTTCT WT: CGAGGCGGATCCAAGCAATA 
Mut: TCAATGGGCGGGGGTCGTT 








E145K GTGCTTGGAGCTGTCTAGGG AGAGAGGTCCCATCCCAGAT 
Neo TGTCCGGTGCCCTGAATGAACT CAAGCTCTTCAGCAATATCACGGG 
 









from respective intercrosses were weighed every 2 days from day 2 through 12 
weeks of age.  
For E145K mice, litters from respective intercrosses were weighed 
every 2 days from day 2 through 12 weeks of age and every week from 12 
weeks to about 70weeks.  Kaplan-Meier method was used to draw the survival 
curves. 
2.1.6 Mouse Necropsy Analysis 
Homozygous E145K mice mice and age-matched littermates were 
submitted for necropsy at 1 year of age. Necropsy was carried out by 
Advanced Molecular Pathology Laboratory (in IMCB).  Organs harvested 
included thymus, lung, heart, thymus, kidney, seminal vesicles, and testes or 




2.1.7 MicroCT Scan 
Bone analysis using MicroCT scans were carried out in collaboration 
with Dr Bina Rai (previously from Dr Simon Cool’s lab in IMB).  The mice 
were scanned with a μ‐CT scanner (Skyscan 1076; Skyscan, Belgium). 
Scanning was performed at a resolution of 35μm and a scanning width of 
35mm. The scanner was set at a voltage of 104kV and a current of 98μA. 
Cone‐Beam CT‐reconstruction® A Sasov software (Skyscan) was used to 
convert the isotropic slice data obtained into 2D images. For this 
reconstruction, the lower and upper threshold values for bone were assumed to 
be ‐315 and 543 Hounsfield units. The data was then analyzed and remodeled 
using the associated CTAn software (Skyscan) for quantification and Mimics 
11.1 software (Materialise, Belgium) to render 3D images. A cylindrical 
region of interest (ROI, concentrically positioned over the desired site) and the 
total number of slices were both kept constant for all the samples. The total 
volume bone within the ROI was measured by assigning pre‐ determined 
thresholds for total bone content. The data is reported as bone volume/total 
volume (%). 
2.1.8 Body Composition Analysis using EchoMRI  
Body compositions of age-matched mutant and control littermates 
were measured with an EchoMRI 100 (Echo Medical Systems) according to 
manufactuer’s instructions.  Briefly, unanesthetized mice were weighed first 
before they were put in a mouse holder and inserted in the MR analyzer.  
Reading of body fat mass and body lean (muscle) mass were generated in 1 




2.1.9 Metabolic  Analysis 
Indirect calorimetry studies on the mice were performed using the 
Oxymax/Comprehensive Lab Animal Monitoring System (CLAMS) 
(Columbus Instruments).  These metabolic cages were used to monitor the 
oxygen consumption (VO2), carbon dioxide (VCO2), physical activity, and 
food and drink intake.  Mice were individually housed in chambers maintained 
at 241°C, and given ad libitum access to food and water.  All the 
measurements were taken every 15 minutes for 5 days after the mice were 
acclimatized for 48 hours.  Basal metabolic rate (BMR) was determined by 
averaging lowest plateau region of oxygen consumption curve corresponding 
to resting periods.  The respiratory (RER) was calculated as the ratio between 
VCO2 and VO2.  In cases where mice were placed in the chamber for 3 days, 
the third day data was used.  In this case where the mice were placed in the 
chamber for 5 days, data from the last 3 days were averaged.   
 
2.2 Cell Culture 
3T3-L1 preadipocytes were grown in Dulbecco’s modified Eagle’s 
Medium (DMEM) high glucose 4500mg/ml containing 10% newborn calf 
serum (NCS) (heat inactivated at 65°C for 30 minutes).  Two days after 
reaching confluence, cultures were induced to differentiate in DMEM (4.5g/L) 
containing 10% fetal bovine serum (FBS) , supplemented with 1mol/l 
insulin, 0.5mmol/l 3-isobutyl-1-methyl-xanthine (IBMX) and 1mol/l 
dexamethasone for 2 days and then supplemented with 1mol/l insulin alone 
for 2 days.  After 4 days, cells were cultured in DMEM containing 10% FBS.   
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Human pulmonary artery smooth muscle cells (PASMC) were 
acquired from Gibco , Life Technologies, and the primary lines are grown in 
Medium 231 supplemented with Smooth Muscle Growth Supplement 
(SMGS), both from Gibco , Life Technologies.   
HGPS patient fibroblast cells and control fibroblasts were purchased 
from Coriell cell repositories (http://ccr.coriell.org/). Human embryonic stem 
cell lines (hESCs) HES2 (gift from Dr Gordon Keller) and induced pluripotent 
stem cells (iPSCs) were cultured on irradiated mouse embryonic fibroblasts 
(MEFs) with Knockout DMEM medium supplemented with 20% knockout 
serum replacement, nonessential amino acid, 2-mercaptoethanol, 
penicillin/streptomycin, GlutaMax, and bFGF. Cells were passaged with 
collagenase IV (all GIBCO).  
Differentiation of HES2 and iPSCs into specific lineages of SMCs 
were carried out according to protocol published by Cheung et al[147].   
All cell cultures were maintained at 37°C with 5% CO2 .   
2.2.1 Primary Mouse Embryonic Fibroblast (MEF) Derivation 
Primary MEFs were derived according to previously established 
protocols [155].  Heterozygote matings were set up and embryos were 
collected at Day 13.5. A small piece of tissue was removed for genotyping 
purposes and the rest of the embryo was placed in a tube containing MEF 
enzyme solution which consists of 100 μg/ml DNase1 (Sigma-Aldrich, cat. D-
4527) and 500 μg/ml collagenase IV (Sigma-Aldrich, C-9407) in serum-free, 
high glucose 4.5 g/l DMEM (GIBCO
® 
Invitrogen, cat. 10829-018).  Embryos 
were homogenized using an 18G needle and digested at 37°C in a water bath 
for 30minutes with occasional gentle mixing.  Tubes were centrifuged at 
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1000rpm for 5 minutes.  The resultant pellets were resuspended in fresh D10 
media which consists of high glucose DMEM—4.5 g/l (GIBCO
® 
Invitrogen, 





Invitrogen, cat. 25030-081)—2 mM final 
concentration, and penicillin/streptomycin (50 IU/ml) (GIBCO
® 
Invitrogen, 
cat. 15140-122). Suspended cells were subsequently plated out and fresh 
media was changed the next day.   
2.2.2 Primary Mouse Adult Fibroblast (MAF) Derivation 
Primary MAFs were derived according to previously established 
protocol [155].  In brief, limbs were obtained from euthanized mice and 
muscles were isolated from bones.  Tissue digestion was performed by 
incubating the muscle tissues in enzyme solution in a 37°C water bath for 30 
min, with occasional mixing.  MAF enzyme solution consists of equal 
volumes of dispase II (Roche, cat. 04 942 078 001) at a concentration of 2.4 
U/ml and 1% collagenase II (GIBCO
® 
Invitrogen, cat. 17101-015).  After 30 
minutes, enzyme solution was neutralized in D10 media (similar to that used 
in MEF derivation).  Mixture is then filtered through 70 μM sterile filter (BD 
Falcon
TM
, cat 352350) and 40 μM sterile filter (BD Falcon
TM
, 352340).  
Suspension is then centrifuged, supernatant removed and subsequently 
resuspended in D10 media and plated out.   
2.2.3 Primary Stromovascular Fraction (SVF) Cell Derivation 
SVF cells were derived from gonadal white adipose tissue (gWAT) of 
8 week old mice.  Soon after mice were euthanized, the gWAT fat pads were 
promptly removed and placed into a 15ml Falcon containing 1mg/ml 
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Collagenase Type II in plain DMEM high glucose (no serum).  The tissue was 
snipped with sterilized surgical scissors in solution until tissues became a 
homogenous pulp.  Next, the tissue was incubated for 45 minutes at 37°C, 
with occasional gentle mixing.  The tissue was then filtered through a 100m 
mesh to remove mature adipocytes.  The resultant solution was centrifuged at 
350g for 5 minutes, and the supernatant aspirated.  2ml of red blood cell ysing 
buffer (155mM NH4CL, 10mM KHCO3, and 0.1mM EDTA) was added to the 
cell pellet for 5 minutes are room temperature to lyse the red blood cells that 
would otherwise overwhelm and impair SVF cell growth.  8ml of media was 
then added and the pellet resuspended and centrifuged for a further 5 minutes.  
Cell pellets were then resuspended in fresh 10% FBS media (formulation is 
the same as the differentiation media described for 3T3-L1) and plated.   
2.2.4 Lentiviral Transfection Experiments 
Lentiviral work was done in collaboration with Dr Alexandre 
Chojnowski in the lab.  Lentiviruses were generated according to the 
manufacturer’s protocol (Thermo Fisher Scientific). v5-LMNA and v5-
Progerin was cloned into pTRIPZ (Thermo Fisher Scientific) by replacing the 
whole shRNA cassette with the full-length cDNA of human LMNA or 
Progerin. Stable cell lines were generated by selecting virally transduced 
human vascular smooth muscle cells for 7–12 d with their respective 
antibiotics: 0.5 µg/ml puromycin (Sigma-Aldrich).  pTRIPZ-based constructs 
(containing  v5-tagged LMNA and v5-tagged Progerin) were induced with 1 





2.2.5 Growth curves and proliferation assays 
Short term growth curves were performed using two different methods.  
In the first method, cells were plated at 104/well in 12-well dishes and counted 
daily, in triplicates. Cells were stained using 0.4% tryphan blue to allow 
exclusion of dead cells. The second method uses the xCELLigence System 
(Roche) where cells are seeded in 96-well plates. Cell Index was monitored 
every hour throughout the experiment.  
For long term proliferation assays, cells were seeded in triplicates in 
12-well culture plates and grown for 3–5 days under various conditions, 
trypsinized, and counted according to 3T3 protocol [156]. 
2.2.6 Oil Red O Staining 
Oil Red O Stain of lipid accumulation was performed as previously 
described [157]. Briefly, the stock solution was prepared by dissolving 0.5g 
Oil Red O in 200ml isopropanol and warmed at 56°C for 1 hour.  The working 
solution was then prepared by adding 1 part of 60% isopropanol and 3 parts of 
distilled water to 6 parts of the stock solution.  This mixture was then filtered 
through a fine paper (No.42 Whatman) before use.  Cells were fixed for 15 
minutes in 1% formaldehyde at room temperature, washed twice in PBS and 
rinsed in 60% isopropanol before working solution was added.  Cells were 








2.3 Molecular Biology 
2.3.1 Quantitative PCR (qPCR) 
RNA was isolated using TRIZOL (Life Technologies) and further 
purified using the RNeasy kit (QIAGEN). DNase treatment was performed on 
a column, and total RNA was quantified by a spectrophotometer (ND-1000; 
NanoDrop Technologies).  cDNA was generated using random hexamers, 
dNTPS and reverse transcriptase using the High Capacity cDNA reverse 
transcription kits (Applied Biosystems), according to the manufacturer’s 
protocol. The resulting cDNA was then diluted and subjected to quantitative 
PCR (qPCR).  
qPCR assays were run in ABI7900HT Fast Real-Time PCR System 
(Applied Biosystems) for 384-well plates or ABI 7500 Fast Real-Time PCR 
System (Applied Biosystems) for 96-well plates.  Reactions were performed in 
10l volumes for 384 wells and 20l volumes for 96 well plates using either 
Fast Taqman master mix with Taqman primers and probes (ABI 
Biosystems) or SYBR green master mix (ABI Biosystems) and primers. 
Primers used have been designed to span exon-exon junction so as to reduce 
the risk of false-positive and amplification of genomic DNA.    
Gene expression data is calculated and presented as relative gene 
expression, normalized to the housekeeping gene.  Dissociation curves for the 
SYBR Green qPCR reactions were also run to check that only one peak was 





Table 2.2  List of primers used in Q-PCR 




















































Table 2.3 List of Taqman Probes used 
Gene Species Assay ID 
CEPB- mouse Mm00514283_m1 
Eln mouse Mm00514670_m1 
Fbn1 mouse Mm00514908_m1 
Col1a1 mouse Mm00801666_g1 
Col3a1 mouse Mm01254476_m1 
Col4a4 mouse Mm00801574_m1 
Col5a1 mouse Mm00489342_m1 
Hprt mouse Mm01318743_m1 
 
 2.3.2 Protein Preparation from Cells  
Whole-cell lysates were generated using the Lysis-M kit solution 
(cOmplete; Roche). Lysates were quantified using the bicinchoninic acid 
protein assay kit (Microplate; Thermo Fisher Scientific), separated by Sodium 
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Dodecyl Sulphate – polyacrylamide gel electrophoresis (SDS-PAGE), and 
transferred onto PVDF membranes. 
Cells were washed in ice-cold PBS and lysed with Roche Lysis M 
buffer.  Samples were lysed and centrifuged at 14,000g for 10 minutes to 
remove cell debris.  Protein concentration was quantified using bicinchoninic 
acid (BCA) protein kit (Bio-Rad) before loading protein samples onto a 
polyacrylamide gel  so as to ensure equal amounts were loaded.   
For nuclear and cytoplasmic protein extraction, the NE-PER Nuclear 
and Cytoplasmic Extraction Kit (Pierce, USA) was used according to 
manufacturer’s protocol.   
2.3.3 Protein Prepartion from Tissues (Whole Tissue Lysates) 
Same lysis buffer was used as above.  Small slices of tissue were 
rapidly placed into Lysing Matrix D tubes (Mp Biomedicals) upon sacrifice of 
mouse, and snap frozen in liquid nitrogen.  After snap freezing, the tubes were 
either stored at -80°C or used directly for protein analysis.  Tissues were first 
homogenized using the FastPrep-24 Instrument (MP Biomedicals) and 
homogenized using a 25G needle.  Samples were then centrifuged at 14,000g 
for 10minutes to remove cell debris. Protein concentration was quantified 
using bicinchoninic acid (BCA) protein kit (Bio-Rad) before loading protein 
samples onto a polyacrylamide gel  so as to ensure equal amounts were 
loaded.   
2.3.4 Immunoblotting 
For immunoblotting, two different methodologies were employed.  
First method uses the chemiluminescence using ECL reagents for protein 
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detection while the second method involved the use of infrared imaging using 
the Odyssey system (Li-Cor).   
All protein samples were resolved by SDS-PAGE and transferred onto 
polyvinylidene fluoride (PVDF) membrane (Millipore) by wet transfer for 2 
hours at 100V.  Membranes were blocked in TBS containing 0.1% Tween 20 
(TBST) supplemented 5% bovine serum albumin (BSA) or Odyssey Blocking 
Buffer solution (Li-Cor) for 1 hour at room temperature.   
Western Blot analysis was performed using primary antibodies and 
diluted in the blocking buffer the blots were blocked it.  Membranes were 
incubated overnight at 4°C.  For secondary antibodies, horseradish-peroxidase 
(HRP) conjugated antibodies were used for chemiluminescence for imaging 
wheras IRDye conjugated antibodies were used for infrared imaging using 
the Odyssey system (Li-Cor).  The membranes were incubated for 1 hour at 
room temperature with the secondary antibodies.  For immunoblots visualized 
using chemiluminescence, membranes were incubated in ECL substrate 
(Pierce) for 1-2 minutes before being exposed to a chemiluminescence 
sensititve film (Thermo Scientific) and subsequently processed in a developer.  
For immunoblots visualized using infrared imaging, membranes were dried on 
lint-free Kimwipes (Kimberly-Clark) and imaged using the Odyssey system 
(Li-Cor).   
2.3.5 Immunofluorescence (IF) 
Cells were grown on glass coverslips and fixed in either 4% 
paraformaldehyde (PFA) for 15 minutes at room temperature or ice-cold 
methanol for 20 minutes in -20°C.  Cells were then rinsed in PBS twice and 
permeablised with 0.01% Triton X in PBS for 10 minutes.  The fixed and 
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permeabilized cells were then rinsed  in PBS three times before being blocked 
in 5%FBS, 1% BSA for 1 hour at room temperature.  Samples were then 
incubated with primary antibodies for 2 hours at room temperature or 
overnight at 4°C.  Samples were then washed with PBS and subsequently 
incubated with secondary antibodies (Life Technologies) and DAPI (Life 
Technologies)  for 1 hour at room temperature .  After three washes in PBS, 
cover slips were mounted in ProLong Gold (Life Technologies) and analyzed 
on a Zeiss 510 Meta Confocal microscope (Zeiss).  Images and recorded and 
analysed using both Zeiss ZEN and Image J (NIH) softwares.   
For tissue sections, immunofluorescence analysis was performed on 
either paraffin-embedded samples or cryo-preserved samples. For paraffin 
embedded samples, sections were deparaffinized and rehydrated through a 
methanol gradient. Antigen retrieval was performed in citrate buffer, pH 6 
(Dako), in a 2100 Retriever (PickCell). Sections were incubated in 1% sodium 
borohydride for 20 min followed by a 10 min wash in PBS, pH7.4, and 
incubated overnight at 4°C with the primary antibodies (Supplemental Table 
S2). With the primary mouse monoclonal antibodies, the sections were 
incubated with Rodent Block M (Biocare Medical) for 20 min to prevent 
nonspecific binding. Nonspecific antibody binding was blocked by incubation 
in 10% normal goat serum or 10% donkey serum (Sigma) for 30 min and then 
washed in PBS. Samples were incubated with 1:500 dilution of secondary 
Alexa 488 antibodies (Invitrogen) for 1 h and the nuclei labeled with 4′,6-
diamidino-2-phenylindole (DAPI), washed in PBS, then in distilled water, and 
incubated in 50 mM copper sulfate prepared in ammonium acetate buffer, pH 
5, for 60–90 min to reduce autofluorescence. The sections were mounted in 
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ProLong gold antifade (Invitrogen) and imaged using a Zeiss LSM510 
confocal microscope. For cryo-preserved samples, specimens were transferred 
in Tissue-Tek OCT (Sakura Finetek, USA) and frozen in liquid nitrogen. 12-
µm sections were cut on a cryostat and placed on Polysine slides (Thermo 
Fisher Scientific) and stored at −80°C. Sections were subjected to similar 
immunostaining methods as the paraffin embedded sections.   
 
Table 2.4 List of Primary Antibodies Used 
Marker Brand Catalog Number 
LMNB1 YenZym Custom 
LMNA/C and Progerin (Jol2) EMD MIllipore MAB3211 
LMNB2 EMD MIllipore MAB3536 
GAPDH Abcam AB9485 
ACTA2 Sigma F3777 
TAGLN Abcam Ab14106 
CNN1 Sigma C2687 
SMTN Abcam Ab8969 
Progerin Enzo Life Sciences ALX-804-662-R200 
SUN1 (UNC-84) Sigma HPA008346 
H3K9me3 Abcam Ab1220 
Emerin Abcam ab156871 
Nup153 Abcam AB24700 
-actin Sigma A1978 
CREST Kind gift from Dr J.B. Rattner (University of Calgary, 
Calgary, Alberta, Canada) 
 
2.3.6 Chromatin Immunoprecipitation Assay (ChIP) 
Chromatin immunoprecipitation assay was performed according to the 
manufacturer’s instruction using EZ-Zymatic Chromatin Prep Kit (Millipore).  
This information has been updated in the main thesis.   
 
2.4 Statistical Analysis 
All results were expressed as mean  standard error or mean (SEM).  
The statistical significance of differences in mean values was determined by a 
student’s two-tailed t-test.  ANOVA analysis was performed to compare mean 
difference among groups. Kaplan-Meier method was used to draw the survival 
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curves. Log-rank test was conducted on the homogeneity of survival curves 












Chapter 3: Tissue Specific Lmna9 Mouse Model 
3.1 Introduction 
The availability of established mouse lines in our laboratory, each 
carrying a different mutation in the Lmna gene, makes it possible for us to 
study the molecular basis of the pathologies of the different laminopathies.  
This is especially useful in studying aging diseases, as the availability of tissue 
samples from patients is severely limited due to ethical issues and the rarity of 
the patients.  The availability of mouse models allows us to perform in vitro 
and in vivo experiments to analyze the molecular mechanisms underlying 
different laminopathies.  In turn, our findings may be a useful basis to develop 
in vitro and/or in vivo screens for potential therapeutics. 
3.1.1 Lmna9 Mouse Model 
The Lmna9 mouse model was created by introducing a nucleotide 
base change into the Lmna gene, in an attempt to substitute proline for leucine 
at residue 530 (L530P). However, as residue 530 was close to splice donor site 
the base changes that were introduced resulted in the creation of an abnormal 
splice donor site that resulted in an in frame deletion of 40 amino acids from 
exon 9. The Lmna
9/9
 as it is now referred to, results in the expression of a 
truncated Lamin A protein that retains the farnesyl group, therefore 
resembling Progerin, albeit being expressed at low levels [144]. In humans, 
this mutation (L530P) causes AD-EDMD [100]. Homozygous Lmna
9/9 
mice 
are indistinguishable from their littermates at birth, but within 4 to 6 days 
develop severe growth retardation, dying within 3 to 4 weeks (Figure 3.1) 
[158].  Similarly, HGPS patients are born normal but later develop severe 
growth retardation by two years of age and usually die at 12 to 15 years [50].  
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Table 3.1 shows a comparison between HGPS phenotypes and the 
homozygous Lmna
9/9 







Figure 3.1  Lmna9/9
 
homozygous mice exhibit severely retarded growth and die early. A. The smaller 
Lmna9/9
 
mouse weighed 5.37 g; the littermate (21.88 g) was wild type. B, Mutants failed to thrive, 
showing marked growth reduction as early as 4 days after birth. Mice were weighed every 2–3 days for 58 
days. n . 8 mutant (Hom,red), 10 wild-type (WT, blue) and 14 heterozygotes (Het, green) mice. C, 
Heterozygotes (green) can live as long as wild-type littermates (blue). Mutants (n . 25, red) died by 38 
days. Adapted from Mounkes et al. Nature. 2003 
Table 3.1 Comparison of HGPS Phenotypes in Human and Lmna9/9 mouse. Adapted from 




 Analysis of mouse adult fibroblasts (MAFs) derived from postnatal 
Lmna
9/9 
mice showed that they have slower proliferation rates, whereas the 
proliferation of the embryonic Lmna
9/9
 fibroblasts (MEFs) was unaffected 
(Figure 3.2), despite them expressing Lmna
9/9 
transcripts at the same level 






While the MAFs did not show any genomic instability, defective DNA 
repair or defective telomere activity[144], initial microarray experiments on 
the gene expression profiles of the MAFs showed that the most significant 
molecular function grouping was for extracellular matrix (ECM).  Intriguingly 
these differences were not detected in the Lmna
9/9
 (MEFs). These results 
were verified using relative quantitative PCR analysis on a subset of the 
ECM/cell adhesion genes (Figure 3.3A). In addition, the expression of the 
same set of ECM genes were also significantly reduced in the Lmna
9/9 
skeletal tissues such as calvaria, tibia and femurs, compared to age-matched 
wildtype mice.  MicroCT comparison of skeletons between Lmna
9/9
 and 
wildtype controls confirmed that the mutants have reduced density in the 
calvaria and long bones (Figure 3.3B to 3.3D) [144]. 
Figure 3.2  Lmna9/9  Result in Accelerated Proliferative Arrest. A WT () and 9 () MEF growth 
curves, with nuclear morphology shown in the inserts (DAPI staining). B WT () and 9  () MAF 








Further analysis of the microarray results, revealed that at least four of 
the differentially expressed genes (fibronectin, BMP-4, Col11A1, R-spondin) 
were transcriptionally regulated by the canonical Wnt pathway.  Chromatin 
Figure 3.3. Lmna9/9Mice Show Reduced Extracellular Matrix (ECM) Gene Expression and Abnormal 
Skeletal and Vascular Development. A. Confirmation of the microarray analysis by RQ-PCR. Differences 
are expressed as the relative log ratio between the Lmna9/9and Wt samples, with a 2-fold decrease 
being equivalent to -0.301, 4-fold decrease -0.602, 5-fold decrease -0.699, *p < 0.05, **p < 0.01, and 
***p < 0.005 at the 95% confidence interval. Error bars are SEM. (B–D) Calvarial B. and long bone C. 
mineral density, as well as long bone volume and trabecular thickness and number D. in P14 WT and D9 
sibling mice; *p < 0.05, **p < 0.01, and ***p < 0.005 (three of each genotype). Adapted from Hernandez 
et al Dev Cell. 2010. 
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Immuno-precipitation (ChIP) experiments performed on Lmna
9/9 
MAFs 
showed that binding of the Wnt regulated Lef1 transcription factor to the 
Col11A1 promoter was significantly reduced as compared to control MAFs.  
And this reduced binding was shown to be due to reduced Lef1 levels in 
Lmna
9/9 
MAFs as verified in RT-PCR, western analysis and 
immunofluorescence (Figure 3.4).  This was confirmed as pre-treatment of the 
cells with a GSK-3 inhibitor, SB415286, enhanced the binding of Lef1 
(Figure 3.4).  It is worth noting that the reduction is specific to Lef1 but not 
Tcf4.  These results suggest that Lmna
9/9 
MAFs showed impaired Wnt 
signalling due to reduced levels and transcriptional activity of Tcf/Lef1.  We 
extended this analysis to two human HGPS fibroblast lines (AG11498, 
AG06297) and found that similarly, expression of LEF1, but not TCF3/4 was 
significantly reduced, as compared to normal fibroblasts Figure 3.4E and F 
[144] revealing that both the Lmna
9/9 
and G608G (HPGS) mutations have 
similar effects at causing a reduction in LEF1 levels.  




DNA microarray experiments performed on livers showed that the pathways 
significantly enriched were those that are associated with stress response. 
These include the up-regulation of the p53 tumor suppressor pathway, the 
ATM related pathway and also hypoxia response pathway mediated by 
induction of  the HIF-1 pathway [159].  Subsequently, they showed that NF-
B is hyperactivated in  LmnaG609G/G609G  , activating ATM kinase which was 
shown by the increased amounts of phophoSer1981-ATM and NEMO in 
Lmna
G609G/G609G  
samples[159, 160].  Similar results were also observed in 
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HGPS fibroblasts showing increased levels of phospoho-Ser1981-ATM and 






Figure 3.4. Lef1 Levels Are 
Reduced in 9 and Progeric Cells. 
A. ChIP analysis of Lef1 binding to 
the Col11A1 promoter in WT and 
9 MAFs, in the presence and 
absence of pre-treatment with the 
SB415286 Gsk-3b inhibitor (10 
μm). B. RT-PCR detection of Lef1 
mRNA in WT and 9 MAFs. C. 
Western analysis of β-catenin, 
Lef1, and Tcf4 in WT and 9  
MAFs and MEFs. D. Immuno-
fluorescent detection of Lef1 and 
Tcf4 in WT and 9 MAF nuclei 
counterstained with DAPI. E. Lef1 
and Tcf4 detection by Western 
analysis of nuclear extracts of 
fibroblast lines from two progeric 
patients (Coriell #AG11498, 
AG06297). F. Immunofluorescence 
showing Lef1 in normal parental 
(WT- AG03512) and progeric 
(AG11498) fibroblasts, nuclei 
counterstained with DAPI. Error 
bars are SEM. Adapted from 
Hernandez et al Dev Cell. 2010. 
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The Wnt signalling pathway is regulated by Gsk-3 and  which 
phosphorylates and promotes the degradation of -catenin.  Inhibition of Gsk-
3 stablilizes -catenin levels, resulting in enhanced -catenin-mediated 
transcriptional activity [144, 161].  Treatment of both Lmna
9/9 
MAFs and the 
human progeric lines with Gsk3 inhibitor, SB415286, improve cell viability 





Besides the findings on the defective Wnt pathway in Lmna
9/9
 mice, 
another interesting observation made in the Lmna
9/9 
mice is that the vascular 
smooth muscle layer (VSMC) in the great vessels was thinner and exhibited 
extensive apoptosis compared to wildtype controls.  TUNEL analysis showed 
extensive apoptosis throughout the circumference of the VSMC layer of the 
pulmonary artery in the mutant mice (Figure 3.6).  This is interesting because 
HGPS patients’ die due to cardiovascular defects, that are associated with 
either loss of VSMCs in the great vessels and/or arteriosclerosis, resulting in a 
Figure 3.5. Cell Proliferation Is Enhanced by Gsk-3b Inhibition A. Treatment of 9 MAFs with the 
Gsk inhibitor SB415286 (25 mm) rescues growth. B. Treatment of the progeric line AG06297 (10 μm 




heart attack or stroke [119]. Furthermore, arterial vascular smooth muscle 
development is greatly dependent on proper ECM synthesis.  The similarity in 
phenotype observed in the great vessels of both Lmna
9/9  
and HGPS makes it 





3.1.2  Vascular Smooth Muscle Cells and ECM Production 
Arterial vessels are comprised of three layers – the adventitia, the 
media and the intima.  Vascular smooth muscle cells (VSMCs) are the major 
cellular component of the tunica media in the vessels (Figure 3.7) and they are 
significant contributors to the vascular ECM.  ECM deposited by VSMCs 
includes collagen and elastin, which are critical components that provide the 
vessel wall with its structure and mechanical properties.  
 
 
Figure 3.6 Apoptosis in pulmonary artery smooth muscle of P16 WT and 9 mice (TUNEL staining 
indicated by arrows).  Adapted from Hernandez et al.  Dev Cell. 2010 
Figure 3.7 Immunofluorescence micrograph 
of E17 mouse aorta. Sections through the 
aorta of an E17 mouse were stained with an 
antibody for elastin (green) and for flk, a 
marker for endothelial cells (red). On the left 
is the lumen (L) of the artery. The intima (I) 
is evident as a single layer of red-staining 
endothelial cells. The media (M) contains 
dense layers of elastin, whereas the elastin 
in the adventitia (Ad) consists of fine fibers. 
The vein (V) on the top right shows the 
presence of endothelial cells but no elastin, 
whereas the small artery (Ar) directly below 
shows both. Scale bar 100m. Adapted from 
Wagenseil JE et al. Physiol Rev. (2009) 
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Elastin forms a three-dimensional, interconnecting lamellar network 
which functions to transfer stress throughout the vessel wall.  Bundles of 
collagen located between the lamellar layers show no definite organization at 
low blood pressure.  However, at high blood pressure, collagen bundles 
become circumferentially aligned [162-165].  This restricts aortic distension, 
resulting in little change in the radius of the vessel wall and accounting for 
nonlinear nature of vascular elasticity [163, 164, 166].  Other than collagen 
and elastin, other ECM components produced by VSMCs include basement 
membrane components, fibronectins, integrins and some matrix 
metalloproteinases [167].  
Besides providing structural and mechanical properties for vessel 
function, ECM is also required for cellular signalling that induce, define and 
stabilize vascular cell phenotype [165].  This includes regulation of gene 
expression by interactions with specific cellular components such as growth 
factors, which may in turn influence cellular functions.  This interaction is 
critical in directing the various physiological events such as developmental 
transitions that occur during embryogenesis, postnatal development and 
response to injury [165]. 
The study of ECM production by VSMCs and ECM function in 
vascular network can be performed by monitoring gene expression for 
vascular smooth muscle cytoskeletal and contractile proteins.  Expression of 
ECM components varies according to the different stages of smooth muscle 
cell differentiation [165].  Some commonly monitored markers include smooth 
muscle α-actin (SMα-Actin), calponin, smoothelin, SM22, and smooth muscle 
myosin heavy chain isoforms SM-MHC1 and SM-MHC2 [165, 168].  
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However, some limitations of studying these genes include the expression of 
these markers in multiple embryonic cell types such as cardiac and skeletal 
muscle.  An example of this includes the SMα-Actin.  On the other hand, other 
markers such as calponin, smoothelin, SM22 and the MHCs appear later in 
vessel wall development as compared to SMα-Actin [165]. 
In the Lmna
9/9
 mouse model generated in our lab, we have observed 
an impaired Wnt signalling pathway caused by the reduced nuclear levels and 
transcriptional activity of Tcf/Lef1.  This, in turn, probably results in a 
reduced ECM production.  In addition, it was also observed that the great 
vessels in the mutant mice have a thinner layer of vascular SMCs as compared 
to control mice.  When TUNEL assays were carried out, increased numbers of 
apoptotic cells was observed in the great vessels of the mutant mice compared 
to WT mice [144].  Taking into consideration the important role of VSMCs in 
ECM production as well as the post-natal development of the phenotype 
observed in our Lmna
9/9 
mutant mice, we decided to create a smooth muscle 
cell specific Lmna
9/9 
line.  This would allow us to investigate if tissue 
specific expression of the Lmna
9
 would be sufficient to reproduce the drastic 
phenotype observed in the constitutive Lmna
9/9 
mutant mice. 
3.1.3 Adult Smooth Muscle Specific Cre Recombinase Mouse  
One VSMC specific marker is SM22α, also known as transgelin 
(Tagln).  This gene encodes a 22-kDa protein that is abundantly and 
exclusively expressed in VSMCs and cardiac myocytes of adult animals [148].  
The protein is structurally similar to calponin, which is an actin-binding 
protein.  In mouse models of atherosclerosis, the protein is involved in plaque 
cell and atherosclerotic lesion formation during atherogenesis [169, 170]. 
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Homozygous SM22α-/- mutant mice exhibit uncompromised vasculature 
development and morphology with normal blood pressure and heart rate [171-
173].   
A mouse model expressing smooth muscle specific cre (SM22α-CreKI) 
has been established [148] and was acquired from The Jackson Laboratories, 
USA.  This mouse model was generated by knocking-in Cre-recombinase into 
the endogenous SM22α gene locus by homologous recombination of 
embryonic stem cells.  SM22α-CreKI heterozygous and homozygous mice 
were fertile and appeared phenotypically normal.  Temporospatial patterns of 
Cre-mediated recombination in SM22α-CreKI mice were established by Zhang 
and colleagues[148] to be specific in all arteries and veins, and also visceral 
smooth muscle cells (SMC) including the bladder and gastrointestinal tract in 
adult mice (Figure 3.8A and 3.8B), but not in other tissues such as brain, liver 
and skeletal muscle  [148].  It is also worth noting that the SM22α-CreKI mice 
failed to exhibit recombinase activity in SMCs at all embryonic stages and 
were only detectable in SMC and cardiomyocytes in newborn pups after birth 
(Figure 3.8C) [148]. The tissue specificity of the SMC-targeted Cre 
recombinase activity suggests the usefulness of this mouse model for 
establishing models for cardiovascular diseases and also for studying smooth 












To investigate and further validate the thinning of the VSMC in 
Lmna
9/9 mice, we have created a mouse model with a tissue targeted 
expression of Lmna9 to be specifically expressed in SMC.  To create this 
mouse model, we have used the Cre-Lox technology by crossing the above 
SM22α-CreKI expressing mice with mice heterozygous Lmna9/flx mice.  The 
rational for generating this line is the 9/flx is functionally equivalent to 9/+ 
mice, as the 9 allele is recessive and so the heterozygous mice are overtly 
normal. By deleting the floxed Lmna allele makes the tissue equivalent to a 
9/9, homozygote, albeit haploid for the mutant allele. Therefore using 
tissue specific Cre, such as the SM22α-CreKI, one can effectively derive mice 
in which the 9 mutant Lmna allele is the only one expressed in a specific 
tissue i.e. smooth muscle by deleting the remaining floxed WT Lmna allele.  A 
schematic diagram showing the crosses required to generate the smooth 
Figure 3.8. Characterization of SM22α-CreKI. A, Cellular expression of Cre-recombinase in SM22α-
CreKI. X-Gal–stained organs and sections were prepared from 8-week-old SM22 α -CreKI and 
Gt(Rosa)26Sor double heterozygous mice or wild-type littermates. X-Gal staining shows that Cre-
recombinase is expressed in SMCs and cardiomyocytes in adult. Bar=100 m B, Western blot analyses 
show GFP protein expressed in the aorta and the heart of 8-week-old SM22 α –CreKI and Gtrosa26 
double heterozygous or double homozygous mice and the control wild-type littermates. GFP protein is 
the positive control. Wt indicates wild-type; A, aorta; B, brain; H, heart; M, skeletal muscle. C. The 
comparison of LacZ expression by X-gal staining. (I) The LacZ gene driven by a SM22α promoter is 
highly expressed in the arterial vasculature and the heart at E13 (a positive control for X-gal staining). 
(II) and (III): The Cre-induced lacZ in a SM22α-CreKI/Gt(Rosa)26Sor embryo at E13.5 (II) or E15 (III) 





 mice can be seen in Figure 3.9. Both strains of mice 





3.1.4 Control Experiment to Check Specificity of SM22α-CreKI  
To define the spatial and temporal extent of Cre-mediated 
recombination of the SM22α-CreKI mice, we obtained a global double-
fluorescent cre reporter mice, mT/mG [149]. The reporter mice was obtained 
from Jax labs.  mT/mG is a double-fluorescent Cre-reporter mouse that 
expresses the cytoplasmic tandem dimer Tomato (mT) prior to Cre-mediated 
excision and membrane targeted green fluorescent protein (mG) after excision 
[149].  A schematic diagram explaining the basis of reporter system is shown 
in Figure 3.10 [149]. The presence of double fluorescent protein system 




enables the identification of not only cells in which Cre-mediated 
recombination has occured, but also non-recombined cells.  By crossing the 
mT/mG mice with the SM22α-CreKI, we are able to validate the specificity of 





Figure 3.10. Schematic diagram of the mT/mG 
construct before and after Cre-mediated 
recombination. mT/mG consists of a chicken 
bactin core promoter with a CMV enhancer 
(pCA) driving a loxP flanked coding sequence 
of membrane-targeted tandem dimer Tomato 
(mT) resulting in tdTomato expression with 
membrane localization. After Cre-mediated 
intra-chromosomal recombination, the 
mTsequence is excised allowing the pCA 
promoter to drive expression of membrane-
targeted enhanced green fluorescent protein 
(mG). Arrows denote the direction of 
transcription. Triangles represent 
loxP target sites for Cre-mediated  
recombination. PA denotes polyadenylation 






3.2.1 Expression of Cre recombinase is Specific to Smooth 
Muscle Cells in SM22α-CreKI Mice 
Homozygous SM22α-CreKI mice were crossed to the reporter mT/mG 
mice.  Cre expression in heterozygous SM22α-CreKI mouse was sufficient to 
induce homologous recombination at loxP sites resulting in the expression of 
the green fluorescent protein (mG) instead of the endogenous red Tomato 
fluorescent protein (mT).  There were some variation in the degree of mT 
labelling between different cell types and this could be attributed by the 
inherent differences in protein synthesis, membrane trafficking, and metabolic 
properties.  Cryo-sectioning was performed on tissues containing smooth 
muscle cells followed by direct imaging.   
As seen in Figures 3.11, 3.12 and 3.13, both fluorescent proteins are 
absent in the original SM22α-CreKI mice, and mG expression is absent in the 
original mT/mG mice.  These are important controls which confirm the 
absence of any background fluorescence that may exist in the original mouse 
strains. Since these images were only nuclear stained with DAPI, the 
possibility of background fluorescence from the secondary antibodies was also 
eliminated.  
Double mutants generated from this cross resulted in only smooth 
muscle specific cells expressing mG, instead of mT, as seen in SMC 
containing tissues such as the small intestine or the ileum (Figure 3.11), large 
intestine or the jejunum (Figure 3.12) and more importantly, in the arteries 
(Figure 3.13).  The distinct cell specific expression of mG in the different 
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tissues provides a clear indication of the specificity of Cre recombinase 
expression in the SM22α-CreKI mice. 
 
 
 Figure 3.11 Characterization of Ileum in 6 weeks old SM22α-CreKI/mT/mG mice. A.  Control 
immunofluorescence on original SM22α-CreKI  and mT/mG mice. B. Immunofluorescence on SM22α-




 Figure 3.12 Characterization of Jejunum from 6 week old SM22α-CreKI/mT/mG mice. A control 
immunofluorescence on original SM22α-CreKI and mT/mG mice. B Immunofluorescence on 









Figure 3.13  Characterization of the aorta from 6 week old SM22α-CreKI/mT/mG mice.      
A Control immunofluorescence on original SM22α-CreKI and mT/mG mice. B 
Immunofluorescence on SM22α-CreKI/mT/mG mice.  mG is only expressed in SMCs 




3.2.2 Smooth Muscle Specific Lmna
9/- 




Mice carrying specific expression of Lmna
9/9 
in smooth muscle cells 
(Lmna
9/-
SM22α-cre+/-) are indistinguishable from their littermates at birth, but 
within 1 week, show growth retardation (Figure 3.14).  Lmna
9/-
SM22α-cre+/-
mice live up to 2 months, compared to 3 to 4 weeks in Lmna
9/9  
mice (Figure 
3.15A) and show a reduced growth rate (Figure 3.15B).  In addition, they 
showed a slight waddling gait, suggesting immobility of joints.   
 






Figure 3.14 Smooth Muscle 
Specific Lmna9 Exhibit Similar 
Phenotype as in Lmna9/9 mice. 
Lmna9/-SM22α-cre+/- (topmost) are 
born normal but exhibited retarded 
growth from 1 week onwards. They 
are much smaller in size as 
compared to WT control mice.  
Representative mice in figure are 







3.2.3 Specificity of Cre Recombinase Expression in Lmna
9/- 
SM22α-cre+/-  Mice  
We subsequently investigated the tissue specific consequences of 
expressing  Lmna
9/- 
 only in smooth muscle.  For this purpose, we specifically 
selected the stomach to perform the immunofluorescence as it contains a thick 
layer of smooth muscle cells.  As seen in Figure 3.16A, Lamin A expression 
is absent in the smooth muscle cells, but present in other cells.  We used the 
Figure 3.15 Smooth Muscle Specific Lmna9  Exhibit Retarded Growth and Die Early.  A. Lmna9/-
SM22α-cre+/-  (purple, median:52.5, n=26) lives up to 70 days after birth as compared to only up to 30 
days for Lmna9/9 (red, median: 21, n=40).  Lmna9/Flox SM22α-cre+/+ (blue, n=41) live as long as WT 
mice (green, n=31). B. Lmna9/-SM22α-cre+/-  shows growth retardation at about 10 days after birth (red, 
n=16) as compared to Lmna9/9which shows growth retardation as early as 4 days after birth (yellow, 




N18 Lamin A antibody (Santa Cruz Biotechnology) which was raised against 
the N-terminus of Lamin A of human origin.  It will be able to detect Lamin A, 
Lamin C and potentially low levels of Lmna
9
.  As a control, Lamin B1 
expression was also investigated and was found to be present in all cells 
(Figure 3.16B).  This shows that only Lamin A is expression is specifically 
floxed out in smooth muscle cells.   
 
 
Figure 3.16 Lmna9 is Expressed Specifically in Smooth Muscle Cells.  A. Immunofluorescence staining on 
stomach cryo-sections from 6-week old mice showed that Lamin A is absent specifically in smooth muscle 
cells, as highlighted by the white arrows.  Smooth Muscle α-Actin is shown in red to highlight which cells 
are smooth muscle cells.  B. As a control, immune-fluorescence was also performed with Lamin B1, which 







Mice Expressed Reduced Levels of ECM 
Components Most Significantly in the Arteries
 
With the results above, we investigated the levels of ECM components 
in the original Lmna
9/9 
mice, specifically in the arteries.  Whole arteries and 
other control tissues - skeletal muscle and hearts were removed from both 
Lmna
9/9  
and wildtype control 18 day old mice. When we re-examined whole 
tissues, we selected that ECM components which had shown the most 
Figure 3.16 (continued 
from previous page) 
Lmna9 is Expressed 
Specifically in Smooth 
Muscle Cells.  A. 
Immunofluorescence 
staining performed on 
stomach cryo-sections from 
6-week old mice showed that 
Lamin A is absent 
specifically in smooth 
muscle cells, as highlighted 
by the white arrows.  
Smooth Muscle α-Actin is 
shown in red to highlight 
which cells are smooth 
muscle cells.  B. As a 
control, immune-
fluorescence was also carried 
out with Lamin B1, which is 
expressed in the smooth 




significant reduction in Lmna
9/9 
mice compared to wildtype mice including 
Collagen Type 1 (Coll1a1), Elastase 1 (Ela1), Collagen Type 2 (Coll2a1) and 
Elastin (Eln).  When we compared the transcript levels of these ECM 
components between three different tissues – heart, skeletal muscle and 
arteries – we found that the most significant reduction in expression levels was 
in the Lmna
9/9 
arteries as compared to skeletal muscle and heart (Figure 
3.17A to 3.17C).  It is also intriguing that the ECM component levels in the 
Lmna
9/9 
heart are not significantly different from wildtype mice.  When we 
re-examined more ECM components specifically in the arteries, we observed 
that the expression levels of all the components were significantly reduced as 




   
 
Figure 3.17 ECM Component expressions in Specific Tissues of Lmna9/9 mice. Relative quantitative 
PCR in whole tissues from 18-day old mice from both Lmna9/9 and Wiltype in A. Heart, B. Skeletal 
Muscle and C. Arteries.  Coll1a1: Collagen Type 1, Ela1: Elatase 1, Coll2a1: Collagen Type 2, Eln: 







Figure 3.18 ECM Components in Arteries of Lmna9/9  mice are Significantly Reduced. Relative 
quantitative PCR in whole arteries from 18-day old mice from both Lmna9/9 and wildtype in arteries.  
Col1: Collagen Type I,  Col3: Collagen Type III, Col4: Collagen Type IV,  Col5: Collagen Type V, Eln: 
Elastin, Fbn: Fibrillin; *P<0.01; n=4; Error bars are SEM.   
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3.3 Discussion  
HGPS is caused by the defective posttranslational processing of LMNA 
to its mature form.  A premature splice donor site is created at Exon 11 as a 
result of C to T nucleotide substitution at position 1824 of LMNA gene [33, 
124, 144, 174].  The presence of the premature splice donor causes a 50 amino 
acid in-frame deletion within the C-terminal domain of Lamin A.  The 
deletion also removes another endoproteolytic cleavage site, resulting in a 
truncated Lamin A protein (Progerin) that remains farnesylated [175].  
Similarly, the Lmna
9 
mutation results in the in-frame deletion of 40 amino 
acids from the Ig fold domain of Lamin A.  It has been suggested that the 
deletion affects the conformation of the Ig fold, preventing the endoprotease, 
ZMpste24, from recognising the second endoproteolytic site.  This results in 
the Lmna
9 
protein that remains farnesylated.  This feature is important 
because it reproduces a similar molecular situation that occurs at the LMNA 
locus of HGPS patients unlike other progeroid mouse models, such as the 
Zmpste24-deficient mice which only phenocopy some alterations present in 
HGPS patients, but does not reproduce the molecular situation that occurs in 
the LMNA locus of patients [48, 50]. 
Another important characteristic of HGPS is that patients are born 
normal with symptoms only appearing at 6 to 12 months [176]. This 
phenotype is similar to Lmna
9/9  
mice, which are born normal with growth 
retardation starting during the first week and death occurring at 3 to 4 weeks 
[158].  This is in contrast to another mouse model which was generated to 
express specifically Progerin, in which the mice exhibits detectable phenotype 
only 3 to 4 weeks after birth and have an average lifespan of 103 days [159].  
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This makes the Lmna
9/9 
mouse model a valid and comparative resource to 
determining the pathological consequences of a persistently farnesylated, 
truncated Lamin A protein [144].   
The discovery of apoptotic cells in the arteries of Lmna
9/9  
mice as 
well as the reports of VSMC depletion in HGPS patients [118] prompted us to 
focus on the effects of Lmna
9 
specifically in the smooth muscle cells. We 
performed this by using the Cre-Lox system that expresses the Cre 





in one allele and a Lmna gene which has 
been flanked with Lox P sites, in the other allele.  Cre recombinase which is 
expressed in the SMCs will delete the Lmna
 
gene, leaving only the expression 
of Lmna
9 
in the specific tissue.  This provides a very useful method of 
targeting specific tissues to express genes of interest.  However, there are a 
few limitations in this system – the first being that it is unsuitable for gene 
targets that may result in pre-natal death. In such cases, inducible Cre systems 
can be used instead [177]. This is not applicable in our case as the mutant mice 
survive post- natal. Another limitation is the need to determine the efficiency 
of the Cre-LoxP system.  In our case, we have used the double reporter 
mT/mG mice which allows the label not only cells after Cre-mediated 
recombination, but also non-recombined cells.  When crossed with the 
SM22α-CreKI mice, the Cre recombinase expression is observed to be specific 
in smooth muscle cells.  
In using the Cre-LoxP system, it is important to include relevant 
controls to ensure that phenotype observed is caused specifically by the 
deletion of the gene of interest.  Besides wildtype mice, we also included 
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additional controls such as the Lmna
9/flox 
SM22α-cre+/+ and Lmna-/- SM22α-
cre
+/- 
in our comparison to show growth retardation and early death is caused 
specifically by the expression of Lmna
9 
in the SMCs and not secondary 




induces a much 




results in complete Lmna 
null mice that does not express all isoforms of Lamin A, including Lamin C, 
and the homozygote mutants  live up to 3 weeks [61].  As compared to 
Lmna
9/9 
mice which survives only up to 3 weeks,  Lmna
9/-
SM22α-cre+/- 
mice survives up to two months.  This difference may be attributed to 
compensatory measures present in the in vivo system.  It is possible that while 
SMCs are the main components of tissues that are most significantly affected 
by Lmna
9 
expression, there might be other possible contributing factors.  For 
example in the mice expressing Progerin, Lmna
G609G/G609G  
it was observed that 
there were altered circulating plasma concentrations of various hormones and 
other biochemical markers.  They reported that in 2 month old mice,  
Lmna
G609G/G609G
 showed a decrease in serum glucose concentrations, relative 
to wild-type mice, an alteration that worsened with age, and leading to 
extreme hypoglycaemia [159].   In addition, Lmna
G609G/G609G
 mice showed 
decreased serum levels of insulin-like growth factor 1 (IGF-1), insulin and 
leptin and increased levels of growth hormone (GH) and adiponectin relative 
to wild-type mice [159].  It is also possible that a single copy expression of 
Lmna
9 
may result in a less severe phenotype.   
It is intriguing that the phenotype of the expression of Lmna
9 
in 
smooth muscle cells alone could result in the severe phenotype reported above.  
Smooth muscle cells are main contributors of ECM production in the 
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vasculature and this clearly indicates the important role played by Lmna
9 
in 
the ECM production, presumably through the Wnt signalling pathway, as 
shown previously in Hernandez et al.  Another reason as to why this result is 
important is because in a previous experiment which targets the expression of 
Lmna
9 
specifically in Collagen Type 2 expressing cells (primarily in the 
skeletal system), the mice were reported to show only slight growth 
retardation and but not in longevity (personal communication with Dr Colin 
Stewart).   
For future work, we will be investigating the level of expression of 
ECM proteins, additional apoptotic markers and Wnt signalling factors such as 
Lef1 specifically in the arteries.  In addition, it would be necessary to look 
more closely at the different parts of the artery as they have been shown to 
originate from different embryonic lineages[146].  And the diversity of SMC 
origins may in part contribute to site specific localization of vascular disease, 
including regional susceptibility to atherosclerosis, vascular calcification and 
aortic aneurysm [147, 178, 179].  In addition, there have been reports of 
HGPS patient who showed high hemodynamic stress in the aortic arch region 




Chapter 4: In Vitro Human Studies 
4.1 Introduction 
Disease modeling using in vitro human systems is an essential means 
to understanding the detailed pathology of vascular diseases.  Mouse models, 
such as those that have been genetically modified by targeting specific genes, 
have undeniably been useful for studies into a variety of diseases.  However, 
there remain significant limitations when modeling human diseases due to 
many factors including inter-species differences in metabolic and biochemical 
physiology, susceptibility to disease causing factors and underlying 
differences in genomic organization[145]. Moreover, drugs used in animal 
models are not always effective for humans [180] and many genetic variants 
associated with human diseases are located in non-coding regions that show 
relatively little evolutionary  conservation, indicating that their modification in 
animals is unlikely to result in phenotypes relevant to the specific human 
disease [181].  It may also be difficult to recapitulate the gain and/or loss of 
function of the disease causative proteins in human disease [182] by the 
genetic modification of mice or other rodents.  An example is the statin, 
Compactin, which initially did not undergo human clinical trials, since it was 
not effective for rats, but was later properly validated in humans [183]. The 
reasons above clearly indicate the usefulness of using human cells/tissues for 
drug evaluation.  





it would also be useful to perform human in vitro studies to determine if there 
are any similarities or differences between this specific mutant line and the 
pathology associated with HGPS.  In addition, human in vitro systems may 
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also be more useful for future drug screens.  Therefore, our next step was to 
create an in vitro system to study vascular smooth muscle cells (VSMCs) 
established from HGPS iPS stem cells to determine if we could establish a 
reproducible model to study vascular degeneration in vitro. 
4.1.1 Embryonic Development of Vascular SMC 
One of the most critical events in embryogenesis is the formation of 
the three germ layers – ectoderm, mesoderm and endoderm during 
gastrulation.  In mice gastrulation is marked by the formation of the primitive 
streak in the posterior region of the epiblast at embryonic day 6.5 [184] and at 
the beginning of the third week in humans [185]. Cells from different region 
of the primitive streak undergo epithelial to mesenchymal transition (EMT) to 
form the extra embryonic mesoderm, embryonic mesoderm and endoderm. 
VSMCs are thought to arise from multiple, independent origins [145, 146].  
VSMCs of the ascending aorta, the aortic arch and pulmonary trunk are neural 
crest derived [145, 186] and VSMCs in the descending aorta originate from 
somatic mesoderm [145, 187].  Fate mapping studies suggests that progenitors 
for coronary VSMCs are found in the proepicardium that originates from the 
lateral plate mesoderm [145, 188].  Through in vivo studies, using lineage 
tracing in chick embryos, it has been reported that VSMCs at the base of the 
aorta and pulmonary trunk originate from the secondary heart field [145, 189].  
A summary of the different embryological origins for aortic VSMCs and 
mesoderm patterning is shown in Figure 4.1A [145].  
In the early stages of development, neural tissue is induced in the 
ectodermal layer of the embryo that is separated into three different layers.  
One of the layers, consisting of the neural cells at the border between the 
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neural and non-neural ectoderm, contributes to the formation of peripheral 
neurons, glial cells, and VSMCs of the ascending aorta, aortic arch and 
pulmonary trunk [145, 186, 190].  The induction of neural crest precursors 
occurs at the edge of the neural plate and is regulated by multiple signaling 
pathways including bone morphogenetic protein (BMPs), Wnts, fibroblast 
growth factor (FGFs) and notch  pathways [145, 191, 192].  In addition, 
previous studies have shown that diminished BMP signaling promotes neural 
induction during vertebrate development [145, 193].   
Endothelial cells (EC) and VSMCs are vascular cells that are 
predominantly derived from the mesoderm lineage.  The mesoderm subtypes 
which include axial, paraxial, intermediate, and lateral plate mesoderm, are 
formed in order of their proximity to the primitive streak, which is the key 
structural component that discriminates the mesodermal precursors [145, 194-
197].  The patterning of mesoderm is influenced by multiple signaling 
gradients, growth factors, and transcriptional factors and is generally 
conserved across species [145, 198-200].  It has also been shown, in Xenopus 
embryos, that higher concentrations of BMP4 facilitate the formation of the 
lateral plate mesoderm while low concentrations give rise to paraxial 














4.1.2 Generation of VSMCs from Human Embryonic Stem Cells  
Human embryonic stem cells (ESCs) are derived from the inner cell 
mass of the blastocyst, are pluripotent and are useful for studying early human 
embryonic development and differentiation.  They are equivalent to the 
epiblast stage of development, and it is possible to differentiate them into all 
embryonic lineages [202].  To date, a number of in vitro methods for 
differentiation of human embryonic stem cells into VSMCs have been 
described [203-206].  The first method is by embryoid body (EB) formation 
followed by treatment with growth factors.  The formation of EBs is a route to 
studying the molecular mechanism of VSMC differentiation in an 
Figure 4.1. Distinct embryological origins for aortic SMCs and mesoderm patterning. A Schematic showing 
different embryonic tissues that contribute to SMCs in different vascular regions. Neural crest gives rise to 
SMCs in the ascending aorta and arch while the descending aorta is derived from the somites. The aortic root 
base originates from the secondary heart field, a lateral plate mesoderm derivative, while coronary SMCs arise 
from the proepicardium, also a lateral plate derivative. B Schematic of proximal–distal BMP gradient depicted 
in the murine E7.5 embryo. Local BMP concentration patterns cells emerging from the primitive streak into 
different mesoderm subtypes. Adapted from Sinha et al. Cell Mol Life Sci. 2014. 
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environment that recapitulates early embryonic development.  This approach 
is complemented by cell sorting using surface markers by fluorescence-
activated cell sorting (FACS) or magnetic bead sorting (MACS) to enrich for 
specific cell types followed by their differentiation.  This is an efficient way to 
induce differentiation selectively into a VSMC or endothelial lineage [204].  
Thirdly, through culture on polymers such as collagen, fibronectin, or on 
feeder cells that mimics the micro-environment found within mammalian 
tissues, this approach can result in differentiation towards functional 
VSMCs[207, 208]. Lastly, cells can be stimulated to form VSMCs by growth 
in the presence of soluble factors such as Platelet-Derived Growth Factor-BB 
(PDGF-BB) and TGF-.   
Recently, Cheung et al reported a chemically defined method for 
generating origin-specific vascular SMCs from human pluripotent stem cells 
through the intermediate lineages, that represent the embryonic origins of the 
majority of vascular VSMCs, namely the neuroectoderm, lateral plate 
mesoderm, and paraxial mesoderm [147].  Intermediate lineages treated with 
PDGF-BB and TGF-β1 for 12 days resulted in differentiated VSMC that 
expressed SMC markers and displayed contractile function.  Validation studies 
performed on these cells, included determining the expression of the 
myocardin-related transcription factor-B (MKL2) for VSMC differentiation 
from neuroectoderm, and the increased proliferation of neuroectoderm-derived 
VSMCs when exposed to angiotensin II or TGF-β1.  These validation steps 
recapitulated previously described differences between distinct VSMC 
populations in vivo [145, 147, 209, 210].  These data suggest that the VSMCs 
produced are in all likelihood origin-specific [145].  The establishment of this 
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in vitro model expands the limitations faced in studying origin specific 
differences in human VSMC and also overcomes the practical difficulties 
associated with obtaining sufficient quantities of healthy human VSMCs from 
a variety of anatomical locations.  More importantly, this method offers a way 
to generate large numbers of lineage specific VSMC subtypes with high 
efficiency from a single pluripotent source that may be used for comparative 
studies on disease development [145]. With the development of patient 
specific induced pluripotent stem cell (iPSC)-based systems, the usefulness of 
this method can be extended even further.   
4.1.3 SMC Disease Modeling Using Induced Pluripotent Stem 
Cells (iPSC) 
 Human iPSC are established by the transcription factor mediated 
reprogramming of patient derived somatic cells into pluripotent stem cells 
[211]. iPSC disease modeling was first established by Yamanaka et al in 2007 
and this approach has offered tremendous potentials to studying human 
disease mechanisms and searching for potential therapies.  This is especially 
useful in the study of vascular diseases where there are practical issues in 
obtaining human tissues. Furthermore surgical specimens usually represent 
end-stage disease, making it difficult to identify the initiators of disease or to 
delineate cause and effect [145]. In addition, an advantage of using patient-
derived iPSCs, e.g. from HGPS patients, the resultant VSMCs not only 
contain the disease causing mutation, but also have the permissive genetic 
background that is required for full expression of the disease [145]. 
A number of studies using iPSCs to model HGPS and elastin 
deficiency have recently been published [212-214]. In collaboration with Dr 
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Alan Colman’s group in IMB, we were the first to show, using HGPS iPSCs 
that VSMCs were among the most severely affected differentiated cell types. 
Defects in VSMCs in HGPS patients are associated with accelerated 
atherosclerosis, a key pathology associated with HGPS [141]. 
In this chapter, iPSC lines were derived from patient derived 
fibroblasts and differentiated into mesenchymal and non-mesenchymal 
lineages to analyze the impact of Progerin on the functional properties of the 
different cell types.  In our previous report we found that that Progerin levels 
are highest in mesenchymal stem cells, VSMCs, and fibroblasts, and lowest in 
neural progenitors [141].  Progerin expressing VSMCs, and MSCs, but not 
controls were sensitive to hypoxia and HGPS-MSCs failed to mediate 
circulatory restoration in a murine hind limb ischemia model [141].  Of note 
the VSMCs used in these studies were differentiated using the EB 
methodology discussed earlier.  Using the established HGPS-iPS cells from 
this study, I differentiated them into the specific lineages using the in vitro 
model established by Cheung et al [147] to investigate if there are any specific 
differences in susceptibility to Progerin between the different VSMC lineages.   
4.1.4 Proximity-dependent biotin identification (BioID) to 
identify potential differences in the protein interactome between Progerin 
and lamin A expressing VSM 
I used BioID system to identify potential differences in the protein 
interactome between Progerin (HGPS) and Lamin A (WT) expressing 
VSMCs. It is hoped that such an approach would identify the molecular 
pathways disrupted by Progerin in the VSM of HGPS patients.  BioID utilizes 
the expression of a “bait” protein fused to a promiscuous biotin ligase (BirA*). 
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The promiscuous BirA* ligase will biotinylate any lysine residue within 10-
20nm of the “bait” protein. Such biotinylated proteins are isolated by 
streptavidin beads and identified by Mass Spectroscopy. The proximity of 
such proteins would then reveal them to be potential interactors with either 
Lamin A or Progerin [215-217].  This approach has been successfully used to 
screen for constituents of nuclear lamina [215], nuclear pore complexes [216], 
cell junction complexes [218-220], centrosomes [221, 222] and also for 
proteins involved in the Hippo signaling pathway [223].  A schematic diagram 







Figure 4.2 The BioID method. A 
Expression of a promiscuous biotin–
ligase fusion protein in live cells leads 
to the selective biotinylation of 
proteins proximate to that fusion 
protein. After stringent cell lysis and 
protein denaturation, biotinylated 
proteins are affinity purified. These 
candidate  proteins can be identified 
by mass spectrometry or immunoblot 
analysis. B In our application of 
BioID to Lamin A to identify 
candidate proteins we used HEK293 
cells stably expressing inducible 
mycBirA*Lamin A. 24 h before lysis, 
cells were induced to express 
mycBirA*LaA with doxycycline and 
to biotinylate endogenous proteins 
with 50 μM biotin. Cells were lysed 
under stringent conditions and  
biotinylated proteins collected on 
streptavidin-conjugated beads for 
subsequent analysis and 
identification.  Adapted from Roux 
KJ et al. J Cell Biol. 2012 
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4.1.5 Approach to Modeling In Vitro systems 
We established an in vitro HGPS VSMC differentiation system using 
two approaches.  In the first, we used a previously established iPSCs from 
both HGPS and control patient fibroblasts.  These iPSCs were differentiated to 
the different embryonic lineages that form VSMCs and correspond to specific 
regions of the vascular system.  The second approach we took, was to use 
commercially available VSMCs and stably transfect them with inducible 
vectors expressing either LMNA or Progerin. When induced, these vectors 
allow the expression of BirA* tagged LMNA or Progerin proteins, allowing us 
to capture and analyse potential protein-protein interactions and determine if 






4.2.1 Directed Differentiation of Stem Cells into Different Lineages 
of VSMCs 
iPS cells used for this project had been previously established and 
characterized  Zhang et al [141, 213].  HES2 was a gift from Dr Gordon Keller 
and are chromosomally euploid.  Directed differentiation of HGPS-iPS 
(differentiated into PG1-1-VSMC), control-iPS (differentiated into N1-1-
VSMC) and HES2 (differentiated into HES2-VSMC) controls was performed 
using protocols developed by Cheung et al [147].  The three different lineages 
into which the stem cell lines were differentiated were neuroectoderm (NE), 
lateral plate mesoderm (LM) and paraxial mesoderm (PM).  For 
neuroectoderm differentiation, fibroblast growth factor 2 (FGF2) and the 
activin/nodal inhibitor SB431542 were used to induce differentiation.  For 
mesoderm differentiation, the lines were induced first using the early 
mesoderm differentiation protocol for the first 36 hours and subsequently 
followed by a more specific differentiation protocol to for the two mesoderm 
subtypes – LM and PM.  For early mesoderm differentiation, a combination 
(termed as FlyB) of FGF2, phosphoinositide 3-kinase (PI3K) inhibitor 
(LY294002) and bone morphogenetic protein 4 (BMP4) were used.  During 
embryogenesis, specification of LM and PM follows a posterior-anterior BMP 
gradient along the primitive streak [147, 201].  As such, optimization of 
protocols set out by Cheung et al indicated that combination of FGF2 and 
LY294002 (termed as FLy) would be required for paraxial mesoderm 
differentiation while FGF2, BMP4 (termed as FB50) are required for lateral 
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mesoderm differentiation.  A summary of the mesoderm subtype 






4.2.2 Characterization of Early Differentiation Markers  
We extracted RNA at different time points of differentiation and Q-
PCR was performed to monitor mesoderm differentiation.  MEOX1, TCF15 
and TBX6 are paraxial markers and as expected are expressed more in PM in 
all three lines compared to LM lines (Figures 4.4A to 4.4C).   
Figure 4.3  Induction of mesoderm subtypes from Human Pluripotent Stem Cells. A iPSCs and HES2 
were initially differentiated to early mesoderm using FGF2, LY294002 and BMP4 (depicted as FLyB) 
for 36 h. Mesoderm subtype specification required another 3.5 d of FGF2+LY294002 (FLy) or 
FGF2+BMP4 (FB) for paraxial or lateral plate induction. B  BMP concentration gradient exists along 
the primitive streak (PS). On the basis of fate map studies, mesoderm subtypes emerge along the 







4.2.3  Characterization of VSMC Markers 
Next we investigated the expression of VSMC markers to determine if 
the lines have indeed differentiated into VSMCs.  We extracted RNA from 
samples at the start of the differentiation and at day 15 of differentiation.  We 
analyzed at 2 sets of VSMC markers – the early and late markers.  Early 
VSMC markers consist of Smooth Muscle Actin Alpha 2 (ACTA2), 
Transgelin/SM22α (TAGLN) and Calponin 1 (CNN1).  Cheung et al showed 
that these early marker are up-regulated between days 9 and 12 of 
differentiation.  As expected, the transcript levels of these early markers are 
elevated in all the three lines that were differentiated in VSMC as seen in 
Figure 4.4 Early Differentiation Markers for Paraxial Mesoderm. Temporal qRT-PCR to analyze mesoderm 
specification. After a common 36-h treatment of FLyB, lateral and paraxial mesoderms were specified using 
FB50 and Fly,  respectively.  HES2-VSMC, N1-1-VSMC and PG1-1VSMC were subjected to qRT-PCR  to 
check for levels of (A) Meox1, (B) TBX6 and (C) TCF15.  Data represent means were normalized Day 0 . 
Error bars represent SEM.   
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Figure 4.5A, Figure 4.6A and Figure 4.7A.  In addition, immuno-fluorescence 
staining was performed to determine protein expression of CNN1 and 
TAGLN.  As seen in Figure 4.5B, Figure 4.6B and Figure 4.7B, these two 
proteins are expressed in the differentiated SMCs.   
 
 
 Figure 4.5 Early VSMC marker characterization during HES2 differentiation. A. qRT-PCR of early 
VSMC markers, ACTA2, CNN1 and TAGLN.  Data represent means and were normalized to Day 0. 
Error bars represent SEM.  B. VSMC subtypes immunostained positively for CNN1 and TGLN .  Scale 











Figure 4.6 Early VSMC marker characterization in N1-1 differentiation A. qRT-PCR of early VSMC 
markers - ACTA2, CNN1 and TAGLN.  Data represent means and were normalized to Day 0. Error bars 
represent SEM.  B. VSMC subtypes immunostained positively for CNN1 and TGLN .  Scale bar 













Figure 4.7 Early VSMC marker characterization in PG1-1 differentiation. A. qRT-PCR of early VSMC 
markers, ACTA2, CNN1 and TAGLN.  Data represent means and were normalized to Day 0. Error bars 
represent SEM.  B. VSMC subtypes immunostained positively for CNN1 and TGLN .  Scale bar represent 




4.2.4  Characterization of LMNA/C and SUN1 
Next, we investigated the expression of the nuclear envelope/lamina 
proteins - Lamin A/C (including Progerin) and SUN1.  As expected, Lamin 
A/C transcript levels increased following the onset of differentiation (Figure 
4.8, Figure 4.9 and Figure 4.10).  This is expected as LMNA/C expression is 
absent in stem cells and is only initiated upon differentiation [56].  When we 
performed immuno-fluorescence on the cells, we noticed that a subtype of 
populations expressed higher levels of SUN1 (Figure 4.10C).  At the same 
time, when we looked at Progerin protein expression in the VSMCs derived 
from HGPS, iPS, we noticed that only a sub-population of cells expressed 
Progerin (Figure 4.10B).  This is not surprising as the cells were just 
differentiated from a stem cell state, and would require a few passages for 
Progerin to accumulate [141] .  More interestingly, when we co-stained for 
both Progerin and SUN1, we observed that the cells that expressed higher 
levels of SUN1 were also the same cells that expressed Progerin (Figure 
4.10D).  This supports the finding that we reported in our recent publication 
where we observed that there was increased SUN1 expression levels in 
fibroblasts derived from Lmna, Lmna
Δ9
 and HGPS patients compared to those 


















Figure 4.9 Lamin A/C and SUN1 levels in N1-1-VSMC Differentiation. A. qRT-PCR of Lamin A/C of 
the 3 lineages.  Data represent means and were normalized to Day 0. Error bars represent SEM .  (B) 
VSMC subtypes immunostained positively for Lamin A/C and SUN1.  Scale bar represent 100μm. 
 
Figure 4.8 Lamin A/C and SUN1 levels in HES2-VSMC Differentiation. A. qRT-PCR of Lamin A/C of the 3 
lineages.  Data represent means and were normalized to Day 0. Error bars represent SEM .  B. VSMC subtypes 








Figure 4.10 Lamin A/C and SUN1 levels in PG1-1-VSMC Differentiation. A. qRT-PCR of Lamin A/C 
of the 3 lineages.  Data represent means and were normalized to Day 0. Error bars represent SEM .  B. 
VSMC subtypes immunostained positively for Lamin A/C and Progerin.  Scale bar represent 100μm. C. 
VSMC subtypes immunostained positively for SUN1.  Scale bar represent 100μm. (D) VSMC subtypes 




4.2.5  3T3 assay of differentiated VSMCs proliferation 
To determine what effect Progerin would have on VSMC proliferation, 
we monitored their proliferation using the 3T3 proliferation assay.  Previous 
results show that HGPS fibroblasts undergo, a sudden catastrophic loss of 
proliferative capacity, at relatively early passage [225]. Here we sought to 
determine if similarly, a decreased proliferative capacity is seen in the  
VSMCs derived from the different lineages. Our preliminary 3T3 findings 
suggested that the VSMCs derived from HGPS-iPS lines had a lower 
proliferation rate in general, compared to VSMCs derived from Normal-iPS 
lines (Figure 4.11).  In the HGPS-VSMCs, we observed that in particular, the 
LM lineage has the slowest proliferation rate compared to the PM and NE 
lines.  This is intriguing because the PM VSMC corresponding to the aortic 
root, and appears to be a common site in which artery defects arise due to high 
hemodynamic stress.  However, it is possible that the embryonic origin of the 
VSMCs may have some influence in their susceptibility to hemodynamic 
stress and/or Progerin expression, resulting in a differential loss in the 
structural integrity at different regions along the aortic wall, as suggest by 
Cheung et al [147]. 
However, these experiments will be extended to determine if the 
different VSMC lineages all undergo a sudden decline in proliferative capacity 














4.2.6  Identification and characterization of the Lamin A and 
Progerin Interactomes 
 Pulmonary Artery Smooth Muscle Cells (PASMCs) acquired from 
Gibco, were stably transfected with a lentiviral vector (developed by A 
Chojknowski in the CLS lab) in which the expression of Lamin A or Progerin 
proteins, tagged with BirA, can be reversibly induced in a quantitative manner 
using doxycycline at a specific concentration.  After selection and induction 
for 2 weeks,  protein extracts were prepared for Mass Spectrometry analysis.  
These Lamin/Progerin proteins were also tagged with a Myc epitope, that was 
Figure 4.11 Cumulative 3T3 Assay of Progeria and Control – iPS derived SMCs of Different Lineages. A.  
Long term proliferation rate of VSMCs of different lineages were monitored using 3T3 assay.  Equal number of 
cells were seeded and every 3 days, cells were trypsinised and counted.  In general, HGPS-iPS derived VSMCs 
(PG1-1 NE, PG1-1 PM, PG1-1 LM) showed lower proliferation rate in compared to Control-iPS derived 
VSMCs (N1-1 NE, N1-1-PM, N1-1 LM).  PG1-1 LM observed to have the slowest proliferation rate.  B. Dotted 
red line highlights the region in the artery corresponding to the PG1-1 LM.   
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used as a marker to monitor the expression and localization of the tagged 
lamin/Progerin in cells expressing endogenous lamins.  
Nuclear and cytoplasmic proteins were extracted separately and as 
seen in Figure 4.12, the expression of Myc epitope, which corresponds to the 
tagged Bir-A protein, was only detected in cells which have been induced with 
doxycyclin (Dox).  No Myc signal was detected in the cytoplasmic extracts, 
indicating that the tagged proteins are localized to the nucleus.   
Immunofluorescence experiments were also performed and verified the 
that expression of the tagged BirA*-proteins in vitro was localized to the 
nucleus.  As expected, only cells which have been induced, showed expression 
of Myc protein.  Further immuno-fluorescence experiments were performed, 
to analyse the expression of the lamina proteins Lamin B1, Lamin B2, as well 
as other VSMC specific markers including Calponin, and Smooth Muscle 
Alpha-Actin (Figures 4.13 and Figure 4.14). Cells were induced for at least 2 
weeks, before the addition of biotin and subsequent protein extraction for mass 
spectrometry analysis.  Potential candidates (listed in Table 4.1) have been 
identified, however, the experiments need to be repeated and the candidates 
verified.   
 
Figure 4.12 Western Blot was carried out using nuclear and cytoplasmic protein extracted from PASMC 
which have been stably transfected with a lentiviral vector with inducible Lamin A or Progerin tagged with 
BirA.  Cells were selected and induced for at least 2 weeks before extraction.  GAPDH was used as loading 




 Figure 4.13 Nuclear Envelope Protein Expression in PASMCs transfected with inducible LMNA and 
Progerin. Immunofluorescence to show expression of A. PASMC control, PASMCS with induced and 
non-induced LMNA and Progerin were stained with anti-Lamin B1 (red), c-Myc (green) and DAPI (blue).  
B. PASMC control, PASMCS with induced and non-induced LMNA and Progerin were stained with anti-














Figure 4.14 VSMC Marker Protein Expression in PASMCs transfected with inducible LMNA and 
Progerin. Immunofluorescence to show expression of A. PASMC control, PASMCS with induced 
and non-induced LMNA and Progerin were stained with SMA  (red), Lamin B1 (green) and DAPI 
(blue).  B. PASMC control, PASMCS with induced and non-induced LMNA and Progerin were 
stained with anti-Calponin (green), Lamin B2 (red) and DAPI (blue).WT, Scale bar represents 50μm 
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Table 4.1 List of Potential Candidates In Close Proximity with LMNA and Progerin in VSMCs.   
A. Potentially Interacts with Both LMNA and Progerin 
GS Name 
HIST1H2AA H2A1A_HUMAN Histone H2A type 1-A  
HIST1H1E H14_HUMAN Histone H1.4  
GTF2A2 T2AG_HUMAN Transcription initiation factor IIA subunit 2  
MYL6 G3V1V0_HUMAN Myosin light polypeptide 6  
PRSS23 B4E2J3_HUMAN Serine protease 23  
SAR1B D6R9R5_HUMAN GTP-binding protein SAR1b (Fragment)  
POM121C P121C_HUMAN Nuclear envelope pore membrane protein POM 121C  
COL5A1 CO5A1_HUMAN Collagen alpha-1(V) chain  
PML PML_HUMAN Protein PML  
COL6A3 E7ENL6_HUMAN Collagen alpha-3(VI) chain  
AHNAK AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK  
  
B. Potentially Interacting with Progerin only 
GS Name 
ITGAM H3BMV4_HUMAN Integrin alpha-M (Fragment)  
ACTG1 I3L3I4_HUMAN Actin, cytoplasmic 2, N-terminally processed 
RCC1 H7C497_HUMAN Regulator of chromosome condensation (Fragment)  
KRT5 H0YI76_HUMAN Keratin, type II cytoskeletal 5 (Fragment)  
COQ4 COQ4_HUMAN Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial  
SORBS2 H7C1R7_HUMAN Sorbin and SH3 domain-containing protein 2 (Fragment)  
TAF2 H0YC37_HUMAN Transcription initiation factor TFIID subunit 2 (Fragment)  
LUC7L H7C2U4_HUMAN Putative RNA-binding protein Luc7-like 1 (Fragment)  
RPS15 S4R456_HUMAN 40S ribosomal protein S15 (Fragment)  
RHPN2 B3KX27_HUMAN Rhophilin-2  
RAPSN E9PJP9_HUMAN 43 kDa receptor-associated protein of the synapse  
MAT1A METK1_HUMAN S-adenosylmethionine synthase isoform type-1  
BSPRY BSPRY_HUMAN B box and SPRY domain-containing protein  
LMNA Q3BDU5_HUMAN Prelamin-A/C  
RP11-397C18.4 Q5T378_HUMAN FERM domain containing 4A, isoform CRA_b  
GLCE H0YNP1_HUMAN D-glucuronyl C5-epimerase  
PTK2 H0YB16_HUMAN Focal adhesion kinase 1 (Fragment) 
POM121B P121B_HUMAN Putative nuclear envelope pore membrane protein POM 121B  
MLL3 H0YMU7_HUMAN Histone-lysine N-methyltransferase MLL3  
CNTROB CNTRB_HUMAN Centrobin  
ADAMTS14 ATS14_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 14  
SRSF9 H0YIB4_HUMAN Serine/arginine-rich-splicing factor 9 (Fragment) 
MRPS33 RT33_HUMAN 28S ribosomal protein S33, mitochondrial  
RPL36A H0Y5B4_HUMAN 60S ribosomal protein L36a (Fragment)  
TAGLN H0YCU9_HUMAN Transgelin (Fragment)  
GS Name 
STOM B4E2V5_HUMAN Erythrocyte band 7 integral membrane protein  
PDYN PDYN_HUMAN Proenkephalin-B  
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B. Potentially Interacting with Progerin only (continued from previous page) 
GS Name 
HNRNPK Q5T6W1_HUMAN Heterogeneous nuclear ribonucleoprotein K  
HAUS8 HAUS8_HUMAN HAUS augmin-like complex subunit 8  
AP2M1 E9PFW3_HUMAN AP-2 complex subunit mu  
KRT7 K2C7_HUMAN Keratin, type II cytoskeletal 7  
KRT28 K1C28_HUMAN Keratin, type I cytoskeletal 28  
SUN1 H0Y6N5_HUMAN SUN domain-containing protein 1 (Fragment)  
TOR1AIP1 J3KN66_HUMAN Torsin-1A-interacting protein 1  
FAM129B NIBL1_HUMAN Niban-like protein 1  
ACSL5 ACSL5_HUMAN Long-chain-fatty-acid--CoA ligase 5  
COL3A1 E7ENY8_HUMAN Collagen alpha-1(III) chain  
VAV2 VAV2_HUMAN Guanine nucleotide exchange factor VAV2  
MCM10 
Q5T670_HUMAN MCM10 minichromosome maintenance deficient 10 (S. cerevisiae), 
isoform CRA_b  
AHCTF1 ELYS_HUMAN Protein ELYS  
  
C. Potentially Interacting with LMNA only 
GS Name 
H2BFS H2BFS_HUMAN Histone H2B type F-S  
GP2 
I3L324_HUMAN Pancreatic secretory granule membrane major glycoprotein GP2 
(Fragment)  
ANAPC7 H0YIX7_HUMAN Anaphase-promoting complex subunit 7 (Fragment)  
LMNA H0YAB0_HUMAN Prelamin-A/C (Fragment)  
MPV17 H0Y7B6_HUMAN Protein Mpv17 (Fragment)  
GNB1L 
C9JPQ6_HUMAN Guanine nucleotide-binding protein subunit beta-like protein 1 
(Fragment)  
SSH1 H0YHR3_HUMAN Protein phosphatase Slingshot homolog 1 (Fragment)  
PPP4R2 F8WCA1_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 2  
SSPN F5H0K2_HUMAN Sarcospan  
PPME1 F5H2D4_HUMAN Protein phosphatase methylesterase 1 (Fragment)  
Q9H8V8 YD018_HUMAN Putative uncharacterized protein FLJ13197  
LGALS8 B1ANM0_HUMAN Galectin-8 (Fragment) 
EIF3D B0QYA3_HUMAN Eukaryotic translation initiation factor 3 subunit D (Fragment)  
GLYATL1 E9PP99_HUMAN Glycine N-acyltransferase-like protein 1 (Fragment) 
VAC14 B3KSM8_HUMAN Protein VAC14 homolog  
SERPINF1 I3L3M1_HUMAN Pigment epithelium-derived factor  
RIMS2 E5RI36_HUMAN Regulating synaptic membrane exocytosis protein 2 (Fragment)  
PEX26 F6UBB5_HUMAN Peroxisome assembly protein 26  
HSH2D H7BYQ7_HUMAN Hematopoietic SH2 domain-containing protein  
hCG_1989573 M0R1U2_HUMAN HCG1989573  
KLF2 K7EJ60_HUMAN Krueppel-like factor 2  
ART4 H7C2G2_HUMAN Ecto-ADP-ribosyltransferase 4 (Fragment)  
DVL2 I3L0Z8_HUMAN Segment polarity protein dishevelled homolog DVL-2 (Fragment)  
Q9NSY0-2 NRBP2_HUMAN Isoform 2 of Nuclear receptor-binding protein 2  
HELT HELT_HUMAN Hairy and enhancer of split-related protein HELT  
LINGO1 
H0YMX3_HUMAN Leucine-rich repeat and immunoglobulin-like domain-containing 
nogo receptor-interacting protein 1 (Fragment) 
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C. Potentially Interacting with LMNA only (continued from previous page) 
GS Name 
OR6C4 OR6C4_HUMAN Olfactory receptor 6C4  
GAS2L3 H0YIT6_HUMAN GAS2-like protein 3 (Fragment)  
KIR2DL3 I3L0I9_HUMAN Killer cell immunoglobulin-like receptor 2DL3  
METTL24 MET24_HUMAN Methyltransferase-like protein 24  
RBM43 RBM43_HUMAN RNA-binding protein 43  
CCDC68 CCD68_HUMAN Coiled-coil domain-containing protein 68 
LMNB1 E9PBF6_HUMAN Lamin-B1  
HCAR3 E9PI97_HUMAN Hydroxycarboxylic acid receptor 3  
F8VSI5 F8VSI5_HUMAN Uncharacterized protein  
ASS1 ASSY_HUMAN Argininosuccinate synthase  
PIP4K2A PI42A_HUMAN Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha  
MAPKAPK2 MAPK2_HUMAN MAP kinase-activated protein kinase 2  
IPMK IPMK_HUMAN Inositol polyphosphate multikinase  
KCNJ14 IRK14_HUMAN ATP-sensitive inward rectifier potassium channel 14  
A6NCN2 KT81L_HUMAN Keratin-81-like protein  
MMP20 MMP20_HUMAN Matrix metalloproteinase-20  
DKFZp686F2281 Q68DB1_HUMAN Metastasis-associated protein MTA2  
NOL11 B7Z5V9_HUMAN Nucleolar protein 11  
KRIT1 C9J684_HUMAN Krev interaction trapped protein 1  
Q15046-2 SYK_HUMAN Isoform Mitochondrial of Lysine--tRNA ligase 
GAN GAN_HUMAN Gigaxonin  
LRRC40 LRC40_HUMAN Leucine-rich repeat-containing protein 40  
EMD EMD_HUMAN Emerin  
FBXL18 H0Y6I6_HUMAN F-box/LRR-repeat protein 18 (Fragment)  
RSF1 H0YCN2_HUMAN Remodeling and spacing factor 1 (Fragment)  
PKP1 PKP1_HUMAN Plakophilin-1  
TCEB3B ELOA2_HUMAN RNA polymerase II transcription factor SIII subunit A2  
PSMD2 F5GZ16_HUMAN 26S proteasome non-ATPase regulatory subunit 2  
PAXIP1 H0Y2Z7_HUMAN PAX-interacting protein 1  
COL5A2 H7C157_HUMAN Collagen alpha-2(V) chain  
IFIH1 IFIH1_HUMAN Interferon-induced helicase C domain-containing protein 1  
ADNP ADNP_HUMAN Activity-dependent neuroprotector homeobox protein  
MCM9 MCM9_HUMAN DNA replication licensing factor MCM9  
ANXA2 H0YKS4_HUMAN Annexin (Fragment) 
KIAA1875 K1875_HUMAN WD repeat-containing protein KIAA1875  
RIMBP3C RIM3C_HUMAN RIMS-binding protein 3C  
TRIP11 F5H1Z0_HUMAN Thyroid receptor-interacting protein 11  
SOGA1 H0YDM2_HUMAN Protein SOGA1 (Fragment)  
Q58EX2-2 SDK2_HUMAN Isoform 2 of Protein sidekick-2  
PCSK5 Q5JSG7_HUMAN Proprotein convertase subtilisin/kexin type 5 (Fragment) 
NLRC5 NLRC5_HUMAN Protein NLRC5  
CCAR1 CCAR1_HUMAN Cell division cycle and apoptosis regulator protein 1  
INO80 INO80_HUMAN DNA helicase INO80  
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C. Potentially Interacting with LMNA only (continued from previous page) 
GS Name 
DYNC1H1 DYHC1_HUMAN Cytoplasmic dynein 1 heavy chain 1  
PLEC PLEC_HUMAN Plectin  
SACS SACS_HUMAN Sacsin  
KIAA0947 K0947_HUMAN Uncharacterized protein KIAA0947  
RPS6 A2A3R7_HUMAN 40S ribosomal protein S6  
TMCO6 D6R986_HUMAN Transmembrane and coiled-coil domain-containing protein 6  
URGCP-MRPS24 S4R325_HUMAN Protein URGCP-MRPS24  
TAGLN3 C9J5W6_HUMAN Transgelin-3  
PCK2 
H0YMA5_HUMAN Phosphoenolpyruvate carboxykinase [GTP], mitochondrial 
(Fragment)  
SUMO3 B4DUW4_HUMAN Small ubiquitin-related modifier 3  
NSUN5P1 NSN5B_HUMAN Isoform 3 of Putative NOL1/NOP2/Sun domain family member 5B  
Q6ZSN1 YI023_HUMAN Putative uncharacterized protein FLJ45355  
C4orf51 H0Y9W7_HUMAN Uncharacterized protein C4orf51 (Fragment) 
HNRNPA1 H0YH80_HUMAN Heterogeneous nuclear ribonucleoprotein A1 (Fragment)  
AP2M1 C9JGT8_HUMAN AP-2 complex subunit mu (Fragment)  
GALK2 H0YK10_HUMAN N-acetylgalactosamine kinase (Fragment)  
HNRNPC G3V2D6_HUMAN Heterogeneous nuclear ribonucleoproteins C1/C2 (Fragment) 
LOXL2 E5RFY0_HUMAN Lysyl oxidase homolog 2 (Fragment)  
PID1 PCLI1_HUMAN PTB-containing, cubilin and LRP1-interacting protein  
HIBCH B8ZZZ0_HUMAN 3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (Fragment)  
MCCC2 D6R9R1_HUMAN Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial  
HNRNPA2B1 ROA2_HUMAN Heterogeneous nuclear ribonucleoproteins A2/B1  
PIP4K2A B4DGX2_HUMAN Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha  
ANXA1 ANXA1_HUMAN Annexin A1  
RBM48 RBM48_HUMAN RNA-binding protein 48  
MAP4 H0Y2V1_HUMAN Microtubule-associated protein (Fragment)  
LRMP F5H006_HUMAN Processed lymphoid-restricted membrane protein  
TMC6 TMC6_HUMAN Isoform 2 of Transmembrane channel-like protein 6  
HSPA1A E7EP94_HUMAN Heat shock 70 kDa protein 1A/1B  
MRE11A B3KTC7_HUMAN Double-strand break repair protein MRE11A  
LEPRE1 P3H1_HUMAN Isoform 3 of Prolyl 3-hydroxylase 1  
NLGN2 NLGN2_HUMAN Neuroligin-2 
GFM2 RRF2M_HUMAN Ribosome-releasing factor 2, mitochondrial  
HSPH1 B4DYH1_HUMAN Heat shock 105kDa/110kDa protein 1, isoform CRA_b  
LIMCH1 
H0Y8P3_HUMAN LIM and calponin homology domains-containing protein 1 
(Fragment)  
COL1A2 CO1A2_HUMAN Collagen alpha-2(I) chain  
MVP MVP_HUMAN Major vault protein  
HKDC1 HKDC1_HUMAN Putative hexokinase HKDC1  
KCNB2 KCNB2_HUMAN Potassium voltage-gated channel subfamily B member 2  
LEMD3 MAN1_HUMAN Inner nuclear membrane protein Man1  
NUP153 F6QR24_HUMAN Nuclear pore complex protein Nup153  
FN1 FINC_HUMAN Isoform 11 of Fibronectin  
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C. Potentially Interacting with LMNA only (continued from previous page) 
GS Name 
ITPR1 G5E9P1_HUMAN Inositol 1,4,5-triphosphate receptor, type 1, isoform CRA_d  
MYH6 MYH6_HUMAN Myosin-6  






Previously established iPSCs from both HGPS and control patient 
fibroblasts were differentiated into specific embryonic lineage VSMCs 
corresponding to specific regions of the vascular system, using a recent 
protocol published by Christine Cheung et al.  Differentiated VSMCs were 
characterized and interestingly,  3T3 assays which monitor the long term 
proliferation rate of cells suggests that VSMCs derived from HGPS-iPS lines 
have a lower proliferation rate compared to the VSMCs derived from control-
iPS lines.  In particular, our preliminary data shows that VSMCs of the lateral 
mesoderm lineage showed the slowest proliferation rate. Another interesting 
observation made through immunofluorescence was the occurrence of 
Progerin in cells which showed a higher expression of SUN1 protein.   
The second approach we took, was to use commercially available 
smooth muscle cells and stably transfect them with inducible vectors 
expressing either LMNA or Progerin. When induced, these vectors allow the 
expression of BirA* tagged LMNA or Progerin proteins, allowing us to 
capture and analyse potential protein-protein interactions and determine if 
there are any differences in their interactomes.  The specificity of the 
induction was characterized and as expected, LMNA and Progerin were only 
expressed specifically in the nucleus of cells induced with doxycyclin.   
Currently, we have obtained a list of potential candidates that may interact 
with Lamin A or Progerin in VSMC. Subsequent validation studies are to be 




Despite progress in generating human SMCs in vitro, specific 
embryonic lineage differentiation is not well established until recently [203, 
226, 227].  The present in vitro models of differentiation of SMCs have 
limitations.  The addition of growth factors to the cultures may only be fully 
effective for cells on the exterior of EB that are in direct contact with the 
media [145, 228].  EB differentiation results in a highly heterogeneous 
mixture of derivatives, limiting the efficiency of VSMC differentiation, thus  
making it difficult to isolate them from other cell types. In addition, sorting by 
FACs reduces cell viability, further diminishing the recovery of mature 
VSMCs.  This also increases the risk of including cells at intermediate stages 
during differentiation [145]. Therefore, the method of directed differentiation 
of stem cells into the different lineage of VSMC is a superior method to 
enhance the recovery of VSMCs.  
The study of disease mechanisms and development of potential 
therapies is enhanced by using iPSC -based disease modeling [180]. One 
major advantage of using patient derived iPSCs for modeling genetic diseases 
such as HGPS is that the resultant VSMCs contain both the disease causing 
mutation and also the genetic background that maybe required for the full 
manifestation of the disease [145].  Furthermore, the iPSC-based models offer 
a complementary system of human cells to compare with established mouse 
models.  However, there are several issues that need to be considered when 
using iPSC based VSMC disease modeling.  The first is that iPSC clones are 
generally derived from each patient during reprogramming.  But, individual 
iPSC clones may vary in their ability to generate somatic tissues and their 
subsequent disease phenotype, raising the question of which line or clone to be 
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used for the study.  Another important question to consider is the nature of the 
wild-type or negative controls used in the experiments.  We have to consider 
whether an age-matched and sex-matched wildtype iPSC or sibling derived 
iPSCs can be used.  The best control is to correct the genetic defect in the 
patient-derived iPSCs and show that the disease phenotype is no longer 
present[145].  The increasing use and sophistication of the CRISPr/Cas9 
system of gene manipulation should make this feasible in future experiments.  
To recapitulate the conditions present in HGPS patients, we used a 
method to help us generate cells that would otherwise be difficult to attain.  
We used a previously established iPS cells derived from HGPS fibroblasts and 
normal patient fibroblasts and differentiated them to specific VSMC lineages.  
This allowed us to investigate if the different embryonic origins maybe a 
contributory factor in the VSMCs disease that is characteristic of HGPS.  
These tissues are principally the major blood vessels, such as the aorta and 
coronary arteries that are susceptible to VSMC cell loss and atherosclerosis’ 
[118, 119].  The differentiated HGPS VSMCs were characterized and 
subsequent analysis suggested they are proliferating at a much slower rate as 
compared to VSMCs derived from normal cells. And interestingly, the results 
suggested that the HGPS-iPS-VSMC cells that have the same embryonic 
origins as the aortic root were the ones most affected, with the lowest 
proliferation rate.   
In addition, the Bio-ID system was set up to identify for proteins that 
may be differentially associated with Lamin A/C and Progerin in the VSMCs 
have provided us with a list of potential interactors that will require further 
validation.  The aim here is to compare these results with list of interactors 
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that have been generated from a BIoID analysis of fibroblasts to see if they are 
any proteins only specific to VSMCs.  
In addition to these results I have started a collaboration with Dr 
Sebastian Bayer (from SMART, NUS), to compare blood vessel formation 
between the HGPS/Wt iPSC-VSMC in fluidic chambers.  In this system, an 
optimized number of endothelial cells and smooth muscle cells are seeded and 
co-cultured.  The shape of the resulting vessels and diameter of of the lumens 
are imaged and measurements made to ascertain cell behaviour and size.  
Preliminary results suggest that the iPS-VSMCs were capable of forming 
micro-vascular networks, compared to endothelial cells alone.  More 
interestingly, the HGPS-iPS-VSMC formed vessels that had a significantly 
increased average diameter compared to control iPS-VSMC cells (personal 
communication with Dr Sebastian Bayer).  Although these experiments are 
very preliminary, the results are encouraging and suggest that such a system 
may, in the future, provide novel insights into vascular formation and 
stabilization in HGPS patients. 
For our future work, in addition to expanding on my preliminary 
results we will be looking to differentiate the iPSCs into endothelial cells, for 
comparative analysis, and which can then be used, in combination with the 
iPSC-VSMC, to compare blood vessel development between HGPS and 
normal cells.  We have acquired commercially available endothelial cells and 
have infected them with the BirA-tagged Lamin A or Progerin.  It will be of 
interest to repeat the Bio-ID experiments in endothelial cells to determine if 
there are any tissue specific differences in the protein interactomes between 
HGPS and normal individuals.     
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Chapter 5: Amelioration of Lmna
9 
Phenotype  
5.1  Introduction 
In mammalian systems, inner nuclear membrane (INM) proteins are 
made up of integral membrane proteins that includes the Lamin B receptor 
(LBR), lamin associated polypeptide 1 (LAP1), LAP2 and emerin.  These 
INM typically have a structure comprising a nucleoplasmic N-terminal 
domain, a transmembrane domain and a C-terminal region.  The N-terminal 
region localizes the protein to the nuclear envelope (NE) and the C-terminal 
region is located in the NE lumen.  Most of the INM proteins have short C-
terminal region, suggesting their major roles as membrane anchors, providing 
structural or scaffold functions within the nucleus [229].  However, other NE 
proteins contain a large, conserved C-terminal SUN (Sad1/UNC-84 
homology) domain [229-231], suggesting its roles extend beyond providing a 
structural functions.   
UNC-84 was the first SUN-domain protein identified, initially in 
Caenorhabsitis elegans where it was reported to regulate nuclear migration 
during embryonic development [63, 231].  Another SUN-domain protein 
identified in C. elegans is Matefin/SUN (SUN1).  SUN1 is found to be 
expressed in the embryo and in germ cells, where it is important for both 
embryonic survival and survival of the germ cell linkage [63, 232].   SUN1 
and ZYG-12, a KASH domain protein in C.elegans, form a functional LINC 
complex that is important for chromosomal recombination in meiosis [63, 
233-235]. In this process, the LINC complex is required to transmit forces 
generated by the cytoplasmic microtubule motor protein dynein with the 
microtubule network and centromeres to induce chromosomal clustering or 
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bouquet formation  [235].  The chromosome attachment of SUN1 is regulated 
by phosphorylation-dependent modifications of SUN1 on CK2 consensus 
phosphorylation sites [63, 236].  In C. elegans another LINC complex is 
formed by UNC-84 and UNC-83, which is another KASH domain protein.  
Localization of UNC-83 to the NE is dependent on UNC-84.  UNC-83 
interacts with the microtubule molecular motor proteins kinesin-light chain 
KLC-2, recruiting KLC-2 to the NE and turning the nucleus in the kinesin 
cargo.  Therefore, the UNC-84/UNC-83 LINC complex is important for 
nuclear migration [237, 238]. 
Mammalian SUN1 was first identified by proteomic analysis of NE 
proteins as a mammalian homologue of C. elegans UNC-84 and was later 
confirmed to function as an INM LINC complex protein in mammalian cells, 
required for proper NE localization of Nesprin 2 [81-83].  In yeast-two hybrid 
experiments performed by Haque et al, using the C-terminal domain of Lamin 
A as bait, they identified SUN1 as one of the five interacting proteins of 
Lamin A [229].  Full-length mSUN1 consists of 23 exons spanning 50kb on 
chromosome 5G1 [229].  This region is syntenic with the region on human 
chromosome 7 containing hSUN1, making it highly likely that the proteins are 
true orthologs [229].  
To date, at least seven different isoforms of mSUN1 have been 
identified, with most being expressed in testis, muscle, and brain (Figure 5.1) 
[63, 84, 239]. The shortest isoform, Sun1η, is only detected in the testis, while 
the expression of the other 6 isoforms varies between different tissues.  
Kidney expresses four variants while the liver only expresses 3 different 
isoforms.  It was also observed that the smaller isoforms are restricted to 
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specific tissues and are expressed in the testis, and the brain, and to a lesser 
extent in muscle and heart tissues.  However, the larger isoforms are expressed 
in all tissues tested and are dominant products in the kidney and liver [84].  
The isoforms differ by the variable exon deletions between exon 7 and exon 
10, therefore affecting the N-terminal part of the protein [84].  Full-length 
SUN1 is a type II transmembrane protein with the N-terminal region and the 
C-terminus extending to the NE lumen [63, 82, 84, 240].  The nucleoplasmic 
domain of full-length SUN1 contains characteristic features that include a zinc 
motif, and three hydrophobic domains [84].  However, due to alternative 
splicing, the other isoforms lack nucleoplasmic regions between the zinc 
finger and the TM domain as seen in Figure 5.1B [84].  In an earlier study, it 
was demonstrated that deletions of nucleoplasmic hydrophobic motifs severely 
affect the dynamic properties of the molecule [84, 240].  This highlights the 
importance of the hydrophobic regions located within the nucleoplasmic part 
of full-length SUN1 for effective INM targeting and membrane retention.  
Therefore, deletions of hydrophobic domains were suggested to provoke 
different properties for the respective isoforms [84].  This is shown in the 
studies on the shortest isoform, SUN1η, which lacks the nucleoplasmic 
domains. SUN1η does not form part of the NE of spermatids, but instead 
localizes to the acrosomal membrane system [84, 239].  The deletions of N-
terminus in the different isoforms may impede binding of interacting proteins 
in the nucleus, which in turn may result in the modification of the 
nucleocytoskeletal linkage.  The variable SUN1 isoform expression between 
different tisssues may also be caused by a cell type-specific adaption of NE 








5.1.1 Mouse Models of Sun1 
Currently, there are two mouse lines in which SUN1 has been deleted.  
The first model was developed by Ding et al [150] where they generated 
SUN1 deficient mice by homologous recombination to remove all three 
putative transmembrane domains of SUN1.  In this model, SUN1
-/- 
males and 
females developed normally into adults and lived for more than 1 year with no 
obvious differences compared to the littermates.  However, it was observed 
that both male and female SUN1
-/- 
were sterile [150]. The testes of the SUN1
-/- 
males were much smaller than the wildtype or heterozygotes littermates.  
Histological examination of testes of SUN1
-/- 
males indicated that in the 
seminiferous tubules, the germ cells – spermatids and spermatozoa – were 
completely absent.  Only abnormal spermatocyte-like cells were accumulated 
in the some tubules [150].  They also observed that in primary spermatocytes, 
SUN1 co-localizes with telomeres, which are attached to the INM.  However, 
Figure 5. 1. Differential expression of murine SUN1 isoforms. A Presence of different SUN1 isoforms 
in selected mouse tissues was analyzed by RT -PCR. To amplify the recently described N-terminal 
SUN1 variants with deletions between exon 7 and 10, primers were selected which specifically 
annealed in exon 6 and exon 11. B Schematic illustration of the mouse SUN1 isoforms as yet 
identified. Triangles mark positions of deleted exons. INM , inner nuclear membrane; ONM outer 
nuclear membrane; AM acrosomal membrane; ZnF, zinc finger; H1, H2, H3, hydrophobic domains; 
TM , transmembranen domain; CC, coiled coil domain. Adapted from Gob et al. Communicative and 
Integrative Biology. 2011 
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co-localization ceases in round spermatids.  SUN1 signal was observed to be 
visible at the chromosome ends in early leptotene stage through diplotene 
stage, including the homolog pairing, synapsis and desynapsis [150, 241], but 
not at the diakinesis stage, suggesting that SUN1 is detached from telomeres at 





mice also exhibited severely impaired homologous 
chromosome pairing, synapsis and recombination [150].  In female mice, it 
was observed that the homologous synapsis during oogeneis was also impaired 
[150].  It was suggested that the depletion of gametes in mutant mice is likely 
the consequence of massive apoptotic events that are triggered by the failure 
of synaptonemal complex formation [150].   
While the first mouse model targets deletion of exons 10 to 13, the 
second SUN1
-/- 
mouse model was developed by Chi et al and it targeted 
deletion of exons 10 to 11 of the SUN1 gene that codes for the transmembrane 
domain. It is worth noting that in this second model, the neo cassette flanked 
by LoxP sites that was inserted during homologous recombination, was 
eventually removed by a constitutive Cre mice [152].  Similar to the first 
model, both male and female SUN1
-/- 
mice were infertile.  Adult SUN1
-/- 
male 
mice had significantly smaller gonads and no sperm was seen in the epididimi 
of adult SUN1
-/- 
testes, as compared to wildtype controls [152].  At four 
weeks, the seminiferous tubules were blocked at the prophase of meiosis I and 





compared to wildtypes [152].  In four-week-old SUN1
-/-
 female mice, ovaries 
were small, retarded and lacked oocytes.  It was observed that meiotic 




mice, resulting in the histone H2A at Ser139 (H2AX) which is a marker for 
synapsis, in SUN1
-/- 
cells to be multiply retained [152].  By microarray 
analysis, the authors showed that there was a reduction in Mili and Miwi-
associated piRNA in SUN1
-/- 
testes [152].  Miwi and Mili are murine Piwi 
gene family members whose expression is restricted to mouse germ cells [242, 
243], and they have been implicated in stem cell renewal, RNA silencing and 
germ cell development [152, 244-246].  Mili and Miwi are involved in the 
biogenesis of a novel class of 24- to 29- nucleotide piRNAs that accumulate 
during meiosis [152, 247, 248]. During gametogenesis, silencing of 
transposable elements via de novo DNA methylation is required.  The loss of 
Mili and Miwi2 is associated with the activation of retrotransposons [249].  
SUN1 depletion in SUN1
-/- 
testis was shown to reduce the expression of 
retrotransposons [152]. In another study performed by Horn et al in our lab, it 
was observed that this second model of SUN1
-/- 
mice has hearing loss resulting 
from the loss of sensory hair cells [75, 79][30, 31].  A summary of mouse 








5.2.1 Loss of Sun1 Ameliorates Lmna
9/9  
Pathologies 
To investigate the possible association between the INM protein 
SUN1, the underlying lamina and disease development, SUN1
+/-
 mice that 
were obtained from the study performed by Chi et al were crossed with 
Lmna




 offspring.  These studies 
were initiated in the CLS lab, as a parallel set of studies by Chi et al. Chi et al 
had investigated the effect of Sun1 loss on the original Lmna
Sul/Sul
 null mice 
where loss of SUN1 had surprisingly ameliorated many of the pathologies 
seen it that line. Initially, it was expected that knocking out both nuclear 




offspring would result in a 
more severe pathological phenotype than that seen in  Lmna
9/9 
mice.  
Unexpectedly, the loss of Sun1 in Lmna
9/9 
mice resulted in the opposite 





larger compared their Lmna
9/9 





mice were increased (Figure 5.3A) (P<0.001).  In addition, 
the lifespan of the mice were greatly extended, with most thriving more than 
twice that of Lmna
9/9 




























Figure 5.2 Knockdown of SUN1-/- Ameliorates Lmna9/9phenotype.  Lmna9/9SUN1-/- weigh less than 
WT littermates but weighs more as compared to Lmna9/9littermates.  Image taken when mice were 3 
weeks old 
 Figure 5.3. Knockdown of SUN1-/- Ameliorates Lmna9/9phenotype.  A. Lmna9/9SUN1 -/- (orange 
line) lives up to 60 days after birth as compared to only up to 30 days for Lmna9/9mice (red).  Median 
survival age in days - Lmna9/9SUN1 -/- (Median=54), Lmna9/9 (Median=21) and Lmna9/9SUN1 +/- 
(Median=26.5). P value <0.0001. B. Lmna9/9failed to thrive, showing marked growth retardation as 
early as Day 4 after birth.  On the other hand, Lmna9/9SUN1 -/- showed growth retardation only at 
about 10 days after birth.  Mice were weighed every 2 days for 70 days.   
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5.2.2 Validation of Lamin A and SUN1 Expression 





to confirm that both the transcript and protein expression were absent.  




also showed improved 
proliferation as compared to Lmna
9/9  
mice (Figure 5.4A).   





mice, Lmna protein was absent as shown in western blot analysis  
(Figure 5.4B).  Similarly, transcript levels of both Lmna and SUN1 were 










Figure 5.4 In vitro Characterization of  
Lmna9/9SUN1-/-. A.  Mouse adult 
fibroblasts derived from 21 day old mice 
showed improved proliferation rates in 
Lmna9/9SUN1 -/- fibroblasts (green) as 
compared to Lmna9/9 fibroblasts (red).  
Growth was measured and normalized 
cell indexes (averages+/-SD) are 
presented. B Western Blot was carried out 
using protein extracted from both adult 
and embryonic fibroblasts.  Expression of 
Lamin A is absent in Lmna9/9 mice. 
GAPDH was used as loading control.  C. 
Transcription levels were checked using 
relative quantitative PCR using RNA 
sample extracted from adult fibroblasts.  
Differences between the expression levels 
are statistically significant (*P<0.001).  
Error bars represent SEM  
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Immunofluorescence analysis was performed on adult fibroblast to 
check the expression of other NE proteins such as SUN2, Lamin B1, NUP153 
and Emerin.  No significant differences were observed in the distribution, 
localization or expression levels of these NE proteins (Figure 5.5 to 5.7).  
Immunofluorescence analysis Lamin A expression (Figure 5.6) was also 





Figure 5.5 Nuclear Envelope Protein Expression in Lmna9/9SUN1-/- MAFs. Immunofluorescence to 
show expression of A. WT, Lmna9/9, and SUN1-/- and Lmna9/9SUN1-/- adult fibroblasts were stained 
with anti-Lamin B1 (red) and DAPI (blue).  B. WT, Lmna9/9and SUN1-/- and Lmna9/9SUN1-/- adult 









Figure 5.6 Immunofluorescence to Show Expression of Nuclear Envelope Proteins in Lmna9/9SUN1-/- 
MAFs. WT, Lmna9/9, and SUN1-/- and Lmna9/9SUN1-/- adult fibroblasts were stained with anti-SUN2 
(red), anti Lamin A/C (green) and DAPI (blue).  As expected Lamin A/C is absent in both Lmna9/9 and 






Figure 5.7 Immunofluorescence to Show Expression of Nuclear Envelope Proteins in Lmna9/9SUN1-/- 
MAFs. WT, Lmna9/9, and SUN1-/- and Lmna9/9SUN1-/- adult fibroblasts were stained with anti-Emerin 
(red) and DAPI (blue).  As expected Emerin expression is affected in both Lmna9/9 and Lmna9/9 
SUN1-/- adult fibroblasts .  Scale bar 50μm 
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As mentioned in the previous chapter, the skeletal system in the 
original Lmna
9/9 mice exhibited reduced mineralization [144, 153].  High 
resolution microCT comparison of skeletons of 2- to 3- week old Lmna
9/9 
mice and age-matched wildtype siblings revealed that the mutants have 
reduced density in the calvaria, and long bones.  In addition, bone volume to 
total volume ratio were significantly reduced in the tibias and femurs of the 
Lmna
9/9 mice, as were the trabecular thickness and number in the tibia and 
femur.  Calvarial, as well as tibial and femoral stiffness were reduced, shorter 
tibial tuberosity, evidence of rib fractures were also detected – all of which 
indicated increased bone fragility [33].  
In collaboration with Dr Simon Cool’s Lab in IMB, similar CT 




mice and age-matched 
controls were performed.  Preliminary results suggest that the calvarial, tibial 
and femoral stiffness were improved in the double mutants as compared to 
Lmna
9/9 mice (Figure 5.8).  These bone scans will be extended to include 
more quantitative results .  
 
 
Figure 5.8 Preliminary -Computer Tomography (-CT) Images of Lmna9/9:Sun1-/- and age-
matched controls.  CT scan analysis was carried out in the skull, femur and tibia of 
Lmna9/9:Sun1-/- and age-matched controls.   
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In collaboration with the late Dr Jeang Kuan-Teh’s lab at the NIH, 
USA, we investigated SUN1 expression in wildtype and Lmna
9/9 
fibroblasts.  
It was observed that in the Lmna
9/9 
fibroblasts, SUN1 was found at the NE 
and at increased levels in the Golgi (Figure 5.9A).   
In parallel work carried out by Dr Jeang Kuan-Teh’s lab, they also verified 
that Sun 1 protein levels are significantly increased in Lmna
-/-
 cells, while 
other NE proteins such as SUN2  and Nup153 were unchanged in levels or 
distribution (Figures 5.9B).  The unchanged levels in SUN2 and Nup153 is  
consistent with the observations we made on Lmna
9/9 
immunofluorescence 
results (Figures 5.5 and 5.6) which showed no difference in the 






5.2.5 SUN1 Overaccumulation in HGPS Cells Correlates with 
Dysfunction 
Together with Dr Jeang Kuan-Teh’s lab, we also looked at SUN1 
expression in HGPS cells to determine whether the G608G mutation also 
affected SUN1 levels and distribution.  HGPS fibroblasts and control 
fibroblasts were immunostained and it was observed SUN1 was brighter 
staining in HGPS nuclei compared to control cells (Figure 5.10).  This result 
is consistent with increased SUN1 expression by western blotting (Figure 
5.9B) and corroborates with an earlier report of SUN1 accumulation in HGPS 
Figure 5.9 Loss of Lamin 
A Correlates with Sun1 
Accumulation in the NE 
and Golgi. A. Lmna9 
MAFs were stained with 
anti-Sun1 (red) and anti-
GM130 (a Golgi marker; 
green).  DAPI staining of 
DNA is in blue. Yellow in 
merged panels indicates 
SUN1 co-localization with 
GM130 in the Golgi, and 
absence Localization of 
SUN1 in the Golgi was 
observed in Lmna9 cells. 
Images are summations of 
z-stacks. B Western 
blotting of SUN1, SUN2, 
Nup153, Lamin B1, 
Emerin and α-tubulin in 
MEFs (left) and mouse 
liver tissue (right). Wild-
type, Lmna-/- and SUN1-/- 
samples were compared. 
Mouse identification (ID) 
numbers indicate 
individual animals. Aside 
from SUN1, no consistent 
difference was noted 
between Lmna-/- and WT 
cells or liver tissues. 
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cells [250].  It is worth noting that not every HGPS cell showed elevated 
SUN1 expression, but that cells that stained brightest for SUN1 were also the 
ones that had larger nuclei and more severe nuclear morphological distortions 
[224]. 
These results are significant as very similar results were obtained, as 
described in the next chapter when induced pluripotent stem cells derived 
from HGPS fibroblasts were differentiated into specific cell types.   
 
  
Figure 5.10 Nuclear 
Irregularities in HGPS 
Fibroblasts Correlate with SUN1 
Expression.  SUN1 and Lamin 
B1 in normal (AG03512 and 
AG03258) and HGPS (AG06297 
and AG11498) skin fibroblasts 
are stained with anti-human 
SUN1 (green) and anti-lamin B1 
(red). DAPI is in blue. Yellow 
arrowheads point to cells 
expressing high SUN1, white 





Lamins are mechanically coupled to the cytoskeleton by a combination 
of SUN and KASH proteins termed the LINC complex.  While a number of 
diseases associated with mutation in the LMNA gene have been identified, the 
mechanisms of how these mutations lead to progression of the phenotypically 
diverse laminopathies are not understood [251, 252].  Current hypotheses on 
laminopathies have focused on two models for how defects in LMNA 
contribute to disease [252, 253].  The first model centres on the mechanical 
role of the lamins - how defects in Lamin A make nuclei more fragile, and less 
resistant to mechanical strain.   The second model suggests that mutations in 
LMNA affects the transcriptional profile and organization of chromatin [252].  
In addition to these two models, it has been long hypothesized that defects in 
SUN protein expression/function may contribute to th laminopathies [250, 
252, 254-256].  SUN proteins play important roles in many cellular and 
developmental functions including gametogenesis, neurogenesis, muscle 
development, and retinogenesis [150, 252, 257, 258].   
To date, a few models have been proposed as to how SUN proteins 
contribute to the laminopathies.  One established model was discovered in 
Saccahromyces cerevisiae.  In these budding yeast, Monopolar spindle 3 
(Msp3) is a member of the conserved SUN family of INM proteins [259] SUN 
domain protein. Pranav et al proposed a model in which the recruitment of the 
telomerase machinery to a double stranded DNA breaks leads to their 
relocation to the nuclear periphery by direct interactions between Mps3p 
components of the telomerase complex [260] and SUN1. Another model 
which indicates SUN protein’s association with DNA repair was proposed by 
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Lei et al who found that both SUN1 and SUN2 bound to the catalytic subunit 
of DNAPK, a protein known to function in DNA repair.  However, knocking 
down DNAPK only led to a small reduction in activated the DNA repair 
enzyme ATM or histone H2AX, suggesting that this could only be part of the 
mechanism [252, 261].  Some mutations in LMNA result in an increase in the 
levels of DNA damage [262, 263] and an increase in the levels of SUN1 
protein [224].  As to how a role in DNA repair be linked to the laminopathies, 
Lei et al suggest that increased SUN1 in the LMNA mutant background could 
contribute to disease pathologies by inducing hyperactivity in the DNA 
response [252, 261].   
SUN1 protein is more stable and accumulates at the NE in Lmna 
mutant mouse lines and HGPS patient fibroblasts [252].   The final proposal is 
that SUN1 abnormally accumulates in the NE and Golgi of the Lamin A 
mutant mouse cells, leading to the proposal that large amounts of SUN1 at the 
Golgi are toxic to the cells and so contribute to the pathology of laminopathies 
[224, 252].   In this alternative model, and in collaboration with Dr Jeang, we 





mutant mice.  SUN1 and Lmna double mutant mice 
lived longer and grew larger than Lmna mutants.  Knockout of SUN1 also 
ameliorated cellular pathologies associated with laminopathies in the Lmna 
mutant mice, including defects in bone structure, muscle formation, 
senescence, heterochromatin marks and shape of cell nuclei [224].  More 
interestingly, similar results were observed when SUN1 was knocked down in 
fibroblasts from patients with HGPS [224].  A similar reversal in ageing 





model in which the pathologic phenotype was found to be alleviated by 
additional knockout of p53 [252, 264]. In addition, rapamycin treatment of 
Lmna
SUL/SUL 
mice results in a very similar improvement in longevity [265] 
From this collaboration, we found that SUN1 protein mislocalizes in 




mutant mice. This led to the suggestion 
that laminopathies, may also in part be caused by disruption of organelle 
function [265] (Golgi) due to mislocalization of the NE protein SUN1. 
Examples of such diseases include lysosomal storage disease including Fabry, 
Tay-Sachs and Gauche, or ER storage disease such as cystic fibrosis, l-
antitrypsin deficiency, hereditary hypoparathyroidism, and pro collagen type I, 
II and IV deficiency.  In these diseases, ‘over-stuffing’ of misaccumulated 
material in subcellular organelles such as lysosomes, ER, Golgi or nuclear 
envelope occurs and  elicits stress signals unfavorable to normal cellular 
physiology [266-271].   
One argument that has been made against this last model is that 
accumulation of SUN1 in the Golgi has not been observed in serially passaged 
human HGPS fibroblasts [252, 266].  It is possible that over accumulation of 
SUN1 is potently toxic in to HGPS cells, hence, all late passaged cells are 
devoid of SUN1 accummulation [266].  It has also been proposed that SUN1 
accumulation in both the NE and the Golgi represents two opposite 
destinations of ER retrograde and anterograde trafficking [266]. It is also 
possible that other NE INM proteins may also redistribute. HGPS cells show 
characteristic NPC clustering[240], Emerin mislocalization [53] and LAP2 
loss[136] although SUN2 localization seems to be normal[224, 250, 266].   
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mouse line, currently includes characterization of the bone density to 




compared to the Lmna
9/9 
line.  As described in Hernandez et al 2010 , it 
would also be interesting to determine the effect of loss of SUN1 on the 



















The most common mutation found in classical HGPS patients is the 
heterozygous base substitution (G608G(GGC . GGT)) occurring within exon 
11 of the LMNA gene.  Besides this mutation, there are 21 other mutations 
causing HGPS including a different heterozygous base substitution was 
identified within the same codon (G608S(GGC . AGC)) and a heterozygous 
base substitution within exon 2 (E145K(GAG . AAG)) in the LMNA gene.  
The E145K mutation is unique compared to the other mutations found in the 
classical HGPS patients because of its occurrence in exon 2 which is located 
in segment 1B of the central rod domain of LA/C protein [33].  It has been 
suggested that the location of the E145K mutation in the rod domain may 
affect the assembly of lamins into dimers and higher order structures [272].   
Besides the E145K mutation, another mutation occurring in exon 1 of 
the LMNA gene had previously been reported [174]. Mutational screening 
which was performed on 13 cell lines from patients with “atypical Progeria”  
symptoms revealed one patient with a mutation, referred to as the T101 
mutation, occurring as the most 5’ end missense mutation in LMNA to date 
[174]. The patient with this mutation showed clinical features including 
hypertriglyceridemia, hyperglycemia, thin skin, lipotrophy and progeroid 
features.  Fibroblasts from this patient exhibited grossly abnormal nuclei.  A 
high percentage of nuclei in this cell line had multiple, extreme lobulations of 
the nuclear-membrane, somewhat resembling a cauliflower or a bunch of 
grapes (Figrue 6.1. Some of these lobulations contained no chromatin, 
indicating that lamina had detached from the chromatin.  T101 mutation 
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affects both lamins A and C in the N-terminal head domain, and has been 




Taimen et al[272] recently showed that alterations in nuclear 
architecture and chromatin organization in the LMNA mutation, E145K (GAG 
. AAG) which is located in segment 1B of the central rod domain of the LMNA 
gene [33]. A patient bearing this mutation showed early onset cardiovascular 
defects, only partial loss of hair and ample subcutaneous fat [33].  They 
showed E145K mutation in LMNA affecting lamin structure and assembly, 
affecting nuclear architecture, a reduction in B-type lamin expression and 
premature senescence [272].  However, E145K mutation would not be 
expected to affect the post-translational processing of the C terminus of the 
LMNA protein.  Fibroblasts derived from an E145K patient have severely 
misshapen nuclei and multiple defects in chromatin organization as reflected 
by centromere clustering of centromeres and their associated H3K9me3, and 
abnormal distribution of telomeres throughout the cell cycle as shown in 
Figure 6.2 and Figure 6.3. It was also suggested that E145K mutation may 
have caused Progeria by altering the structure of the lamina.  They confirmed 
this by showing that E145K mutation has a deleterious effect on LaminA 
polymerization into higher order structures in vitro [272]. 
Figure 6.1 Representative nuclear morphologies of T101 mutant fibroblasts. A shows nuclear DNA 
stained with anti-Toto-3, B shows cells stained with anti-Lamin A/C and C is a composite of Toto-3 and 
Lamin A/C staining.  Adapted from A B Csoka et al. J. Med. Genet. 2004 
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To investigate the effects of the mutation, we created a mouse model 
with the same mutation.  This allows us to reproducibly perform in vivo 
investigations and effectively compare in detail the progeric phenotype with 




and G609G mouse 














Figure 6.2 Lamin alterations in human 
E145K cells. A. E145K (p11) and control 
cells (p19) were stained with anti-LA/C, 
anti-LB1, and Hoechst. Mid-plane confocal 
sections show extensive lobulation of the 
NE in E145K cells. LA/C is associated 
mainly with the outer region of the lobules 
(bracket), which stain weakly for LB1 and 
surround a euchromatic region as indicated 
by weak staining with Hoechst. Arrows 
indicate small blebs containing LA/C, but 
no detectable LB1. LB1 is associated with 
the heterochromatic proximal regions of the 
lobules, which contain little LA/C 
(arrowheads). (Scale bars, 5μm.) B. 
Immunoblotting analysis of E145K and 
control cells at p14. The amount of LB1 and 
to a lesser extent of LB2 is reduced in 
E145K cells, while LA and LC are 
expressed at levels comparable to controls. 
Adapted from Taimen et al. PNAS. 2009. 
Figure 6.3. Mislocalization of heterochromatin, centromeres, and telomeres in E145K cells. A. E145K (p11) and control 
cells (p11) were stained with either anti-H3K9me3 or anti-H3K27me3 and Hoechst. Mid-plane confocal sections show 
enrichment of H3K9me3 in the central region of the nucleus in E145K cells (arrowhead), while it is enriched in the nuclear 
periphery and in perinucleolar regions in controls (arrowheads). H3K27me3 is distributed throughout the nucleus in both 
cells and enriched in the Xi in female control cells (arrowhead). (Scale bars, 5 μm.) B. E145K (p13) and control cells (p15) 
were stained with anti-LA, CREST antiserum, and Hoechst. Maximum projections of series of z-sections spanning the 
entire nucleus and side projections are shown. Centromeres are clustered in the central region of the nucleus in E145K 
cells, while they are either closely associated with the peripheral lamina region or elsewhere in the nucleoplasm in control 
cells. Inset shows an example of the close association of one centromere with the lamina in a single confocal section. (Scale 
bars, 5 μm.) C.  E145K and control cells were stained with anti-LA/C, CREST antiserum, and Hoechst. A FISH probe was 
used to visualize telomeres. Maximum projections of series of z-sections spanning the entire nucleus and side projections 
from merged images are shown. Centromeres and telomeres are distributed throughout the nuclei in control cells. In E145K 
cells centromeres are clustered in the middle of one region of the nucleus, while telomeres are more frequently associated 




6.2.1 E145K Mutant Mouse Missense Mutation 
The E145K construct was generated in the National Cancer Institute 
(NCI), Maryland, USA, in Dr Colin Stewart’s previous lab and analyzed here 
in Singapore.  To create the construct, a missense mutation encoding an 
E145K alteration was introduced into the murine Lmna gene by homologous 
recombination.  Chimeric mice were derived and from them recombinant 
mouse lines harboring the Lmna-E145K variation and neomycin cassette were 
derived.  
Subsequent removal of neomycin resistance marker and its PGK 
promoter is important because both coding sequences may have unintended 
consequences on the targeted gene and on adjacent genes if they are left in the 
gene.  This, in turn, may result in a false phenotype being expressed in the 
mutant mouse.   
The neomycin resistance marker and PGK promoter are flanked by 
LoxP sites, which are specific 34 base pair (bp) sequences consisting of an 8-
bp core sequence, where recombination takes place, and two flanking 13-bp 
inverted repeats.  In this case, where the deletion of the Neomycin marker is 
desired, the loxP sites are oriented in the same direction on the chromosome 
segment (cis arrangement).  In the presence of Cre-recombinase, which is an 
enzyme that catalyzes recombination between two loxP sites, deletion of the 
floxed segment is mediated.  Cre-recombinase is introduced by crossing Neo-
positive mice to two Cre-deletor lines, namely the B-Actin Cre and the Zp3 
Cre lines. Due to the initial unavailability of the Zp3 Cre lines, the mice were 
first crossed with the β-Actin Cre line obtained from Dr. Nancy Jenkins 
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(IMCB).  In this line Cre recombinase is under control of the human beta actin 
gene promoter and is on an outbred background. This strain expresses Cre 
recombinase in all cells of the embryo by the blastocyst stage. It is useful as a 
"deleter" mouse for virtually any genomic sequence flanked by loxP 
sites[274].  The other Cre-deletor line, Zp3-Cre, was obtained from Dr Barbara 
Knowles. It is a transgenic line in which cre expression is controlled by the 
regulatory sequences from the mouse zona pellucida 3 (Zp3) gene and is on an 
inbred C57Bl6 background. This promoter normally directs expression 
exclusively in the growing oocyte prior to the completion of the first meiotic 
division. This strain is useful for deleting a floxed sequence specifically in the 
female germ line [274].  Phenotypic characterization was performed on Neo-
deleted lines.  To investigate whether the E145K mouse model is 
representative of the human patient, characterization of the mouse model was 
performed.  A flow chart summarizing the steps taken to generate the mutant 





Figure 6.4. A point mutation introduced into Lmna encodes mutant A-type lamins with an E145K 
variation. A. The targeting strategy for introducing point mutations into Lmna  (adapted from 
Mounkes et al 2005). B. Sequencing data of the three different genotypes resulting from the 
recombinant mutation.  C. The mutant locus contained a single nucleotide change, resulting in a 




6.2.2  E145K Mutant Mouse Phenotype Characterization 
Phenotypic characterization of the Lmna
E145K/E145K
,crossed with the β-
Actin Cre line, was initially performed by monitoring the weight of the mice, 
on a weekly basis, as they aged.  Wild-type age- and sex-matched littermates 
were simultaneously monitored to allow direct comparison with the E145K 
homozygous and heterozygous mice. Monitoring the growth of the mice as 
they aged, revealed that the homozygous Lmna
E145K/E145K
 mice remained small 
compared to the heterozygous and wildtype siblings.  On an average, they 
stopped gaining weight from 6 months onwards and became progressively 
growth smaller, with a reduction in weight, over the next months, dying at 1 
year (Figure 6.5).  Wildtype mice, on the other hand, typically survive for 
about 2 years.  By 10 months, the homozygous Lmna
E145K/E145K 
mice 
characteristically displayed features such as alopecia, where the hair follicle 
density was greatly reduced, a waddling gait, kyphosis and reduced body size 
and weight- all signs of ageing.  
6.2.3 Necropsy Analysis of Lmna
E145K/E145K
 mouse 
Full necropsy results show that the Lmna
E145K/E145K 
homozygotes are 
reduced in size as compared to the wildtype controls in both males and 
females (Figure 6.6 and 6.7).  Overall, no significant differences were 
observed in the different organs between the Lmna
E145K/E145K 
homozygotes and 
the wildtype siblings.   However, it was noted that epithelial layers in many 
organs such as the stomach were thinner in the homozygote compared to the 
wildtype (Figure 6.8).  It was also observed that the skin of some of the 
homozygotes had a thicker dermis, with dense collagen compared to the 
wildtype controls.  
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One interesting observation made from the whole-body necropsy 
images taken was the reduction in white fat in all depots in the 
Lmna
E145K/E145K
.  A summary of the necropsy results can be found in Table 6.1 











Figure 6.5. E145K Mouse Model.  A. Although early development of homozygous 
LmnaE145K/E145Kmice appeared to be normal, postnatal growth of mutant mice were altered when 
compared with WT mice.  Homozygous LmnaE145K/E145K mice were generally smaller as compared to 
WT mice of the same age.  (i) male homozygous LmnaE145K/E145K weigh 30.18g (ii) male wildtype 
littermate weigh 48.46g (iii) female homozygous LmnaE145K/E145K weigh 22.07g (iv) female wildtype 
littermate weigh 34.60g.  B. The difference in weight and size becomes more apparent when the mice 
were aged to 12 months, as seen in both males and females. C. LmnaE145K/E145K showed growth 
retardation at about 1 month post birth and does not increase in weight (red, n=35) as compared to 
WT (blue, n=30).  Mice were weighed every week for a period of 15 months.  D. LmnaE145K/E145K 




















Veterinary Pathology Report for E145K Males     
Veterinary Pathologist: Dr. Jerrold M. Ward         
Mouse No #267  #358  #360 #310 #299 
Genotype E145K Mutant E145K Mutant E145K Mutant Wildtype Wildtype 
Sex M M M M M 
Block/tissue Observations: Observations: Observations: Observations: Observations: 






mostly normal but 
















  Normal 
Esophagus Normal Normal Normal Normal Normal 
Parathyroid   Normal Normal     
Thyroid Normal Normal Normal Normal Normal 
Trachea Normal Normal Normal Normal Normal 
Adrenal aging lesions++ Normal Normal aging lesions++ Normal 
Pituitary           
Heart 







mostly normal, fatty 








Med LN-atrophy, ectopic 
parathyroid, no thymus 
section 
Med LN-normal, no 
thymus section 
Normal Normal atrophy++ 
Gall bladder Normal Normal Normal Normal Normal 
Liver Normal Normal Normal Normal Normal 
Spleen lymphoid atrophy++ 
mostly nomral, wide 
marginal zone 
Normal Normal Normal 




Duodenum           
Ileum Normal Normal Normal Normal Normal 
Rectum           
Stomach glandular 




+; cystic glands++ 
focus of 
hyperplasia 
Stomach forestom Normal Normal Normal   Normal 
Cecum Normal Normal Normal Normal Normal 
Colon Normal Normal Normal Normal Normal 
Jejunum Normal Normal Normal Normal Normal 
LN Mesenteric atrophy+ 
mast cell 
hyperplasia++ 




Normal Normal Normal Normal 
Epididymis Normal Normal       
Ovary           




focal fibrosis++ Normal Normal Normal 
Testis 
mostly normal, some 
giant cells (testes 
degeneration+) 
Normal Normal Normal Normal 
Urinary bladder inflammation in lumen Normal   Normal Normal 
Uterus           
Eye           
Harderian gland           
Nasal cavity           
Teeth           
Femur           
Bone marrow, Femur           
Bone marrow, Sternum Normal Normal   Normal Normal 
Vertebrae Normal Normal Normal Normal Normal 
Spinal cord Normal Normal Normal Normal; few vacuoles Normal 
Skin Normal 





Tongue foci of mast cells+C23 focus of mast cells   focal mast cells   
LN, Popliteal     Normal   Normal 
muscle, skeletal Normal Normal Normal Normal Normal 




adjacent ot atrophic 
preputial gland 
        
 
 














Veterinary Pathology Report for E145K Females 
  
      
Veterinary 
Pathologist: 
Dr. Jerrold M. Ward         
Mouse No #244 #314 #243 #125 #276 
Genotype E145K Mutant E145K Mutant E145K Mutant Wildtype Wildtype 
Sex F F F F F 
Block/tissue Observations: Observations: Observations: Observations: Observations: 
Brain Normal Normal Normal Normal Normal 
Pancreas vacuolization+ 








lymphocyte focus   Normal lymphocyte foci+ Normal 
LN 
Mandibular 
mast cell hyperplasia, 
focal++, plasma cell 
hyperplasia++ 
pigment in 










Esophagus Normal Normal Normal Normal Normal 
Parathyroid Normal  Normal Normal  Normal  Normal 
Thyroid Normal Normal Normal 
2 foci of cystic 
hyperplasia 
inflammation, focal; 
1 hyperplastic gland 
Trachea Normal Normal Normal Normal Normal 
Adrenal aging lesions++ aging lesions+ aging lesions+ aging lesions++; aging lesions 
Pituitary           
Heart Normal Normal cardiomyopathy+ Normal Normal 
Kidney Normal Normal Normal Normal Normal 
Thymus cysts++; atrophy+++; no section  atrophy+++; cysts++ atrophy+ atrophy+ 
Gall 
bladder 
Normal   Normal Normal Normal 
Liver Normal Normal Normal Normal Normal 
Spleen Normal Normal Normal Normal Normal 
Lung 
Normal; Med LN-mast 
cell hyperplasia 
Normal Normal Normal Normal 
Ileum Normal Normal Normal Normal Normal 










Normal Normal Normal Normal Normal 
Cecum Normal   Normal Normal Normal 
Colon Normal Normal Normal Normal Normal 
Jejunum Normal Normal Normal Normal Normal 
LN 
Mesenteric 
Normal Normal Normal Normal Normal 
Coagulating 
Gland 
          
Epididymis           
Ovary atrophy+ atrophy+++ atrophy+ atrophy+++ atrophy++ 
Urinary 
bladder 
Normal Normal Normal Normal Normal 
Uterus Normal Normal 
one cystic horn or 
dilated gland, other 
horn is normal 
Normal Normal 
Eye           
Harderian 
gland 
          
Nasal cavity           
Teeth           








Normal Normal Normal Normal Normal 
Vertebrae     Normal Normal Normal 
Spinal cord     Normal Normal Normal 
Skin   Normal Normal Normal Normal 
Tongue 
mast cell hyperplasia, 
focal+  
Normal Normal mast cell foci Normal 
Mammary 
gland 
Normal Normal Normal Normal Normal 
LN, 
Popliteal 
Normal mast cell hyperplasia++ 
mast cell 
hyperplasia+++  




Normal; LN-mast cell 
hyperplasia+++, 










6.2.4 Computed Tomography (CT) Analysis 
Computed Tomography (CT) scans were performed to study the 
differences in bone structure between the genotypes.  This was performed with 
help from Dr Bina Rai (ex-IMB). 
CT scan results suggested that the bone densities of female 
homozygotes were significantly reduced compared to the heterozygous and 
wildtype female age-matched mice (Figure 6.9B). However, no significant 






Figure 6.8 Thinning of Stomach Wall in LmnaE145K/E145K (4.7B – male, 4.7D – female) as compared 









Figure 6.9 Summary of Computer Tomography (CT) Analysis in Lmna-E145K mice. A CT Scan results of 
Tibia Femur and Skull in male Lmna-E145K Mice.  (N=4) B CT Scan results of tibia femur and skull in 
female Lmna-E145K mice.  (N=4) C Representative images of bone scans from female Lmna-E145K mice.  




6.2.5 In vitro Characterization 
Mouse adult fibroblasts (MAFs) were derived and maintained.  
Proliferation rates of homozygous Lmna
E145K/E145K
 fibroblasts were slower 
compared to fibroblasts derived from wildtype littermates (Figure 6.10).  
 
 
Lamin A, Lamin B1 and Lamin B2 immunofluorescence staining in 
Lmna
E145K/E145K  
showed  extensive lobulation in the nuclear envelope (Figure 
6.11).  These results indicated a similarity to the extensive lobulation seen in 
patient derived fibroblasts as seen in Taimen et al.  Lobulation is observed in 
more than 50% of Lmna
E145K/E145K 
cells.  It is observed that histone H3 
trimethylated at lysine 9 (H3K9me3) is enriched in the central region of the 
nucleus in Lmna
E145K/E145K 
cells, while it is enriched throughout the nuclear 
periphery and in perinucleolar regions in control MAFs. This is consistent 
with results shown in Taimen et al.  Immuno-fluorescence with CREST anti-
serum, and Hoechst showed that centromeres are distributed throughout the 
nuclei in control cells, while in Lmna
E145K/E145K 
cells, centromeres are clustered 
in the middle of one region of the nucleus (Figure 6.11).   
 
 
Figure 6.10 Growth curve of E145K MAFs. (A) Short term growth curve of E145K MAFs  (B) Cumulative 










Figure 6.11  Immunofluorescence analysis shows the deformity of the LmnaE145K/E145K  mouse fibroblasts. 
.In the first 3 panels, LMNA, Lamin B1 and Lamin B2 staining in LmnaE145K/E145K revealed extensive 
lobulation in the nuclear envelope.  These results suggest a similarity to the extensive lobulation seen in 
patient derived fibroblasts as reported in Taimen et al.  LmnaE145K/E145K  and wildtype mouse fibroblasts 
were stained with H3K9me3 and Hoechst in the 4th panel.  The H3K9me3 is more diffuse in 
LmnaE145K/E145K  nuclei, while it localizes to the nuclear periphery and in DAPI dense foci in controls., 
consistent with results reported in Taimen et al.  LmnaE145K/E145K  and wildtype mouse fibroblasts were 
stained for Emerin and Hoechst in the 5th panel and Nup153 and Hoechst in the 6th panel. In the last panel, 
LmnaE145K/E145K  and wildtype mouse fibroblasts  were  stained with CREST antiserum, and Hoechst. 
Centromeres are distributed throughout the nuclei in controls. In LmnaE145K/E145K cells  centromeres  are 




Western blot was carried out using protein extracted from early 
passage MAFs and no significant difference was observed in the nuclear 
components Lamin A, Lamin C, Lamin B1 and Lamin B2, between the 
Lmna
E145K/E145K 
 cells and control cells as seen in Figure 6.12.  Investigation 
on transcription levels of Lamin A, Lamin B1  and Lamin B2 revealed that 
there are no significant diference in the transcriptional expression levels, 
except for Lamin B1 which shows decreased levels of expression as compared 
to control cells (Figure 6.13).   
 
 
Figure 6.12 Quantitative Analysis of Lamin Proteins in E145K MAFs.  A Total protein extracts 
were loaded and protein expression was quantitatively analyzed with the Odyssey infrared 
imaging system.  Western blot was carried out on both E145K (62M, 71M, 77F, 78F) and WT 
MAFs (60M, 61M, 64F, 68F) to compare expression levels of Lamin A,Lamin C, Lamin B1 and 
Lamin B2.  B-Actin was used for loading control.  B to D Relative quantitation levels represend 







We subsequently passaged the MAFs and collected protein extracts at 
later passages to compare if there are any differences in the expression levels 
over time.  E145K MAFs at late passage show reduced protein expression of 
Lamin C and Lamin B1 (Figure 6.14) consistent with the reduction in Lmnb1 
levels as cells enter into senescence [1, 275].   
 
 
Figure 6.13 Relative quantitation of Lamin transcript levels in E145K MAFs.   No significant difference in 
expression levels were observed in (A and B) Lamin A and in Lamin B2 (D).  However, a lower expression 













Figure 6.14 Quantitative Analysis of Lamin Proteins in Early and Late Passage E145K MAFs.  
A Total protein extracts were loaded and protein expression was quantitatively analyzed with 
the Odyssey infrared imaging system.  Western blot was carried out on both E145K (62M, 78F) 
and WT MAFs (61M, 64F) to compare expression levels of Lamin A, Lamin C, Lamin B1 and 
Lamin B2.  B-Actin was used for loading control.  B to D Relative quantitation levels 




6.2.6 Metabolic Analysis 
  6.2.6.1 Body Composition Analysis  
The reduction of fat in the Lmna
E145K/E145K 
homozygotes prompted the 
investigation of the metabolic characteristics of these mutant mice.  Metabolic 
studies were performed to investigate further the cause of the reduction of fat 
in the mice as they age.  
Male Lmna
E145K/E145K  
homozygotes and controls were subjected to 
echo MRI to examine the body composition of the mice.  At 8 months of age, 
male Lmna
E145K/E145K  
homozygotes had significantly reduced levels of fat 
mass compared to their age-matched wildtype controls (Figure 6.15A).  
However, no significant differences were observed between percentage of lean 
mass between Lmna
E145K/E145K  
homozygotes and controls (Figure 6.15B).  
This suggests that the reduction in weight is specifically caused by the 







Figure 6.15 Echo-MRI Analysis of E145K Mice. A Echo-MRI analysis of 8 month old E145K male mice 
showed a significant reduction in Percentage of Fat Mass in a 8-month old LmnaE145K/E145K male compared 
to age-matched male (WT)  mice. B However, the percentage of lean mass is almost similar in both E145K 
and WT mice (n=6) (*P<0.05).  Error bars rep SEM.   
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  6.2.6.2  Indirect Calorimetry / Metabolic Cage Studies 
Male Lmna
E145K/E145K  
and controls were placed in metabolic cages at 6 





 similar food intake to the controls in both the dark 
(active cycle) and light cycles. 
At 8 months, Lmna
E145K/E145K  
consumed similar amounts of regular 
chow diet and fluid as compared to the wildtype controls (Figures 6.16A to 
D).  Male Lmna
E145K/E145K  
mice consumed more oxygen that was statisticaly 
significant, compared to the wildtype controls (Figure 6.17A to D).  Both 
Lmna
E145K/E145K  
and wildtype controls exhibited similar levels of respiratory 
exchange ratio (RER) (Figure 6.18).  The similar levels of RER indicate that 
there are no differential preference for either fat or carbohydrate utilization, 
between the two genotypes.   
Lmna
E145K/E145K 
display a higher basal metabolic rate (BMR) as 
compared to wildtype controls (Figure 6.19).  These data suggests that the 





Figure 6.16 Food and Fluid Intake Analysis in 8 month old E145K Male Mice. Measurements were 
made on food intake (A and B) and drink intake (C and D) by E145K mutant and age-matched 
wildtype mice. A and C shows the average hourly food and fluid intake respectively.  B and D shows 
the average food and fluid intake during the light and dark time, respectively.  The data were normalized 










Figure 6.17 Oxygen Consumption in 8 month old E145K Male Mice.  Measurements were made on 
volume of oxygen consumption of E145K mutants and age-matched wildtype controls.  A and B shows 
volume of oxygen consumption normalized to total body weight in A and B, but normalized to lean 
body mass in C and D.  A and C shows the average hourly volume of oxygen consumption.  B and D 
shows the average food and fluid intake during the light and dark time.  N=6 for each genotype.  Error 
bars indicate SEM.  *P<0.0001 
Figure 6.18 RER Analysis in E145K Male Mice.  Measurements were made on Respiratory Exchange 
Ratio (RER) in 8 month old E145K mutant and age-matched wildtype controls.  A shows the average 
hourly rate of respiratory exchange ratio.  B shows the average rate of respiratory exchange ratio during 








6.2.6.3 In Vitro Adipocyte Differentiation of E145K MAFs 
To determine if there are any defects in the fat formation in the 
homozygotes, fibroblasts obtained were subjected to in vitro adipogenesis.  
Preliminary results suggested that when subjected to in vitro differentiation, 
the E145K homozygote fibroblasts differentiated into adipocytes to a lesser 
extent compared to WT controls (Oil Red O staining) of differentiated 
fibroblasts (Figure 6.20).  In addition, Q-PCR that was performed and showed 
that the expression of adipogenic factors including PPAR-gamma, SREBP and 
CEBP-alpha were lower in the E145K homozygotes as compared to WT 
controls as (Figure 6.21). However, these experiments are preliminary and 
will need to be repeated to fully substantiate these findings.  
Figure 6.19 Basal Metabolic Rate Analysis in E145K Male Mice.  Measurements were made on Basal 
Metabolic Rate (BMR) in 8 month old E145K mutant and age-matched wildtype controls.  A shows the 
BMR normalized against total body mass.  B shows the BMR normalized against lean body mass.  N=6 








Figure 6.21  Q-PCR Relative Quantitation of In vitro Differentiation of Pre-Adipocytes Derived from 
Subcutaneous Depot.  Relative Quantitation of adipocyte transcription factors A. CEBP-α, B. PPAR- and 
C. SREPB.  Relative Quantitation of mature adipocyte markers D. GLUT4 and E. AP2.  Error bars 
represent SEM.  




6.2.6.4  In Vitro Adipo Differentiation of E145K Pre-Adipocytes 
Next, we extracted pre-adipocytes from the subcutaneous and gonadal 
fat depots from 6 month E145K homozygotes and age-matched wildtype 
controls. Isolated pre-adipocytes were differentiated into adipocytes in vitro 
and at different time points RNA extraction was performed for Q-PCR 
analysis of adipocyte differentiation markers.  From the Oil-Red-O staining, 
preliminary results from both fat depot suggests that differentiation into 
adipocytes is reduced in E145K homozygotes compared to WT controls in 
both male and females, (Figure 6.22 and Figure 6.23).  Preliminary 
transcriptional analysis of adipogenic markers reveal that both male and 
female E145K homozygotes expressed lower levels of both early and mature 
adipogenic markers compared to the corresponding WT controls (Figure 
6.24).  The first set of markers include adipocyte transcriptional factors CEBP-
α, PPAR- and SREBP, and the second group consisted of the mature 
adipocyte markers, Glut4 and AP2.  However, these experiments will need to 






Figure 6.22 In vitro Differentiation of Pre-Adipocytes Derived from Gonadal Depot.   














Figure 6.24  Q-PCR Relative Quantitation of In vitro Differentiation of Pre-Adipocytes Derived from 
Subcutaneous Depot.  Relative Quantitation of adipocyte transcription factors A. CEBP-α, B. PPAR- and 
C. SREPB.  Relative Quantitation of mature adipocyte markers D. GLUT4 and E. AP2.  Error bars 
represent SEM.  
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4.3  Discussion 
The E145K mutation in human has been reported to cause early onset 
of cardiovascular defects and partial loss of hair.  In cells, the E145K mutation 
in LA/C changes lamin structure and assembly, causing alterations in nuclear 
structure, a reduction in B-type lamin expression and premature senescence.  
Compared to the common G608G mutation Progeria mutation, the E145K 
mutation did not alter the post-translational processing of the C terminus as 
revealed by western analysis [272].  In human fibroblasts, the E145K mutation 
causes clustering of centromeres and alters the distribution of H3K9me3 
histone mark, but does not alter the distribution of H3K27me3 
heterochromatic mark [272].  This is in contrast with the G608G Progeria 
mutation where both these epigenetic marks are altered and the association 
between H3K9me3 and some centromeres is lost [276].  In addition, cells 
containing G608G showed abnormal distribution of NPCs, while the E145K 
mutation does not affect the distribution of NPCs [175].  It has been suggested 
that in G608G Progeria patients, it is likely that the abnormal association and 
accumulation of permanently farnesylated G608G Progerin at the NE 
membrane disrupts the normal function of the lamina in these patients [137, 
175, 276-278].  In the E145K mutant, it proposed that abnormal 
polymerization of LA that prevents the assembly of a normal lamina structure. 
The impact of alterations in E145 residue is suggested to be most likely 
attributable to its location in subdomain 1B of the central rod domain of LA/C 
[272].  This suggestion was proposed because similar mutations occurring in 
the central rod domain of cytoskeletal IF proteins, such as desmin, keratins, 
and vimentin, have severe consequences for filament assembly and function.  
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This causes a variety of diseases including skeletal and cardiac myopathies 
[279], skin blistering diseases [280], and cataracts [281]. In addition, a similar 
mutation in the corresponding site of C. elegans lamin (lmn-1), Q159K, alters 
the structure of in vitro assembled filaments [282, 283].   
Here, we describe the characterization of a mouse model with the 
E145K mutation in the Lmna gene.  E145K homozygotes are born normal and 
develop normally until they reach about 4 to 6 months when they show signs 
of weight loss or growth retardation, as compared to heterozygotes and WT 
mice.  E145K homozygots fails to gain weight after 6 months and have a 
shorter lifespan of about 1 year, as compared to 2 years in heterozygous and 
WT mice.  This is in contrast to the Lmna9 mice that dies at about 3 weeks.  
Whole body necropsy was performed both male and female mice and the 
results showed no significant difference between the E145K mutant and WT 
controls.  The only difference noted was that the stomach lining in the E145K 
homozygote was much thinner as compared to the WT controls.  MicroCT 
scans carried out in the mice showed that the femur in the female E145K had 
lower density as compared to the wildtype and heterozygotes.  
Mouse adult fibroblasts extracted from the E145K mice showed that 
both short- and long-term proliferation rates were lower compared to control 
WT fibroblasts extracted from age-matched mice.  Immunofluorescence 
experiments carried out on the cells showed that more than 50% of the cells 
exhibited extensive lobulation and centromere clustering, but no alteration in 
NPCs. These results are similar to what was observed in the E145K patient 
fibroblasts as reported in Taimen et al.   
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Another intriguing observation made from the necropsy results is the 
lack of fat in one-year-old E145K mice. To investigate this observation, we 
measured the fat percentage in 8 month old E145K male mice and WT male 
controls using the EchoMRI system.  The results showed a significantly lower 
fat mass percentage in the E145K mice as compared to control mice, but the 
lean mass remained at very similar levels between the two genotypes.  This 
shows that the reduction in weight is attributed by loss of fat in the E145K 
mice.  Loss or reduction of percentage fat mass can either be caused by a 
disruption in the adipogenesis process which affects fat formation, or it can it 
be caused by increased lipolysis.  Other possible causes of reduced fat mass in 
these mice include reduced food intake or increased metabolic rate.    
To investigate this, we set the mice up in metabolic cages (CLAMS 
system) which allowed the observation and record of oxygen consumption, 
food intake, fluid intake of the mice over a period of three days.  The mice 
given some time to adjust to the cage before readings were taken.  It is 
interesting to observe that while the oxygen consumption and basal metabolic 
rate of E145K mutants were higher as compared to age-matched WT controls, 
no difference were observed in diet and fluid intake  in the mice.  This shows 
that the E145K mice consumed same amounts of diet and fluid as compared to 
WT controls.  This ruled out the possibility that the reduction in weight and 
percentage of fat mass in the E145K mice is caused by a reduced food intake.   
We then carried out in vitro differentiation of adipocytes using fibroblasts 
extracted from 6 month old mice.  Adipocytes can be differentiated from 
fibroblasts by using specific cocktail of differentiation media [284]. 
Preliminary results obtained from these experiments suggest that the E145K 
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fibroblasts had a reduced ability to differentiate into adipocytes as compared 
to the WT mice.  Q-PCR results showed E145K had lower levels of expression 
of adipocyte transcription factors and mature adipocyte markers as compared 
to WT fibroblasts when induced to differentiate into adipocytes.   
Adipose tissue is divided into specific regional depots with differences 
in structural organization, cellular size and biological function [115, 285].  The 
two main types of adipose tissues are white adipose tissues (WATs) and 
brown adipose tissues (BATs).  The main WATs are abdominal subcutaneous 
tissue (SAT) and visceral adipose tissue (VAT).  VATs surrounds the inner 
organs and can be divided into omental, mesenteric, retroperitoneal 
(surrounding the kidney), gonadal (attached to the uterus and ovaries in female 
and epididymis and testis in men) and pericardial.  The omental depot starts 
near the stomach and spleen and can expand into the ventral abdomen, while 
mesenteric depot is attached in a web-form to the intestine.  The gluteofemoral 
adipose tissue is the SAT located to the lower body parts and is measured by 
hip, thigh and leg circumference.  WAT can also be found intramuscularly.  
On the other hand, BATs is found above the clavicle and in the supscapular 
region [285].   
We extracted pre-adipocytes from different adipose depots, namely 
SAT and gonadal adipose tissues.  These pre-adipocytes were differentiated 
into adipocytes in vitro and were extracted at different time points.  While the 
results are still preliminary, data indicated a reduction in expression of 
adipogenic transcription factors as well as mature adipocyte markers in the 
E145K pre-adipocytes as compared to WT controls.  Oil-red-O staining data 
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indicate a reduction in adipocyte differentiation occurring in the E145K pre-
adipocytes as compared to control WT mice.   
While it is likely that there is a defect in the adipocyte formation in the 
E145K mice, it is important to ensure that the reduction in weight and fat mass 
in the mice is not because of increased breakdown of fats.  This can be done 
by analyzing the serum obtained from the mice to check for levels of lipids 
and any other components that could indicate the increased breakdown of 
adipocytes in the system.  These experiments are still on-going in the lab.  In 
addition, it would also be useful to investigate the metabolic activity of the 
mice in the Oxymax/Comprehensive Lab Animal Monitoring System 
(CLAMS) system at a younger age.   
While the E145K pheonotype in mice are somewhat different from the 
actual disease symptoms in human patients, the fibroblasts showed extensive 
lobulation and centromere clustering.  However, an interesting phenotype 










Chapter 7: General Discussion and Conclusion 
In this thesis, the role of the Lmna gene as a potential contributing 
factor to the ageing process was examined. In particular I investigated how 
specific mutations in the LMNA lead to accelerated ageing or Progeria using 
the Lmna9 mouse line, a novel E145K mouse line and in vitro studies using 
fibroblasts and iPS cells derived from HGPS patients.  In the Lmna9 mouse 
,expression of Lmna9 in smooth muscle cells and the effects of SUN1 
knockdown were examined.  Extensive studies were also performed on a novel 
mouse line E145K that showed evidence of accelerated ageing. These studies 
were complemented by in vitro studies on patient derived HGPS fibroblasts 
that were used to produce iPS cells. From these iPS lines lineage specific 
VSMCs were differentiated to study the effects of Progerin on these cells. 
These effects were also studied by expressing Progerin in commercially 
available VSMCs.   
 
7.1  The Lmna9 Mouse Model 
The Lmna9 mutation in mice causes an in-frame deletion of 40 amino 
acids from exon 9, resulting in the expression of a truncated Lamin A protein 
that retains the farnesyl group, and therefore this mutation resembles Progerin 
(or 50), although Lmna9 is expressed at low levels than Progerin.  
Homozygous Lmna
9/9 
 mice exhibit a phenotype similar to HGPS patients in 
which they age prematurely, die within 3 to 4 weeks after birth, exhibit 
abnormal dentition, hyperkeratosis, decreased bone density, poor muscle 
development and/or atrophy[153].  Through microarray studies, it was 
determined that the ECM was disrupted with many components being sharply 





compared to age-matched WT controls[144] .  The decrease in ECM in the  
Lmna
9/9 
was associated with defective Wnt signaling as a result of reduced 
Lef1 levels, compared to WT controls.  These findings (Altered ECM 
synthesis-LEF1 reduction) were also exhibited in HGPS cells, suggesting a 
possible combination of molecular pathways common to both the Lmna9  
and HGPS (G608G) mutations.  Significantly, when tunel assays, to measure 
apoptosis, were performed on major vessels in the mice, extensive regions of 
apoptotic cells were observed in the vascular smooth muscle in the Lmna
9/9 
mice.  This is a significant, as HGPS patients can show a decrease vascular 
smooth muscle cellularity. Smooth muscle cells are major contributor of ECM, 
and occurrence of increased numbers of apoptotic cells in the VSMC of 
Lmna
9/9  
motivated us to create a mouse in which Lmna9 was specifically 
expressed in SMCs.  We wished to investigate if the specific expression of 
Lmna
9/9  
in SMC alone would be sufficient to cause an accelerated ageing 
phenotype in mice.  
 
As expected the tissue specific expression of Lmna9  in SMC resulted 
in a significant reduction in longevity.  Mice expressing a single allele of 
Lmna9 specifically in the SMCs, survived for 2 months, showed a reduced 
growth rate and exhibited a slight waddling gait.  Specificity of the SM22α-
CreKI mice was verified using the mT/mG reporter mice.  
Immunofluorescence analysis of Lmna expression in SMC-containing tissue 
sections ,such as the stomach, from the Lmna
9/-
SM22α-cre+/- verified the 
specificity of the of the cre line.  Relevant controls included in the study 
confirmed that the early death of the mice is maybe due to the expression of 
Lmna9 in the SMC.  Subsequently, we investigated the transcript levels of 
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ECM factors in the arteries of the original Lmna
9/9  
mice and found that the 
expression levels of some specific ECM proteins such as Elastase I, Elastin, 
Fibrillin, Collagen Types I, II, III, IV and IV  were significantly lower 
compared to control mice. A reduction in the expression levels in components 
of the canonical Wnt signaling pathway were also noted. 
 
 These results are intriguing because in another mouse line in which 
Lmna
9 
was expressed specifically in the skeletal system by using Collagen 
Type II –Cre line, the mice showed only slight growth retardation, without any 
effect on the lifespan of the mice (L. Hernandez unpublished). Importantly, 
these results indicate the importance of the tissue specificity of the Lmna
9 
mutation and how this affects the overall phenotype of the mice.   
7.2 Amelioration of Lmna
9/9 
Phenotype by Loss of SUN1
 
  The LINC complex has important roles in regulating nuclear and 
cytoskeletal interactions, by providing vital functional roles in nuclear 
positioning and chromatin organization.  Initially, it was expected that deletion 





would result in a more severe pathological phenotype than that seen in the 
Lmna
9/9 
mice.  Unexpectedly, the deletion of SUN1 in Lmna
9/9   
mice 




mice was greater compared their Lmna
9/9 
siblings  In addition, the lifespan of 
the double null mice was significantly extended, with the majority living more 
than twice as long as the Lmna
9/9 





also showed improved proliferation compared to Lmna
9/9 
fibroblasts . In the Lmna
9/9 
fibroblasts, SUN1 was localized to the NE 
although some was also redistributed to the Golgi.  When HGPS fibroblasts 
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and control fibroblasts were immunostained for SUN1 many HGPS nuclei 
exhibited a more intense signal compared to normal fibroblasts.  This result 
was consistent with increased SUN1 levels being detected by western analysis 
and  was supported by an additional report describing SUN1 accumulation in 
HGPS cells [250].  Since SUN1 protein is both increased, as well as being 
mislocalized,in the cells from Lmna
-/-
 and Lmna
9/9 mice, this has led to the 
suggestion that laminopathies, may in part be caused by disruption of 
organelle function (Golgi) due to disrupted SUN1 expression [265]. 
7.3 In Vitro Studies on Human HGPS cells 
In vitro studies on HGPS VSMC were performed using two 
approaches.  In the first system, we compared previously established induced 
pluripotent stem cells (iPSCs) from both HGPS and control patient fibroblasts.  
These iPSCs were differentiated into the different embryonic lineages that 
give rise to VSMCs to determine whether VSMCs from a particular lineage 
were more susceptible to the effects of Progerin than other lineages, since 
VSMCs from the different lineages give rise to different parts of the great 
vessels.  The second approach was to use commercially available smooth 
muscle cells and stably transfect them with inducible vectors to express either 
exogenous LMNA or Progerin. This approach was also used to express BirA* 
ligase tagged LMNA or Progerin, to determine if the Lamin-Progerin protein 
interactome differed.  
Characterization of the VSMCs derived from the differentiated iPSCs 
was performed by quantifying transcript levels of early markers of mesoderm 
differentiation, markers of SMCs and nuclear envelope proteins.  While, 
LMNA transcript levels increased following differentiation and confirmed by 
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co-staining for Progerin and SUN1, we observed that the cells expressing 
higher levels of SUN1 in their nuclei were the same cells expressing high 
levels of Progerin.  This observation supported the findings that we previously 
reported that there was increased SUN1 expression in fibroblasts derived from 
HGPS patients compared to fibroblasts from normal individuals. More 
significantly, preliminary 3T3 proliferation assay suggested that the VSMCs 
derived from HGPS-iPS lines had a lower proliferation rate in general, 
compared to VSMCs derived from normal-iPS lines.  In the HGPS-VSMCs, 
we also observed that, the latero-mesodermal (LM) lineage has the slowest 
proliferation rate compared to the paraxial mesodermal (PM) and neural crest 
NE derived lines.  This is intriguing because the aortic root, which is a 
common site for vascular defects in the great vessels to arise, is derived from 
the PM.  
Although work on these in vitro studies is still ongoing, they provide a 
useful basis for future investigations such as determining the molecular 
differences between the three different lineages from which VSMCs are 
derived, whether blood vessel formation is disrupted by Progerin using 3D re-
construction and more potentially to establish a system for the screening of 
drugs that may ameliorate the effects of Progerin. While the testing of 
potential drugs for HGPS is undeniably useful, these platforms may 
potentially be applicable for testing drugs that target cardiovascular and 
atherosclerotic disease.   
7.4 Analysis of a Novel Progeric Mouse Model 
Homozygous E145K mice are growth retarded compared to their 
heterozygous and wildtype siblings.  On an average, they stopped gaining 
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weight from 3-4 months onwards and progressively lost weight over time 
before dying at 1 year.   
Proliferation rates of the homozygous E145K fibroblasts were slower 
compared to fibroblasts derived from wildtype littermates.  Lamin A, Lamin 
B1 and Lamin B2 immunofluorescence staining in E145K showed extensive 
lobulation in the nuclear envelope.  H3K9me3 and centromeres 
immunofluorescence staining were enriched in the central region of the E145K 
 
nuclei, while it is enriched throughout the nuclear periphery and in 
perinucleolar regions in control MAFs.  E145K MAFs at late passage show 
reduced protein expression of Lamin C and Lamin B1 consistent with the 
reduction in Lmnb1 levels that occurs as cells enter into senescence [275, 286].   
One potentially interesting observation made from the whole-body 
necropsy was the extensive reduction of white fat in all depots in the E145K 
mice.  At 8 months, male E145K homozygotes had significantly reduced 
levels of fat compared to their age-matched wildtype controls.  However, no 
significant differences were observed between percentage of lean (muscle) 
mass between E145K homozygotes and controls, suggesting the mice were not 
cachexic.  This suggests that the reduction in weight is specifically caused by 
the reduction in fat mass and not muscle mass.  E145K homozygotes 
consumed similar amounts of regular chow diet and fluid compared to the 
wildtype controls. Male E145K
 
mice consumed more oxygen compared to the 
wildtype controls and displayed a higher basal metabolic rate (BMR) 
compared to their normal siblings.  These findings provide preliminary 
evidence that the E145K mutation results in an increase in the whole body 
metabolism. Whether this has any effect on their reduced lifespan is unclear, 
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although it may be consistent with the hypothesis that an increase in 
metabolism accelerates ageing[287, 288].  
E145K homozygote fibroblasts differentiated into adipocytes to a 
lesser extent compared to WT controls of differentiated fibroblasts.  
Adipogenic factors were also expressed to a lower extent in the E145K pre-
adipocytes compared to WT controls. Preliminary results from the Oil-Red-O 
staining of the fibroblasts, from both subcutaneous and gonadal fat depot 
suggested that adipogenesis is reduced in E145K cells. Transcriptional 
analysis of adipogenic markers revealed that both male and female E145K 
homozygotes expressed lower levels of both early and mature adipogenic 
markers compared to the controls so suggesting that the reduced levels of fat 
are due to some intrinsic, rather systemic, defect in the mice.  However, these 
experiments will need to be repeated for confirmation and to understand what 
is happening in the E145K mice. Future experiments will include analysis of 
mitochondrial and metabolic function in the E145K cells. 
The E145K mutation is unique compared to the other mutations found 
in the classical HGPS patients because of its occurrence in exon 2 which is 
located in segment 1B of the central rod domain of LA/C protein, a region 
completely removed from the C-terminal globular domain where most 
progeri/progeric mutations have been mapped.  Analysis of the E145K mouse 
model will provide novel and intriguing insights, as to how and which 







While accelerated ageing models might not fully recapitulate normal 
ageing process, the study of ageing through the use of accelerated models such 
as mouse models and human in vitro models described here have provided 
insights into potential factors that affect ageing.  In this case, the focus on 
smooth muscle cells has shown how mutations in the LMNA gene specifically 
diminish VSMC integrity and growth/survival and that this maybe a 
significant factor in causing, accelerated ageing which may also affect other 
tissues. Although these studies have focused on Progeria/Progeric phenotypes, 
the importance of VSMCs can be extended to more widespread diseases such 
as vascular arteriosclerosis, and is one of the main causes of death in the 
world. The mouse models and the development of a reproducible in vitro 
model of vascular degeneration may also provide new routes to develop drug 
screens for new therapeutic discoveries such as the amelioration of vascular 
degeneration.  In particular more effort should be performed on determining 
how increased levels of SUN1 contribute to the overall pathology and what 
role the LINC complex has in disease.  Similarly, preliminary analysis of the 
E145K mutation has provided unexpected insights as to the existense other 
pathways that may potentially contribute accelerated ageing.   
Finally, the above studies highlight how different mutations within a 
single gene (LMNA) result in different types of disease.  These studies 
reinforce the notion that although the lamins are strutural proteins, their role in 
the nucleus is still poorly understood. However this role(s) is potentially of 
some sophistication given that often a single missense mutation has a very 
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tissue specific effect, a feature that is surprising given how widely the Lamins 
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